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Conjugated polymer nanoparticles (CP NPs) have emerged as an 
attractive fluorescent probe in bioimaging as well as other biological 
applications due to their large absorption coefficient, high brightness, good 
photostability and low cytotoxicity, which are even superior to the 
conventional fluorescent probes (e.g. organic dyes and quantum dots). 
Currently, CP NPs have been mainly fabricated through emulsion method and 
precipitation approach. Unfortunately, CP NPs prepared by these strategies are 
mainly built up through the hydrophobic or π-interaction between CP chains 
or CP/matrices, which could lose their structural stability in aqueous media. In 
this thesis, several strategies have been developed to improve the structural 
and mechanical stability of CP NPs to facilitate their bioimaging applications. 
Firstly, CP NPs with covalent cross-linked surfaces have been 
synthesized via click reaction between CPs and hyperbranched polyglycerol in 
miniemulsion. Secondly, CP embedded silica NPs with a SiO2@CP@SiO2 
structure have been fabricated by combination of a precipitation approach and 
a modified Stöber method. Thirdly, a micelle/silica co-protection strategy has 
been developed to yield CP loaded NPs with a high fluorescence quantum 
yield and a large two-photon action cross section in aqueous medium. The 
obtained CP NPs show good performance in both cellular and vascular 
imaging. On the other hand, CP NPs with strong near-infrared absorbance and 
high non-radiative fluorescence quantum yield have also been designed for 
photoacoustic imaging, broadening the applications of CP NPs in bioimaging. 
viii 
LIST OF TABLES 
Table 2.1 Reaction Parameters and the Optical Properties of the Water-
Dispersible CP-HPG NPs.
[a]
 ............................................................................ 47 
Table 3.1 Characterization of SiO2@CP@SiO2 NPs. ..................................... 68 
Table 4.1 Emission decay components of PFBT-F127-SiO2 NPs and PFBT-
















LIST OF FIGURES 
Figure 1.1 FE-TEM image of poly(para-phenylene) NPs prepared with SDS 
as the emulsifier (A)
[58]
 and CP NPs prepared with PVA as the emulsifier 
(B).
[59]
 Copyright 2002 and 2009 John Wiley and Sons. ................................... 8 
Figure 1.2 (A) SEM image of poly(phenylene ethynylene) NPs.
[70]
 (B) AFM 
images of MEH-PPV NPs.
[71]
 Copyright 2002 Royal Society of Chemistry and 
2006 American Chemical Society. .................................................................. 12 
Figure 1.3 Fluorescence images of live (A) and fixed (B) cells. A) BALB/C 
3T3 cells were incubated sequentially with PPE NPs (green) and Hoechst dye 
(blue). B) Live BALB/C 3T3 cells were incubated with PPE NPs and fixed for 
confocal microscopic study.
[72]
 Copyright 2007 John Wiley and Sons. .......... 17 
Figure 1.4 Confocal images of MCF-7 (A) and NIH/3T3 cells (B) incubated 
with folic acid-functionalized CP NPs.
[59]
 Copyright 2009 John Wiley and 
Sons. ................................................................................................................. 18 
Figure 1.5 Confocal images of live MCF-7 cells incubated sequentially with 
anti-EpCAM primary antibody and PFBT NP-IgG conjugates (A), and PFBT 
NP-IgG conjugates only (B).
[89]
 Copyright 2010 American Chemical Society.
.......................................................................................................................... 21 
Figure 1.6 (A) Ex vivo fluorescence imaging of healthy brains in wild-type 
mice and medullo blastoma tumors in ND2:SmoA1 mice. Each mouse was 
injected with either PFBT/ PFDBT NP (top), or PFBT/PFDBT-CTX NP 
(middle). Control: no injection (bottom). (B) Biophotonic images of resected 
livers, spleens, and kidneys from wild-type (middle) and ND2:SmoA1 (bottom) 
mice receiving PFBT/PFDBT-CTX NP injection. Control: no injection 
(top).
[84]
 Copyright 2011 John Wiley and Sons. .............................................. 22 
Figure 1.7 Effects of various ions on the fluorescence intensity of solution 
containing PFBT NP and PFVT/PFTBT NP.
[86]
 Copyright 2011 American 
Chemical Society ............................................................................................. 25 
Figure 1.8 (A) The schematic illustration of pH sensitive CP-FITC NPs. (B) 
Fluorescence spectra of CP-FITC NPs at different pH.
[82]
 .............................. 25 
Figure 1.9 (A) SEM images of PFO/doxorubicin NPs. (B) A schematic 
illustration of the component of NPs and uptake of NP by cells.
[108]
 Copyright 
2010 American Chemical Society. .................................................................. 28 
Figure 1.10 (A) Chemical structures of CP and photosensitizer TPP. (B) A 
schematic illustration of NP formulation. (C) AFM image of CP/TPP co-
encapsulated NPs. (D) Normalized UV-vis and PL spectra of PDHF NPs 
doped with 10% of TPP as well as that of pure PHDF NPs.
[112]
 Copyright 2011 
Royal Society of Chemistry. ............................................................................ 30 
x 
Figure 1.11 (A) FE-TEM images of PPy NPs. (B) The temperature evolution 
of PPy NPs at different concentrations.
[120]
 Copyright 2012 Royal Society of 
Chemistry. ........................................................................................................ 33 
Figure 2.1 FT-IR spectra of HPG, HPG-Alk, PFBT-N3 and CP-HPG-1. ....... 46 
Figure 2.2 (A) Hydrodynamic radius distribution and (B) FE-TEM image of 
CP−HPG-1. UV−vis absorption (dashed line) and emission (solid line) spectra 
(C) of PFBT−N3 in dichloromethane and CP−HPG−1 in aqueous solution (λex 
= 450 nm). The inset shows the aqueous solution of CP−HPG-1 NPs under 
daylight (left) and 365 nm UV light illumination (right). ................................ 48 
Figure 2.3 Hydrodynamic radius distribution of (A) CP–HPG–2, (B) CP–
HPG–3, (C) CP–HPG–4 and (D) CP–HPG–5. ................................................ 48 
Figure 2.4 Photograph of HPG–Alk (left), PFBT–N3 (middle), and CP–HPG 
NPs (right) in the mixture of water and chloroform. ....................................... 50 
Figure 2.5 FE-TEM image of CP–HPG–6 NPs. ............................................. 51 
Figure 2.6 pH (A), NaCl concentration (B), BSA and γ-globulin concentration 
(C) dependent fluorescence intensity ratio (I/I0), where I0 is the emission 
intensity of CP-HPG-1 in aqueous solution at pH 6.8 without addition of NaCl, 
BSA and γ-globulin, and I is the emission intensity of CP-HPG-1 in aqueous 
solution at different (A) pH or (B) different concentrations of NaCl, (C) BSA 
and γ-globulin. (D) Radiation time dependent fluorescence intensity ratio (I/I0) 
of CP-HPG, Alexafluo 488, and fluorescein, the radiation was provided by 
confocal laser, where I0 and I are the emission intensity of fluorescent probe 
without and with radiation for different time, respectively. ............................ 53 
Figure 2.7 (A) Cell viability of MCF-7 cells after incubation with CP−HPG-1 
at different concentrations for 24 and 48 h, respectively. Confocal 
fluorescence image of MCF-7 cells upon incubation (B) with and (D) without 
CP−HPG-1 ([RU] = 1 μM) for 2 h. (C) 3-D confocal image of cell line MCF-7 
incubated with CP-HPG-1 for 2 h. ................................................................... 55 
Figure 3.1 (A) Normalized UV-vis absorption (dashed line) and PL spectra 
(solid line) of SiO2@CP@SiO2 NPs in water. (B) Photographs of 
SiO2@CP@SiO2 NP suspensioin in water under a hand held UV lamp (excited 
at 365 nm). ....................................................................................................... 68 
Figure 3.2 FE-TEM images of SiO2@PFBT@SiO2 NPs taken at different 
reaction times after adding TEOS (A-E) as well as APTES (F). All images 
share the same scale bar as that in F. ............................................................... 70 
Figure 3.3 FE-TEM images of PFBT dots in ethanol/water mixture (v/v = 9:1) 
upon sonication. ............................................................................................... 72 
Figure 3.4 FE-TEM images of the mixture of SiO2 NPs and CP dots before 
APTES addition (A) and further reaction for 12 h in the presence of APTES 
(B). ................................................................................................................... 72 
xi 
Figure 3.5 FE-TEM images of SiO2@PFBT@SiO2 NPs with the addition of 
APTES (upper row; A, B) or TEOS (bottom row; C, D) for further 12 h 
reaction followed by centrifuging once (A, C) and five times (B, D). The 
insets show the respective photographs of SiO2@PFBT@SiO2 NPs after 
centrifugation. All images share the same scale bar as that in D. .................... 73 
Figure 3.6 Confocal fluorescence images of SKBR-3 breast cancer cells after 
2 h incubation with (A) SiO2@PFBT@SiO2-pep and (B) SiO2@PFBT@SiO2-
COOH NP suspensions at 100 μg·mL-1 NPs at 37 °C. Confocal fluorescence 
images of NIH/3T3 fibroblast cells after 2 h incubation with (C) 
SiO2@PFBT@SiO2-pep and (D) SiO2@PFBT@SiO2-COOH NP suspensions 
at 100 μg mL-1 NPs at 37 °C. All images have the same scale bar as that in A.
.......................................................................................................................... 78 
Figure 3.7 (A) CLSM fluorescence image of SKBR-3 breast cancer cells 
without incubation with SiO2@PFBT@SiO2 NPs. (B) 3D CLSM fluorescence 
image of SKBR-3 breast cancer cells incubated with SiO2@PFBT@SiO2-pep 
NPs. .................................................................................................................. 79 
Figure 3.8 Flow cytometry histograms of pure SKBR-3 breast cancer cells 
without NP incubation (black) and SKBR-3 breast cancer cells after 2 h 
incubation with SiO2@PFBT@SiO2-Pep NP (red) and SiO2@PFBT@SiO2-
COOH NP (blue) suspensions at 100 μg·mL-1 NPs. ........................................ 79 
Figure 3.9 (A) Metabolic viability of SKBR-3 breast cancer cells after 
incubation with SiO2@PFBT@SiO2-pep at various NP concentrations for 24 h 
(gray) and 48 h (shadow). (B) Photostability of SiO2@PFBT@SiO2-pep NPs, 
PFBT NPs and fluorescein in SKBR-3 breast cancer cells upon continuous 
laser excitation at 488 nm for 10 min. I0 is the initial fluorescence intensity 
and I is the fluorescence intensity of the sample at different time points after 
illumination. ..................................................................................................... 80 
Figure 4.1 (A) UV-vis (dash-dotted line) and PL (solid line) spectra of PFBT-
F127-SiO2 NPs (red) and PFBT-DSPE NPs (black) at 25 µg/mL of PFBT. (B) 
Fluorescence decay curves of PFBT-F127-SiO2 NPs (red) and PFBT-DSPE 
NPs (black). Instrument response (IRF) (blue) is also indicated. FE-TEM 
images of PFBT-F127-SiO2 NPs (C) and PFBT-DSPE NPs (D). ................... 94 
Figure 4.2 The DLS size evolution of PFBT-F127-SiO2 NPs in 10 days. ...... 97 
Figure 4.3 (A) UV-vis (dashed) and PL (solid) spectra of PFBT loaded F127 
NPs with (red) and without (black) silica layers, respectively. (B) 
Photostability of PFBT loaded F127 NPs with and without the protection silica 
layer upon continuous laser excitation at both 405 nm and 488 nm with 100% 
light confluence, where I0 is the initial fluorescence intensity and I is the 
fluorescence intensity of the sample at different time points after illumination.
.......................................................................................................................... 97 
Figure 4.4 Histograms of the total number of photons collected for (A) PFBT-
F127-SiO2 NPs, (B) PFBT-DSPE NPs and (C) QD655. Note the different 
binning and scales for A, B and C, λex = 488 nm for all samples. ................... 99 
xii 
Figure 4.5 (A) PL intensity evolution of PFBT-F127-SiO2 NPs upon 
incubation with 1 × PBS at 37 °C for different times, where I0 is the 
fluorescence intensity at 545 nm for the fresh NP suspension and I is that for 
NPs after incubation for different time, respectively. The inset shows the PL 
spectra of freshly prepared PFBT-F127-SiO2 NPs (black) and after 10 days 
incubation with 1 × PBS at 37 °C (red). (B) Metabolic viability of NIH/3T3 
fibroblast cells after incubation with PFBT-F127-SiO2 NP suspensions at 
various NP concentrations for 24 h and 48 h, respectively. ........................... 100 
Figure 4.6 TPA spectra of PFBT-F127-SiO2 NPs (based on CP chain 
concentration) and Evans blue in water. ........................................................ 102 
Figure 4.7 Intravital TPFI of PFBT-F127-SiO2 NPs stained blood vessels of 
mice brain at depth of 0 µm (A), 50 µm (B), 100 µm (C), 200 µm (D), 300 µm 
(E), 400 µm (F) and 500 µm (G), and the respective Z-projected image (H) as 
well as 3D image (I). All the images share the same scale bar of 50 µm. ..... 103 
Figure 4.8 Images of intravital TPFI of brain blood vessels in mouse without 
injection of PFBT-F127-SiO2 NPs. The scale bar is 50 µm………………  104  
Figure 5.1 (A) UV-vis absorption spectra and (B) PA imaging as well as the 
PA intensity of PFTTQ NPs and Au NRs with same mass, the scale bar is 100 
µm. (C) The PA intensity of PFTTQ NPs at concentrations from 0.05 mg/mL 
to 0.5 mg/mL. ................................................................................................. 122 
Figure 5.2 (A) UV-vis absorption spectra and (B) PA imaging as well as the 
PA intensity of PFTTQ NPs and Au NRs, the scale bar is 100 µm. .............. 124 
Figure 5.3 (A) Absorbance intensity evolution of PFTTQ NPs and Au NRs 
upon continuous pulse laser irradiation with a power of 15 mJ/cm
2
 for 
different times, where I0 is the absorbance intensity at 800 nm for the fresh NP 
suspensions and I is that for NPs after irradiation for different time, 
respectively. (B) UV-vis absorption spectra of PFTTQ NPs and Au NRs 
before and after laser irradiation with a power density of 15 mJ/cm
2
 for 6 mins. 
FE-TEM images of PFTTQ NPs (C) and Au NRs (D) before (1) and after (2) 
laser irradiation for 6 mins. All images share the scale bar of 100 nm.......... 126 
Figure 5.4 Metabolic viability of NIH/3T3 fibroblast cells after incubation 
with PFTTQ NP suspensions at various NP concentrations for 24 h. ........... 127 
Figure 5.5 (A) Schematic illustration of PA imaging for rat brain vasculature. 
(B) PA rat cortical vasculature C-scan images before and after 10 mins 
injection of PFTTQ NPs. (C) The evolution of the integrated PA intensity at 






LIST OF SCHEMES 
Scheme 1.1 Chemical structures of representitive CPs used in devices and 
luminescence. ..................................................................................................... 4 
Scheme 1.2 Schematic illustration of Jablonski diagram. IC stands for internal 
conversion, ISC stands for intersystemm crossing, S0 stands for ground singlet 
state, S1 stands for first excited singlet state, Sn stands for higher excited 
singlet state, T1 stands for excited triplet state. .................................................. 5 
Scheme 1.3 Schematic illustration of CP NPs prepared with emulsion method 
(A), precipitation approach (B) and cross linking approach (C). ...................... 8 
Scheme 2.1 Schematic illustration of the preparation of CP-HPG NPs. ......... 45 
Scheme 3.1 Chemical structures of four CPs used in this study. .................... 67 
Scheme 3.2 Schematic illustration of the synthesis of SiO2@PFBT@SiO2 NPs 
with surface functionalized targeting peptide. (A) Sonicatioin of a THF 
solution of CPs in ethanol/water mixture (v/v = 9:1) affords single CP chain 
dots. (B) Addition of TEOS and ammonia into the CP dots dispersed solution 
leads to the formation of CP dots-punctuated silica NP pattern after reaction. 
(C) Further addition of APTES into the mixture results in CP dots embedded 
silica NPs with surface functionalized amine groups. (D1) Surface 
carboxylation with maleic anhydride in the presence of Et3N. (D2) Peptide 
conjugation via EDC/NHS reaction. ................................................................ 75 
Scheme 3.3 The chemical structure of peptide, GGHAHFG. ......................... 76 
Scheme 4.1 (A) Chemical structure of F127 and PFBT. (B) Schematic 
illustration of the fabrication of PFBT-F127-SiO2 NPs. .................................. 93 
Scheme 5.1 Synthetic route and chemical structure of PFTTQ. Reagents and 
conditions: I) KOH, 1-bromohexane, H2O, 100 
o
C, 1 h; II) CuI, Pd(PPh3)2Cl2, 
trimethylsilylaceylene, i-Pr2NH/THF, room temperature, overnight; III) KOH, 
THF/MeOH/H2O, room temperature, 1 h; IV) CuI, Pd(PPh3)2Cl2, 1, i-
Pr2NH/THF, room temperature, overnight; V) KMnO4, NaHCO3, TBAB, 
CH2Cl2, room temperature, 2 days; VI) H2SO4, HNO3, 100 
o
C, overnight; VII) 
Pd(PPh3)2Cl2, 2-(tributylstannyl)thiophene, THF, 80 
o
C, overnight; VIII) NBS, 
DMF, 60 
o
C, 3 h; IX) i) Iron, acetic acid; ii) acetic acid, 135 
o
C, 24 h; X) 
Pd(OAc)2, Cy3P, Et4NOH, toluene, 18 h. ...................................................... 119 
Scheme 5.2 Schematic illustration of the fabrication of PFTTQ NPs using 
DSPE-PEG2000 as the matrix through a precipitation method. ...................... 121 
Scheme 5.3 Experimental setup of the PAM system. The pulled tubing was 
filling with the venous samples in the focusing depth. The laser was pulsed 
with a pulse repetition rate of 10 Hz and coupled by a lens to an optical fiber 
to illuminate samples. PA waves were detected with a 50-MHz transducer and 
then through the A/D card to the PC for further data analysis. ...................... 122 
xiv 
 LIST OF SYMBOLS 
APTES 3-aminopropyl triethoxysilane 
Au NRs gold nanorods 
BSA bovine serum albumin 
CLSM confocal laser-scanning microscopy 
CMC critical micelle concentration 
CP conjugated polymer 
CPEs conjugated polyelectrolytes 




DLS dynamic light scattering 
DMDES dimethyldimethoxysilane  
DMEM Dulbecco’s Modified Eagle Medium 
DMF dimethylformamide 
DMSO dimethyl sulfoxide 
DSPE-PEG2000 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-2000] 
EPR enhanced permeability and retention 
FBS fetal bovine serum 
F127 poly(ethylene oxide)-block-poly(propylene oxide)-
block-poly(ethylene oxide) 
FE-TEM field emission transmission electron microscopy 
FITC fluorescein isothiocyanate 
FRET förster resonance energy transfer 
FT-IR fourier transform infrared 
xv 
GPC gel permeation chromatography 
HA 5-hexynoic acid 
HPG hyperbranched polyglycerol 
IC inter conversion  
ICG Indocyanine green 
LLS laser light scattering 
MRI magnetic resonance imaging 
NMR nuclear magnetic resonance 
NIR near infrared 
NPs Nanoparticles 
PA Photoacoustic 
PAM photoacoustic microscopy 
PAE photoacoustic endoscopy 
PAT photoacoustic computed tomography 
PBS phosphate buffer saline 
PDI polydispersity index 
PEG polyethylene glycol 
PET positron emission tomography 
PL photoluminescence 
PLGA poly(lactide-co-glycolide) 
PVA poly (vinyl alcohol) 
QDs quantum dots 
QY quantum yield 
RU repeat unit 
S0 ground state 
S1 first singlet excited states 
SDS sodium dodecyl sulphate 
xvi 
T1 first triplet excited states 
TEOS Tetraethsilane 
THF Tetrahydrofuran 
TPA two-photon absorption 
TPFI two-photon fluorescence imaging 
 radiative decay rate 
knr non-radiative decay rate 
 quantum yield 








Biological imaging is one of the most important techniques to study 
the fundamental issues in life science and solve the practical problems in 
clinical diagnosis and therapy.
[1-4]
 It helps researchers to observe the objects 
and investigate fundamental biological processes from the macroscopic level 
to microscopic range and further to the sub-cellular scope. So far, various 












 have been widely utilized to achieve reliable and 
accurate biodetection and bioimaging. Among these strategies, the 
fluorescence imaging technique has emerged as an essential strategy in 
biosensing as well as bioimaging due to their non-invasive, high temporal-
spatial resolution and real time properties.
[18-22]
 The precise and accurate 
analysis of the targets from bimolecular level to cellular and tissue stages 
usually depends on the performance of exogenous fluorescent reporters in 
biological system. As a result, fluorescent probes with high fluorescence QY, 
good photostability, low cytotoxicity and easily functionalized groups in 
aqueous or biological environment are highly desirable for biological 
scientists.  
Organic dyes, the conventional versatile fluorophores, have been 
widely utilized in bioimaging and biodetection.
[16,23]
 Advances in the progress 
Chapter 1 
2 
of organic chemistry and material science have facilitated the synthesis and 
design of numerous organic fluorophores, including rhodamine, alexa, 
BODIPY and cynanine dyes. Unfortunately, these organic fluorophores 
usually show poor photostability and narrow Stokes shift, which hamper their 
applications in bioimaging with high sensitivity and resolution. Although 
encapsulation of organic fluorophores into matrices could improve their 
stability, the intrinsic narrow Stokes shift could not be solved. In this respect, 
inorganic quantum dots (QDs) have shown large Stokes shift, good 
photostability and high brightness.
[20,24]
 However, their intrinsic toxicities 
from heavy metal components also limit their practical applications in 
biological and clinical studies.
[15]
 The inherent limitations of conventional 
fluorescent materials are incentives to explore alternative fluorescent probes 
with improved performance.  
More recently, fluorescent conjugated polymer (CP) based materials 
have attracted great research interest in biological applications.
[25-29]
 CPs are 
macromolecules with delocalized π-conjugated backbones and fantastic light-
harvesting property. Fluorescent CP encapsulated nanoparticles (CP NPs) 
show large absorption coefficients, large Stokes shifts, good photostabilities, 
low cytotoxicity and high brightness, which are even superior to the 
conventional fluorescent reporters (e.g. organic dyes, QDs).
[30-34]
 The NP 
formulation could not only help to improve the fluorescence and colloidal 
stability of CPs in biological environment but also provide surface-
functionalized groups, allowing to further conjugation for specific detection or 
targeted imaging.
[35,36]
 Furthermore, fine-tuning the size and surface property 
of CP NPs would facilitate the enhanced permeability and retention (EPR) 
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effect of NPs in tumor microvasculature through passive targeting role to 
improve their performance in targeted tumor imaging.
[37-39]
 In view of the 
obvious advantages of NP formulation for CPs, various approaches have been 
developed to synthesize CP NPs and their applications in biological detection, 
imaging and therapy have been well investigated.
[30,35,40]
 In this chapter, the 
developed approaches for CP NP synthesis have been summarized firstly. 
Secondly, the applications of CP NPs in specific biological applications 
including imaging, detection and therapy have been reviewed. Finally, the 
objectives and outline of this thesis have been illustrated. 
1.2 Properties of CPs  
CPs are macromolecules with unsaturated backbones. Due to the 
highly delocalized π-electrons, CPs show distinguished conductivity or 
photoluminescence, which have been widely applied in light-emitting diodes, 
field effect transistors, photovoltaic devices
[41-45]
 as well as 
chemical/biological detection and bioimaging.
[25,26,33,46]
 Noteworthy is that 
both conductive and optical properties of CPs can be easily tuned by choosing 
suitable monomers as well as proper conjugation approaches.
[47-49]
 Specifically, 
polyacetylene (PA), polyaniline (PAN), polypyrrole (PPy) and their 
derivatives are famous for their intrinsic conductivity, while polyfluorene (PF), 
polyphenylene (PPE), poly(phenylene vinylene) (PPV), and polythiophene 
(PT) are prominent for their electro- and photoluminescence (PL). The 




Scheme 1.1 Chemical structures of representitive CPs used in devices and 
luminescence. 
The electron transfer process of CPs could be depicted with the 
classical Jablonski diagram. As shown in Scheme 1.2, the energy level of CP 
is divided into the ground state (S0), singlet excited states (S1, Sn) and triplet 
excited states (T1). Upon energy absorption, the electrons in the ground state 
are excited into higher energy levels. When electrons return to the ground state 
from the excited states, the energy could be relaxed through non-radiative and 
radiative pathways. The non-radiative pathway is divided into internal 
conversion and intersystem crossing, which is generally related with heat 
generation; while the radiative pathway involves the production of 
fluorescence or phosphorescence. In detail, the electrons in CPs are excited 
from the lowest energy level in the ground state (S0) to the higher excited 
states (S1 to Sn). The excited electrons in higher energy level could release part 
of energy and relax to the lowest energy level with singlet excited state (S1) or 
to ground state through inter conversion (IC) or change their spin to the lowest 
energy level with triplet excited state (T1). The fluorescence is produced from 
the radiation when electrons transfer from the lowest excited energy level with 
singlet state (S1) to the ground state (S0). Alternatively, phosphorescence is 
induced when electrons relax from the lowest excited energy level with triple 
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state (T1) to the ground state (S0). It is noted that the triple state energy could 
transfer to nearby molecules (e.g. oxygen) to induce singlet species. Both 
fluorescence and phosphorescence signals could be applied for detection and 
imaging in biological system. On the contrary, the excited electrons could 
release their energy through the non-radiative decay pathway, which is 
accompanied with the heat generation. This could be utilized in photothermal 
therapy. Meanwhile, the excited electrons could also induce the production of 
singlet species, which may be utilized in photodynamic therapy for disease 
treatment.  
 
Scheme 1.2 Schematic illustration of Jablonski diagram. IC stands for internal 
conversion, ISC stands for intersystemm crossing, S0 stands for ground singlet 
state, S1 stands for first excited singlet state, Sn stands for higher excited 
singlet state, T1 stands for excited triplet state. 
The photophysical properties of CPs (e.g. absorption and emission) are 
highly dependent on their chemical structures as well as 
conformations.
[25,26,50,51]
 Specifically, the backbone structure, the effective 
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conjugation length, the side chain arrangement and the packing or 
conformation of CP chains could influence the absorption, radiative and non-
radiative processes of CPs. For instance, when the interchain interaction  of a 
specific CP backbone increases, the excited electrons could find low-energy 
level to relax, resulting in obvious red-shifts of the emission spectra of  CP 
aggregates as compared with separated CP chains.
[26]
 This also means that the 
photophysical properties of CPs could be simply adjusted by chemical 
modification of their backbone and side chain structures, controlling their 
conjugation length, as well as adjusting their packing states or morphologies 
for different applications.  
 1.3 Synthesis of CP NPs  
The pioneer work of preparation of CP NPs can be traced back to 
1980s, in which CP NPs have been synthesized by direct polymerization. The 







 They have been mainly utilized in device applications. 
Although the direct polymerization method has been extended to fluorescent 
CPs, it requires either oxidative monomers or water compatible metal catalysts, 
which is hard to be widely explored into other CP systems.  
In contrast, the postpolymerization approach mainly utilizes 
commercially available polymers or the synthesized CPs to fabrication of CP 
NPs, which is facile and convenient to be applied to various types of CPs. 
Since this thesis is mainly focused on bioimaging applications of CP NPs, the 
discussion is limited to CP NPs with water solubility or dispersibility. It is 
noted to worth that there is another formulation of water soluble CPs, 
conjugated polyelectrolytes (CPEs). CPEs are macromolecules with 
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hydrophobic backbones and hydrophilic side chains, which own the property 
of polyelectrolytes.
[33,50,51,55-57]
 The synthesis of CPEs usually starts with 
sophisticated design of monomers for both backbone conjugation and side 
chain modification to render them water solubility requirement, which is 
tedious, cost, time consuming and more importantly not generic.
[36]
 On the 
other hand, the NP strategy is generally applied to various hydrophobic CPs. 
To make our discussion more concise, the NPs discussed in this thesis is 
confined to water soluble or dispersible CP NPs prepared with the 
postpolymerization approaches. 
In general, the process of CP NP fabrication involves the dissolving of 
hydrophobic CPs in the organic solvent, mixing the organic solvent with water, 
and removing the organic solvent from the mixture. Depending on miscibility 
of the organic phase and the water phase, the methods of CP NP fabrication 
are generally classified into emulsion and nanoprecipitation. In addition, there 
is another apporach, named cross-linking, which is aimed to improve the 
stability of CP NPs. 
1.3.1 Emulsion 
A typical procedure for emulsion method is shown in Scheme 1.3A. 
CPs are firstly dissolved in the organic solvent which is immiscible with water, 
while emulsifier is dissolved in the aqueous phase. These two solutions are 
mixed together, followed by rapid mixing or sonication to disperse the organic 
phase into aqueous phase. The small emulsion droplets are obtained 
simultaneously and protected by the surfactants absorbed at the interface of 
organic/water droplets. The organic solvent is subsequently evaporated to 




Scheme 1.3 Schematic illustration of CP NPs prepared with emulsion method 
(A), precipitation approach (B) and cross linking approach (C). 
 
Figure 1.1 FE-TEM image of poly(para-phenylene) NPs prepared with SDS 
as the emulsifier (A)
[58]
 and CP NPs prepared with PVA as the emulsifier 
(B).
[59] 
Copyright 2002 and 2009 John Wiley and Sons. 























by Landfester and co-workers in 2003.
[58]
 In detail, they chose poly(para-
phenylene), polyfluorene and polycyclopentadithiophenes and utilized sodium 
dodecyl sulphate (SDS) as the surfactant. Upon ultrasonication of chloroform 
solution containing CPs in the aqueous solution with SDS as the emulsifier, 
stable miniemulsion droplets have been formed. The water dispersible CP NPs 
has been obtained after chloroform evaporation. The size of CP NPs could be 
controlled from 30 to 500 nm by adjusting the initial CP concentration. A 
typical field emission transmission electron microscopy (FE-TEM) image of 
poly(para-phenylene) NPs is shown in Figure 1.1A. This approach has been 
further applied to synthesize other CP NPs, including polyfluorene, poly(2-
methoxy-5-(2-ethylhexyl)oxy)-1,4-phenyl-ene)vinylene (MEH-PPV)  and 
poly(cyclopentadithiophene).
[60]
 In addition, two types of CP co-encapsulated 
NPs have also been fabricated using SDS as the surfactant, which shows phase 
separation of two different polymers due to their different hydrophobicities.
[61]
 
Moreover, this approach has been utilized to encapsulated the förster 
resonance energy transfer (FRET) pair of two different CPs, poly(9,9-di-
octylfluorenyl-2,7-diyl) (PFO) and poly(2,5-dioctyl-1,4-phenylenevinylene) 
(POPPV). The emission of CP NPs could be manipulated by adjusting their 
respective percentages in NPs.
[62]
  
In 2009, Beneventi and co authors utilized the cationic surfactant, 
tetradecyltrimethylammonium bromide (TTAB) as an emulsifier and 2,7-
poly(9,9-dialkylfluorene-co-fluorenone) as a typical CP to study the influence 
of cationic surfactant in the CP NPs. Their study suggested that large amounts 
of TTAB segregated at the NP surface to reduce the interface tension between 
polymers and water, yielding stable CP NPs.
[63]
 Although the emulsifiers of 
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SDS and TTAB could help to synthesize water dispersible CP NPs, they could 
destroy cellular membranes due to their detergent effect, which hamper their 
applications in biological system.  
In 2009, Li et al. has developed a generic strategy to fabricate CP 
loaded poly(lactide-co-glycolide) (PLGA)  NPs through a modified solvent 
extraction single emulsion method by sonication of the mixture of 
dichloromethane (DCM) solution containing CPs as well as PLGA matrices 
using poly (vinyl alcohol) (PVA) as the emulsifier.
[59]
 The emission of PLGA 
NP suspensions could be easily manipulated by choosing suitable CPs. The 
hydrodynamic diameters of the CP NPs in water were measured to be in the 
range of 240 to 270 nm by DLS. The FE-TEM images illustrate that the 
obtained CP NPs are spherical in shape with a size ~150 nm as shown in 
Figure 1.1B. The smaller CP NP size is resulted from the shrink of polymeric 
NPs in vacuum. Although low CP concentration was presented in NP 
formulation, the obtained CP NPs showed high brightness and good 
photostability. Due to good biocompatibility of PLGA matrices and PVA 
emulsifiers, the obtained CP NPs have been successfully applied in cellular 
imaging. In addition, Li and co-workers also developed a modified emulsion 
approach using a mixture of PLGA and poly((lactic-co-glycoclic)-b-
amine(polyethylene glycol)) (PLGA-b-PEG-NH2) as co-encapsulation matrix 
to facilitate conjugation with antibodies for targeted cellular imaging.
[64]
 
Through conjugation of trastuzumab (Herceptin) at NP surfaces, efficient 
targeted cellular imaging for SKBR-3 breast cancer cells has been achieved. 
More recently, this strategy has been extended to encapsulate both CPs and 






At the same time, Green’s group reported a facile strategy to prepare 
CP NPs using polyethylene glycol (PEG) as both emulsifier and encapsulation 
matrices.
[67]
  Thanks to the highly diluted CPs in DCM, the attained CP NPs 
only show a small size of ~5 nm. Later, both block copolymer 1,2-diacyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)] (lipid-
PEG) and 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) have been 
utilized as co-emulsifier to prepare CP NPs.
[68]
 The hydrophobic lipid parts 
were embedded into CP to form a core and PEG segments oriented into water 
phase to stabilize the formed CP NPs. The obtained CP NPs had an average 
diameter of 80-100 nm in water. They further used this strategy to synthesize 





A typical scheme of the precipitation approach, also named 
reprecipitation or nanoprecipitation by different researchers, is shown in 
Scheme 1.3B. Generally, a hydrophobic CP is dissolved in a benign organic 
solvent, followed with rapid injection into a large amount of water. Upon 
vigorous stirring or sonication, CP chains rapidly collapse from organic phase 
to water phase. Subsequent evaporation of water yields the CP NPs. Unlike the 
above emulsion method, emulsifiers are not used in the precipitation approach. 
The CP NPs are mainly built up through the hydrophobic interaction between 
CP chains. When the organic solution is mixed with water, hydrophobic CP 
chains fold into spherical morphology to minimize their surface tension to 




Figure 1.2 (A) SEM image of poly(phenylene ethynylene) NPs.
[70]
 (B) AFM 
images of MEH-PPV NPs.
[71]
 Copyright 2002 Royal Society of Chemistry and 
2006 American Chemical Society. 
In 2003, Moon et al. reported the synthesis of poly(phenylene 
ethynylene) (PPE) NPs by mixing dimethyl sulfoxide (DMSO) solution 
containing (PPE) with aqueous medium.
[32]
 The obtained NPs show a diameter 
of 500-800 nm as shown in Figure 1.2A. Later, Moon and co-worker 
optimized the CP structures by conjugation of PPE with amine groups and 
obtained CP NPs with an average size of 97 nm with a polydispersity index of 
0.13.
[72]
 Using the same strategy, CP NPs with pentiptycene-containing 
poly(p-phenylene ethynylene) have also been synthesized.
[73]
 Due to the 
purification with a membrane filter, the size of CP NP was decreased to ~28 
nm characterized with laser light scattering (LLS). By grafting the side chain 
PPE with amine functionalized tartaric acid, the CP NPs have been optimized 
with a size of ~8 nm.
[74]
 In addition, the synthesized CP NPs showed good 
stability, which did not show obvious size change in 3 months.  
In 2005, McNeill and co-workers developed a novel strategy to 
synthesize CP NPs by ultrasonication of CP dissolved tetrahydrofuran (THF) 
solution in aqueous medium.
[75]
 Noteworthy is that no need to modify CP side 
A B
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chains with cationic or water soluble groups and the CP NPs could be formed 
through hydrophobic interaction between CP chains. Furthermore, the NP size 
could be fine-tuned by changing the starting CP concentration.
[71,76]
 The AFM 
image of MEH-PPV NPs prepared with this approach is shown in Figure 1.2B, 
which shows a size around 15 nm.
[71]
 The surfaces of CP NPs prepared with 
this approach could be functionalized with reactive groups by using 
poly(styrene-g-ethylene oxide) (PS-PEG-COOH) or poly(styrene-co-maleic 
anhydride) (PSMA) as co-matrices to conjugate with biological reagents for 
targeted detection or imaging, which have been widely developed by Chiu’s 
group.
[34,77-93]
 Increasing the concentration of CPs in THF solution resulted in 
the enlarged sizes of CP NPs. The comparison of the photophysical properties 
of CP NPs with that of Qdot 565 and Alexa 488 demonstrated that CP NPs 
show better photostability and high brightness than the other two, facilitating 
their biological applications.
[89]
 In addition to single CP encapsulated NPs, a 
donor CP, poly[(9,9-dioctylfluorenyl-2,7-diyl)-co-(1,4-benzo-thiadiazole)] 
(PFBT), and an acceptor CP, poly[(9,9-dihexylfluorene)-co-4,7-di(thiophen-2-
yl)-2,1,3-benzothiadiazole] (PFDBT), have been co-encapsulated into PSMA 
matrix to afford FRET based NPs.
[84]
 The obtained CP NPs show an emission 
maximum at ~650 nm with a higher QY of 0.56 (measured with 4-
(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran in 
methanol as the standard). The surface functionalized carboxyl groups could 
be conjugation with chlorotoxin (a tumour targeting peptide). In combination 
with the high brightness of near infrared (NIR) emission and low cytotoxicity, 
the FRET based CP NPs have been successfully applied in targeted brain 
tumour imaging. This FRET strategy has also been utilized to endow CP NPs 
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 as the acceptors, which open a 
new avenue for CP NPs in NIR biological imaging.  
Another type of precipitation approach is to synthesize amphiphilic 
polymers, which are composed of hydrophobic backbones and hydrophilic 
side chains. By adding a large amount of water into the THF solution of 
amphiphilic CPs, NPs with hydrophobic CP backbones as the core and 
hydrophilic side chains as the shell would be obtained. Controlling the 
hydrophobic/hydrophilic ratio of polymer, fluorescent CP NPs with various 
sizes from 85 nm to 178 nm have been synthesized as reported by Chen and 
co-workers.
[94]
 In addition, poly(fluorenylene-alt-phenylene) modified with 
lipid groups and alkylammonium groups have also been reported to  form CP 
NPs with a size about 50 nm in water.
[95]
 The same strategy has been utilized 
by Liu’s group to synthesize various types of CP NPs with strong far-red/near 
infrared fluorescence
[96,97]
 and high fluorescence QY.
[98]
 
The CP NPs prepared from both emulsion and precipitation approaches 
are mainly built up through the hydrophobic interaction between CPs or 
CPs/matrices. From the long term application perspective, these NPs are 
deficiency in stability due to the weak hydrophobic interaction. In addition, 
these CP NPs are mechanically instabilbe and cannot be redispersed in water 
after drying. To further improve the stability of CP NPs, a cross-linking 
approach has been developed.  
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1.3.3 Cross Linking 
A typical scheme for the cross linking approach is shown in Scheme 
1.3C. The cross linking method mainly involves grafting the hydrophobic 
backbones with hydrophilic side chains as well as cross linking groups. As the 
existence of functional groups at the side chains, the cross link reaction can 
occur to form a stable shell to improve the stability of CP NPs. Park, et al. 
synthesized CP backbones with azide groups at side chains.
[99]
 Followed by 
precipitation, CP chains entangled to form CP NPs in water. The formed CP 
NPs solution was further irridated with UV light, which initiated the cross 
linking reaction between azide groups. The obtained CP NPs show obvious 
improved mechanical and photophysical stabilities as compared to that 
prepared with precipitation method, which is due to the protective cross-
linking shell. Later, the same group utilized similar strategy to prepare CP NPs 
with cross linked shell using copper (І) or cucurbit[6]uril as catalysts, which 
could be potentially applied in cellular imaging.
[100]
 Although these 
approaches could greatly enhance the stability of CP NPs, the density of 
functional groups at NP surfaces is hard to control, which may hamper their 
further biological applications. 
1.4 Biological Application of CP NPs 
Accompanied by the extensive development of CP NPs, their 
biological applications have also been widely investigated. So far, their 
applications in biological system have also been mainly explored in imaging, 




CP NPs usually show large absorption coefficient, high fluorescence 
brightness, good colloidal stability and photostability, low toxicity and 
functional surfaces, which meet the harsh requirement of fluorescent probes 
for biological imaging. The bioimaging application of CP NPs could be 
divided into non-specific cellular imaging, targeted cellular imaging and in 
vivo imaging. 
The early application of CP NPs in cellular imaging was mainly 
conducted by nonspecific imaging with bare hydrophobic NPs. For example, 
in 2007, Moon and co-workers prepared PPE NPs with an average size of 97 
nm and a QY of 0.17 in aqueous medium.
[72]
 The obtained PPE NPs could 
help to stain both living and fixed cell lines through overnight incubation. CP 
NPs were found exclusively around the perinuclear region as shown in Figure 
1.3. In addition, the location of CP NPs could not overlap with the 
LysoTracker, and the uptake mechanism of these NPs by cells has not been 
investigated in this study. Another typical of CP NPs developed by Wu et al. 
has also been studied in nonspecific cellular imaging of J774A1 macrophages 
cells. The developed CP NPs without any encapsulation layer were found to 
be efficient labelling probes for cellular imaging. The high fluorescence signal 
of CP NPs could help to clearly observe the cell morphologies under confocal 
microscopy. Moreover, the CP NPs showed good overlap with LysoTracker, 
illustrating that they entered the cells through endocytosis process.
[101]
 The 
detailed mechanism has been further examined by Fernando and co-
workers.
[102]
 As the endocytosis process is highly dependent on temperature, 
the authors studied the NP uptake at different temperature. Only weak 
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fluorescence could be observed after long incubation time at 0 °C, which is 
much lower than that at 37 °C, illustrating that endocytosis plays an important 
role in NP uptake. In addition, PFBT NPs showed good overlap with the 
dextran tracker (a specific endocytosis tracker) which further confirmed the 
endosytosis mechanism. Moreover, the endocytosis involves several possible 
pathways, including clathrin-mediated endocytosis, caveolae-mediated 
endocytosis and macropinocytosis. To better understand the pathway, the 
authors further investigated the NP uptake by cells treated with various 
inhibitors, which could influence the definite pathways. The authors 




Figure 1.3 Fluorescence images of live (A) and fixed (B) cells. A) BALB/C 
3T3 cells were incubated sequentially with PPE NPs (green) and Hoechst dye 
(blue). B) Live BALB/C 3T3 cells were incubated with PPE NPs and fixed for 
confocal microscopic study.
[72]
 Copyright 2007 John Wiley and Sons. 
Another non-specific staining example using CP NPs have been 
reported by Green’s group.[67] The PEG capped CP NPs could stain HEp-2 
cells after 1 hour incubation and more efficient staining could be achieved by 




cytoplasm of cells after 24 h incubation. Noteworthy is that the fluorescence 
intensity of this CP NP did not decrease obviously upon laser irradiation for 5 
minutes at a power density of 12.5 mW/cm
2
. The same group also investigated 
non-specific cellular imaging of lipid-PEG encapsulated CP NPs,
[68]
 which 
also showed low cytotoxicity and good staining effect.
 
Besides nonspecific cellular imaging, CP NPs could be endowed with 
targeting capacity by surface conjugation with targeting molecules, such as 
proteins, or peptides. One of the earliest examples of targeted cellular imaging 
for CP NPs has been demonstrated with folic acid conjugated PPE polymer 
chains.
[103]
 As the side chains of CPs have numerous ionic carboxyl groups, 
CP NPs could be well dispersed in water. In addition, the carboxyl groups 
have been further conjugated with folic acid molecules via an amide coupling 
reaction. The folic acid conjugated CPs could enter KB cells more efficiently 
than those without folic acid conjugation.  
 
Figure 1.4 Confocal images of MCF-7 (A) and NIH/3T3 cells (B) incubated 
with folic acid-functionalized CP NPs.
[59]
 Copyright 2009 John Wiley and 
Sons. 
Another example of targeted cellular imaging has been reported by Li 




encapsulated PLGA NPs, and the CP NP surfaces could be functionalized with 
folic acid due to the existence of carboxyl acid groups at NP surfaces.
[32]
 
Taking PFVP as an example, folic acid conjugated PLGA NPs capped PFVP 
NPs (FPPFVP NPs) have been synthesized. After incubation of MCF-7 cancer 
cells with FPPFVP NP suspension for 2.5 h, bright fluorescence signal from 
NPs were detected from cell cytoplasm (Figure 1.4A). On the contrary, only 
week fluorescence was observed from NIH/3T3 fibroblast cells upon staining 
with FPPFVP NPs since lower folate groups at cell surfaces (Figure 1.4B). In 
addition, FPPFVP NPs showed almost no cytotoxicity with a concentration up 
to 2 mg/mL of NPs (700 nM of PFVP based on polymer chain), indicating that 
FPPFVP NPs have low cytotoxicity. As a result, FPPFVP NPs were able to act 
as an efficient targeting probe to discriminate folate receptors over expressed 
cancer cell lines. 
In 2010, Wu et al. reported the application of PS-PEG-COOH 
encapsulated PFBT NPs for visualizing cell surface marker (EpCAM) in 
MCF-7 cancer cell membrane.
[89]
 Thanks to the carboxyl groups at NP 
surfaces, biomolecules, such as IgG, could be grafted at NP surfaces. Taking a 
specific cellular target of EpCAM as an example, the authors demonstrate the 
specific targeting ability of CP NPs. The PFBT NPs were conjugated with IgG 
via the EDC catalyzed coupling reaction. On the other hand, the surfaces of 
MCF-7 breast cancer cells were labelled with EpCAM receptors. In the 
presence of both PFBT-IgG probes and the detection antibody, EpCAM, 
MCF-7 cancer cells could be labelled with fluorescent probe as shown in 
Figure 1.5A; while in the absence of EpCAM, PFBT-IgG probe could not 
label MCF-7 cell surfaces (Figure 1.5B). In addition, they compared the 
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labelling effect of their probes with a commercially available probe, Qdot-IgG. 
The quantitative analysis of the flow cytometry data suggested that the 
average intensity of PFBT NP-labeled cells was ~25 times brighter than the 
Qdot-IgG-labeled cells and ~18 times brighter than Alexa-IgG-labeled ones. 
As a result, the CP NPs provide a significantly higher signal-to-noise ratio 
than that of Qdots and Alexa at low excitation conditions. 
Besides immunofluorescent labelling, Wu and co-workers have also 
utilized the CP NPs for bioorthogonal labelling of targeted cells through click 
chemistry.
[85]
 Using biosynthetic approaches, the targeted biomolecules could 
be endowed with the bioorthogonal groups, which is ready for highly specific 
targeted labelling. Wu et al. utilized the amino acids of azidohomoalanine 
(AHA) and homopropargylglycine to synthesize fresh proteins in the cells, 
which possess the functional groups for click reaction. The counterpart groups 
were conjugated at the surfaces of CP NPs. Bright fluorescence have been 
detected at the AHA incubation cells after reaction with alkyne modified CP 
NPs under cobber (І) catalysts. In contrast, no cell labelling was observed for 
the cells without eating AHA amino acids. However, the existence of copper 
ion is toxic to cells, which may hinder their applications in live cellular 
imaging.  
In addition to the applications of CP NPs in in vitro cellular targeting, 
the application of such fluorescent probes in in vivo imaging has also been 
investigated. For in vivo imaging, NIR fluorescent probes are highly desirable 
due to their high penetration depth, low autofluorescence background and 
weak photodamage to biological species. The first example of CP NPs applied 





They synthesized CP NPs by in suit Knoevenagel polymerization in the 
micelles formed by Tween 80. Through choosing different monomers, CP NPs 
could show fluorescence from blue color to red color. Among these CP NPs, 
the NIR-cvPDs showed an intense NIR fluorescence with an emission peak at 
693 nm and a QY of 21%. The NIR-cvPDs NPs have been further applied into 
sentinel lymph node imaging by intradermally injected into the forepaw pad of 
mice. Their data showed that the NP could efficiently be trapped in the 
sentinel lymph nodes of the mice.  
 
Figure 1.5 Confocal images of live MCF-7 cells incubated sequentially with 
anti-EpCAM primary antibody and PFBT NP-IgG conjugates (A), and PFBT 
NP-IgG conjugates only (B).
[89]
 Copyright 2010 American Chemical Society. 





PFBT and PFDBT co-encapsulated PSMA NPs. The obtained NPs showed an 
NIR emission with a peak at 655 nm and a high QY of 56%. The NP surfaces 
were conjugated to a peptide with targeting effect, chlorotoxin (CTX), for 
targeted tumor imaging and PEG to increase the circulation time of NP in in 
vivo condition. The capability of PFBT/PFDBT-CTX conjugates to traverse 
the blood-brain barrier and specifically target a tumor was evaluated in a 
transgenic mouse model (ND2:SmoA1), which was counter-illustrated with 
wide-type mouse. It was observed that PFBT/PFDBT-CTX conjugates 
accumulated at the brain tumor regions of the ND2:SmoA1 mice after NP 
injection, confirming their targeting ability to malignant brain tumors (Figure 
1.6A). On the contrary, PFBT/PFDBT NPs without CTX conjugation did not 
show obvious tumor site accumulation in brain. Real-time investigation of the 
circulation profile of the PFBT/PFDBT NP-CTX conjugates indicated that the 
accumulation of conjugates in the brain tumor has been accomplished within 
24 h and the signal intensity remained steady for 48 h during the 72 h analysis. 
However, the conjugates also showed obvious non-specific accumulation in 
liver and kidney during the tested period (Figure 1.6B). 
 
Figure 1.6 (A) Ex vivo fluorescence imaging of healthy brains in wild-type 
mice and medullo blastoma tumors in ND2:SmoA1 mice. Each mouse was 
injected with either PFBT/ PFDBT NP (top), or PFBT/PFDBT-CTX NP 
(middle). Control: no injection (bottom). (B) Biophotonic images of resected 
A                                                                       BWide type ND2:SmoA1 Liver                 Spleen Kidney
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livers, spleens, and kidneys from wild-type (middle) and ND2:SmoA1 
(bottom) mice receiving PFBT/PFDBT-CTX NP injection. Control: no 
injection (top).
[84]
 Copyright 2011 John Wiley and Sons. 
Besides the fluorescence imaging, the application of CP NPs in PA 
imaging have also been reported recently. PA imaging is built up through 
measurement of ultrasonic waves generated by the targets upon pulse laser 
absorption.
[12-14]
 Benefiting from ballistic light, PA imaging could observe 
high deeper biological targets than other optical imaging modalities. In 
general, the PA signal is highly dependent on the absorption coefficient and 
non-radiative QY of the contrast agent. The first report of CP NP based PA 
contrast agent has been reported by Zha et al.
[12]
 The synthesized PPy NPs 
showed high PA intensity due to their large absorption coefficient and high 
non-radiative QY. The application of PPy NPs as PA contrast agents have been 
further demonstrated in mice vascular imaging.  
1.4.2 Biological Detection 
The applications of CP NPs have also been extended to the detection of 
physiologically important species. Most of the CP NP based fluorescent 
biosensor is utilizing the FRET between CPs and another sensitive reporter. 
Generally, the CP NPs with high stable fluorescence have been synthesized, 
and small fluorophores which are sensitive to the targeted molecules or 
environments have been doped or grafted at the surface of CP NPs, leading to 
efficient energy transfer between CPs and sensitive fluorophores. In the 
presence of the detection molecules or environment variation, the fluorescence 
property of fluorescent reporter could be influenced, resulting in the change of 
energy transfer between CP and organic dyes. This could further lead to a big 
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ratiomatric change of donor and acceptor intensity for highly sensitive 
detection.  
The early example of CP NP based bisosensors has been developed by 
Wu et al. in 2009.
[105]
 The sensor was consisted of a polymer (PDHF) and an 
oxygen sensitive platinum octaethylporphyrin (PtOEB). The fluorescence of 
PDHF was greatly quenched by PtOEB in the presence of nitrogen due to 
efficient energy transfer between them, and strong red fluorescence has been 
detected upon excitation of PDHT. However, in the presence of oxygen, the 
fluorescence of PtOEB was quenched, resulting in less energy transfer 
between PDHF and PtOEB, and strong blue emission was observed upon 
excitation of PDHF. Another example of CP NP based singlet oxygen sensor 
has been reported by Zhang and co-workers.
[106]
 A singlet sensitive oxygen 
molecule (diaryltetracene) has been conjugated at the side chain of 
poly(phenlyene-co-fluorene). Due to energy transfer from CPs to the side 
diaryltetracene pendants, their conjugates showed a yellow emission from the 
diaryltetracene pendants upon excitation of the CPs. Upon mixing with the 
singlet oxygen molecules, energy transfer between them was blocked and the 
fluorescence of CP backbones was restored, resulting in an observable strong 
blue fluorescence from CPs. A large ratiometric contrast of 200-fold from the 





Figure 1.7 Effects of various ions on the fluorescence intensity of solution 
containing PFBT NP and PFVT/PFTBT NP.
[86]
 Copyright 2011 Royal Society 
of Chemistry. 
 
Figure 1.8 (A) The schematic illustration of pH sensitive CP-FITC NPs. (B) 
Fluorescence spectra of CP-FITC NPs at different pH.
[82]
 Copyright 2011 
American Chemical Society. 
A ratiometric fluorescent sensor for metal ion detection has been 
constructed by Chiu’s group using a mixture of bare PFDBT NPs and PSMA 
encapsulated PFBT NPs.
[86]
 The mixture showed two emission peaks at 540 





, the fluorescence intensity at 540 nm was quenched 
while the fluorescence at 623 nm was stable, leading to an efficient ratiometic 
changing. The linear correlation between the ratio of I540 nm/I623 nm and ion 




in 1-30 μM and 10-25 




recovered by addition of EDTA into NP/Cu
2+
 aggregates, which is not 
achievable in NP/Fe
2+





 concentration in Dulbecco’s Modified Eagle Medium (DMEM). 
In addition to metal ions, intracellular pH is also of high importance to 
understand the physiological processes in subcellular organelles.
[82]
 Chan 
developed an intracellular pH sensing platform, which was consisted of pH-
insensitive PFVP and pH-responsive fluorescein isothiocyanate (FITC). Two 
emission peaks at 440 nm and 513 nm have been observed upon excitation at 
390 nm. Gradual changing pH from 5.0 to 8.0 increased the emission peak of 
FITC while the fluorescence intensity of PFVP kept constant as shown in 
Figure 1.8. The ratio of fluorescence intensities (I513nm/I440nm) was found to 
change linearly as a function of pH in the range of 5.0-8.0 with good 
sensitivity and reversibility. The ability of the NPs in intracellular pH 
monitoring was further carried out. Quantitative study of the confocal images 
of Hela cells after internalization of the NPs via endocytosis suggested that the 
average pH value of Hela cells was ~5.0, which was consistent with the 
reported pH range for the acidic organelles involved in endocytosis (4.5-5.0 in 
lysosomes and ~6.5 in early endosomes). This strategy has also been utilized 




Besides small molecules and environment monitoring, the FRET based 
strategy has also been extended to biomolecular detection. The detection of 
proteases, an important species involved in cancer and other diseases, has been 
achieved by Cordovilla and co-workers.
[107]
 The CP was consisted of a highly 
emissive PPE backbone grafted with perylene unit for red emission and a 
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hydrophilic chain with a terminal functional succinimide groups. The 
amphiphilic polymers could self assemble into NPs. Due to the aggregation 
induced fluorescence quenching, CP NPs showed weak fluorescence after 
cross-linking the succinimide groups with a proteases sensitive peptide. In the 
presence of proteases, the sensitive peptide broke and the aggregation induced 
CP fluorescence quenching became less dominant, resulting in the 
enhancement of CP fluorescence. The platform shows a 15-fold enhancement 
of the fluorescence intensity upon incubation with protease under 
physiological condition. 
1.4.3 Therapy 
Both imaging and detection applications utilize the fluorescent 
properties of CP NPs. More recently, other properties of CP NPs have been 
explored in therapy applications. In view of the polymer nature of CP NPs, 
several researchers investigated their applications as drug and gene carriers. In 
addition, CPs could produce singlet oxygen, which has been used in 
photodynamic therapy. Moreover, fine-tuning CP structure could increase 
their non-radiative QY, which could be utilized as photothermal therapy 
reagents. 
In 2010, Wang’s group reported the CP NP based drug delivery 
system.
[108]
 The NPs were synthesized by electrostatic assembly of cationic 
PFO and anionic poly(L-glutamic acid) grafted with doxorubicin. The CP NPs 
showed a size of 50 nm with good photostability and low cytotoxicity as show 
in Figure 1.9A. The advantageous feature of these NPs is due to their capacity 
to trace the drug delivery and release process. As shown in Figure 1.9B, the 
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fluorescence of PFO was quenched due to energy transfer between PFO and 
doxorubicin. After drug release, the quenching effect would greatly decrease 
and the fluorescence of PFO would recover. As a result, the PFO could be 
used an indicator of drug delivery and release process in targeted cancer cells. 
 
Figure 1.9 (A) SEM images of PFO/doxorubicin NPs. (B) A schematic 
illustration of the component of NPs and uptake of NP by cells.
[108]
 Copyright 
2010 American Chemical Society. 
The CP NPs could be functionalized with cationic groups to be used as 
a platform for gene delivery. Wang’s group graft lipid at the side chain of 
cationic poly(fluorenylene phenylene), which has formed CP NPs in water due 
to its amphiphilic property.
[95]
 The plasmid (pCX-EGFP) has been 
successfully loaded in NPs and delivered into A549 lung cancer cells for 
transcription and translation. The fluorescence from CP could help researchers 
to track the entrance of plasmids into cells. The expression of GFP in A549 
cancer cells has been observed, illustrating the successfully plasmid delivery 
with the help of CP NPs. Moon and co-workers synthesized amine groups 
functionalized PPE polymer, which were precipitation to form CP NPs with a 
size about 60-80 nm.
[109]
 Thanks to the existence of positively amine groups at 
NP surfaces, negatively charged gene could be easily loaded in CP NPs. The 




addition, CP NPs have also been used as fluorescent probes to monitor the 
uptake mechanism of NPs by cells.  
The photodynamic therapy of CP has been discovered by Whitten and 
co-workers in 2005. They found that a cationic PPE could efficiently kill 
bacterial through produce singlet oxygen or other reactive oxygen species 
upon white light irradiation.
[110]
 Whitten’s group synthesized various types of 
CPs for photodynamic therapy. One typical example is that through absorbing 
positively charged PPE at the surface of negatively charged silica particles,  
efficient biocidal reagents have been constructed.
[111]
 They chose silica 
particles with a size of 5 µm or 30 µm, respectively, and PPE with positively 
charged chains were adsorbed on silica particles surfaces. The fluorescence of 
PPE could be clearly observed under fluorescent microscopy. Light induced 
biocidal activity has been successfully demonstrated on Cobetia marina and 
Pseudomonas aeruginosa treatment. 
Besides the capacity to generate singlet oxygen by CPs, they also help 
to increase the singlet oxygen generation ability of other photosensitizer. Since 
CPs could help to collect excitation light more efficiently due to their large 
extinction coefficient, and the absorbed light energy could transfer from CP to 
photosensitizer, resulting in great enhancement of singlet oxygen generation 
amount. One example of this concept has been demonstrated by Wang’s group 
in 2009.
[113]
 The authors selected an anionic polythiophene (PTP) as the donor 
and a cationic porphyrin (TPPN) as an acceptor to form complexes through 
electrostatic interactions in aqueous. Due to efficient energy transfer between 
them, the singlet oxygen generated from TPPN has been greatly improved by 
PTP as compared with bare TPPN. Under the irradiation with white light with 
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a fluence of 90 mW/cm
2
 for only 5 minutes, 70% reduction of bacterial 
viability has been realized.  
 
Figure 1.10 (A) Chemical structures of CP and photosensitizer TPP. (B) A 
schematic illustration of NP formulation. (C) AFM image of CP/TPP co-
encapsulated NPs. (D) Normalized UV-vis and PL spectra of PDHF NPs 
doped with 10% of TPP as well as that of pure PHDF NPs.
[112]
 Copyright 2011 
Royal Society of Chemistry. 
In 2011, Shen et al. synthesized photosensitizer doped CP NPs for 
photodynamic therapy, which can be utilized upon both one-photon and two-
photon excitation.
[114,115]
 Meanwhile, McNeil’s group also developed CP 
based photodynamic therapy reagents under one- and two-photon 
excitation.
[112]
 They chose poly(9,9-dihexylfluorene) (PDHF) and poly(9,9-
dioctylfluorenyl-2,7-diyl) (PFO) as the donor and tetraphenylporphyrin (TPP) 





encapsulated NPs. The chemical structures of the used reagents and the 
corresponding CP NPs with a size of ~15 nm are shown in Figure 1.10A and 
1.10B, respectively. Efficient energy transfer occurs between CPs and TPP 
due to the good overlap between the PFO emission and the TPP absorption 
(Figure 1.10D). In addition, the NPs are suitable for two-photon excitation, 
which shows deeper penetration depth as compared with one-photon 
excitation.  
In 2011, Wang’s group further conjugated the photosensitizer to the 
side chain of PTP, which forms CP NPs by self-assembly.
[116]
 In addition, 
targeted molecules could be grafted at the surface of CP NPs for targeted 
photodynamic therapy. In addition to the biocidal capacity, they can 
distinguish malignant and normal cells. Taking folic acid as an example target 
molecule, the formed CP NPs could specifically kill more folate positive KB 
cells (80% damage) than that of folate negative NIH-3T3 cells (30% damage). 
Very recently, the same group grafted a photosensitizer (a protein inactivation 
drug) as well as targeted molecules (folic acid) with CP backbone for targeted 
cancer therapy.
[117]
 Upon light irradiation, the CP could induce the drug to 
release singlet oxygen species to inactivate the targeted protein at specific 
cancer cells, leading to the inhibition of tumor growth.  
More recently, CP NPs with strong NIR absorbance and high non-
radiative decay QY start to serve as photothermal reagents. Photothermal 
therapy mainly utilizes the heat generation of materials under light absorption. 
For CPs, the heat is mainly produced when the excited electrons are 
transferred to the ground state through non-radiative pathway. In this regard, 
Chapter 1 
32 
conductive CPs should have great potential to generate heat due to the high 
non-radiative QY.  
The first report of CP based photothermal agents is polyaniline. 
Polyamiline is easily to be doped with strong aid, alkali ion or transition metal 
to generate an interband gap between valence and conduction bands, 
facilitating the decrease of excitation-energy level and the transfer of electrons. 
The doping process could transfer the NP state from emeralidine base (EB) to 
emeralidine salt (ES), which is accompanied by the red-shift of its absorption 
peak to NIR region. In view of multi-components exist in cellular 
microenvironment, polyaniline could be potentially doped by protons, alkali 
ions or other oxidative species inside cytosol to change its status from EB state 
to ES state with a strong NIR absorbance. Yang et al. synthesized polyaniline 
NPs with EB state with good water solubility, which could be uptaken by 
cancer cells.
[118]
 In the intracellular environment, EB polyaniline is changed to 
ES state. The temperature could be increased from 27 °C to 68 °C upon laser 
irradiation (2.45 W/cm
2
) of 0.5 mg/mL of polyaniline NPs. Upon laser 
irradiation, cancer cells could be effectively killed. Taking A431 cells as an 
example, both in vitro and tissue experiments illustrated that polyaniline was 
an efficient photothermal material for cancer cell therapy.  
In addition, Liu’s group developed poly-(3,4-
ethylenedioxythiophene):poly(4-styrenesulfonate) (PEDOT:PSS) based 
organic photothermal agents with strong NIR absorbance in 2011.
[119]
 The 
synthesized NPs showed an NIR absorbance with an average diameter of 80-
90 nm based on scanning electron microscope characterization. PEGs were 
absorbed at NP surfaces to render NPs with stealth property, resulting in their 
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efficient accumulation in mice tumor due to EPR effect after 48 h intravenous 
injection of NPs. To monitor the therapy effect of NPs, an infrared thermal 
mapping instrument was applied to check the temperature evolution in the 
tumor upon NIR laser irradiation. The temperature in tumor was increased to 
51 °C after 5 minutes laser irradiation with a power density of 0.5 W/cm
2
, 
while no obvious temperature increase was observed for tumor without NP 
injection. The tumor was eliminated after 15 days treatment, demonstrating the 
good therapy effect of the synthesized NPs as a photothermal agent. 
 
Figure 1.11 (A) FE-TEM images of PPy NPs. (B) The temperature evolution 
of PPy NPs at different concentrations.
[120]
 Copyright 2012 Royal Society of 
Chemistry. 
In addition, polypyrrole (PPy) has also been extensively utilized as a 
photothermal agent.
[120-124]
 PPy NPs could be simply fabricated through 
emulsion polymerization using FeCl3 as oxidation agent and PVA as an 
emulsifier. Zheng’s group firstly reported the photothermal application of the 
PVA stabilized PPy NPs in 2012.
[120]
 The synthesized NPs show good water 
dispersibility and excellent photostability with a size around 50 nm as shown 
in Figure 1.11A. The temperature of PPy NP suspension in water (with a 




minutes upon 808 nm laser irradiation at a density of 1 W/cm
2
 as shown in 
Figure 1.11B. In view of the high heat generation efficiency and good 
biocompatibility of PPy NPs, they have been further used in in vitro and in 
vivo photothermal experiment. The tumour temperature reached 60 ℃ after 
only 5 minutes laser irradiation with the power density of 1 W/cm
2
, and the 
treated 4T1 tumors disappeared quickly without noticeable side effects on 
normal tissues. Later, both Liu’s group[121] and Dai’s group[124] reported the 
application of PPy NPs in photothermal therapy.  
In a recent work, MacNeill’s group synthesized CPs through a donar-
acceptor (D-A) concept to fine-tune their absorption properties.
[125] 
Conjugation of 2-ethylhexyl cyclopentadithiophene with 2,1,3-
benzothiadiazole or 2,1,3-benzoselenadiazole, two different polymers, 
PCPDBO and PCPDTBSe were synthesized. They respective polymeric NPs 
have been synthesized via the conventional precipitation apporach. The 
obtained PCPDTBSe NPs showed an obvious NIR absorbance peak, 
benefiting energy conversion to heat. In addition, these CP NPs were low 
cytotoxicity in MTT experiment using RKO and HCT116 colorectal cancer 
cells as examples. However, most cancer cells were killed by PCPDTBSe NPs 
at above 125 μg/mL concentration upon 808-nm NIR laser irradiation at a 
power density of 0.6 W/cm
2
. 
1.5 Research Objectives 
In view of the obvious advantages of CP NPs in fluorescence imaging 
as compared with the conventional fluorescent materials, various strategies 
have been developed to synthesize CP NPs. Generally, the obtained CP NPs 
show large absorption coefficient, bright fluorescence, large Stokes shifts, 
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good photostabilities and benign biocompatibility in their respective 
bioimaging applications. However, most CP NPs are synthesized by taking 
advantage of the weak hydrophobic interaction of CP backbones, which may 
not be stable in long term study. Considering the above issues, it is necessary 
to design and develop new approaches to synthesize CP NPs and improve their 
colloid and structure stabilities. In addition, the fluorescence performance of 
CP NPs (e.g. brightness) is essentially important for their fluorescent imaging. 
However, less work is focused on the optimization of their performance by 
controlling the internal structures. Furthermore, although some CP NPs show 
high fluorescence in imaging, there are also many CP NPs do not emit high 
fluorescence, which means they have strong high non-radiative QYs. Since the 
PA imaging performance of contrasts is highly related to non-radiative QY, 
we also investigated whether CPs with high non-radiative QYs could be 
applied as PA imaging contrast agents, which broadens the imaging 
application of CPs based materials. 
As such, this Ph.D. thesis is focused on developing new strategy to 
synthesize CP NPs with high structure stabilities, high fluorescence as well as 
exploring their applications in PA imaging. The specific objectives are listed 
as following. 
1. To develop a facial approach to synthesize CP NPs with cross-linked shell 
to increase their stability as well as surface functional groups for specific 
applications. 
2. To develop a general method to fabricate CP loaded silica NPs to increase 
both physical stability and photostability and explore their applications in 
targeted cellular imaging. 
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3. To enhance fluorescent performance (e.g. fluorescence QY) of CP NPs as 
well as their application in in vivo fluorescence imaging. 
4. To design CP NPs with high non-radiative QYs and study their applications 
in PA imaging. 
Through this Ph.D. project, it is anticipated that both stability and the 
fluorescence performance of CP NPs would be improved through our material 
and formulation design. In addition, the application of CP NPs in PA imaging 
modality would also be exploited.  
1.6 Thesis Outline 
This thesis consists of six chapters. Chapter 1 introduces the general 
research background, the progress of CP NPs in literatures as well as the 
objectives of this Ph.D. project. In Chapter 2, a facile strategy to synthesize 
stable CP NPs with multihydroxy by dendritic cross-linking is illustrated. The 
detailed influencing factors on the size and other property of CP NPs are 
discussed and their application in cellular imaging is also investigated. In 
Chapter 3, a general approach to prepare CP embedded silica NPs without any 
tedious chemical modification of both CP chains and silica precursors is 
developed. The formation mechanism of CP doped silica NPs is studied 
followed by the examination of their application in targeted cellular imaging. . 
In view of the protection of both polymer and silica matrices, we explored the 
polymer/silica co-protection strategy to improve both stability and 
fluorescence QY of CP NPs in Chapter 4. In addition, their two-photo 
absorption property is investigated. Their application as two-photon 
fluorescent probes is further studied in two-photon excited vascular imaging. 
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Chapter 5 describes the synthesis of CP NPs for PA imaging, which involves 
the design of CPs with a high non-radiative QY, formulation of CP NPs and 
their application as a PA probe in biological imaging. Chapter 6 summarizes 




FACILE SYNTHESIS OF STABLE MULTIHYDROXY 
CONJUGATED POLYMER NANOPARTICLES BY 
DENTRITIC CROSS-LINKING 
2.1 Introduction 
The development of fluorescent bioimaging reagents has gained 
significant attention in recent years. An ideal bioimaging reagent generally 
requires high fluorescence QY, good optical stability, biocompatibility, and 
surface functionality.
[126,127]
 As a promising candidate, CPs have shown 
advantages over small fluorophores, fluorescent proteins, and even 
semiconductor QDs, which include large absorption cross sections, bright 
fluorescence, and favourable biocompatibility.
[26,35,36,74,85]
 However, CPs with 
inherent hydrophobic backbones are insoluble in water. As a consequence, it is 
highly desirable to endow CPs with good water dispersibility to facilitate their 
biological applications. 
Several strategies have been developed to transform organic soluble 
CPs into aqueous media, which include emulsion technique, precipitation 
technique, design and synthesis of conjugated polyelectrolytes (CPEs) and 
direct polymerization in heterophase system.
[31,51,128-133]
 Among them, 
synthesis of CPEs and formation of CP NPs) via precipitation technique are 
the two most widely used strategies. However, the synthesis of CPEs generally 
requires laborious synthetic steps and the modification has to be specifically 
designed for each CP. In addition, the charged side chains of CPEs often lead 
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to nonspecific interactions with biomolecules.
[134,135]
 The other commonly 
employed strategy is to form CP NPs by precipitation technique in the absence 
or presence of surfactants.
[99,136,137]
 It involves the dissolution of CPs in 
organic solvents, followed by injection of the CP solutions into water with 
ultrasonication. CP NPs are formed when hydrophobic CP chains fold into 
spherical shape to release interface energy. A variety of water-dispersible CP 
NPs have been synthesized via this approach, however, these CP NPs with 
hydrophobic surface are not inherently stable, and their surface possesses no 
functional groups for further functionalization.
[32,138-140]
 Recently, embedding 
CPs into polymer matrix such as carboxylic polyethylene glycol and poly(DL-
lactide-co-glycolide) afforded CP NPs with surface functional groups.
[59,141]
 
The poor structural stability resulted from noncovalent interaction may cause 
microphase separation or CP leakage, which is problematic for practical 
applications.
[59,142]
 As the polymer encapsulated CP NPs generally have -
COOH or -NH2 functional groups, they could also lead to undesired 
association with cell membrane and other charged biomolecules via 
hydrophobic and electrostatic interactions.
[59,100,141-143]
 Despite the progress on 
CP NPs in recent years, the preparation of CP NPs with inherent hydrophilic 
surface, multiple neutral functional groups, and high structural stability is still 
in its infancy.  
In this chapter, we report a new strategy toward water dispersible CP 
NPs via copper-free click chemistry in an oil-in water miniemulsion system, as 
shown in Scheme 2.1. Hyperbranched polyglycerol (HPG) was selected as the 
cross-linker because it is a well-known biocompatible dendritic polymer with 





addition, HPG can be easily synthesized by one step polymerization as 
compared to dendrimers.
[147]
 As one of the most widely used CPs for CP NP 
formation, PFBT was chosen as a representative CP to react with HPG. 
Detailed studies reveal that the cross-linked CP-HPG NPs. with multiple 
surface hydroxyl groups exhibit good structural stability and water 
dispersibility, high fluorescence QY, stable optical properties, and low 
cytotoxicity. In addition, CP-HPG NPs show tunable size in the range of 40-
210 nm with narrow size distribution, simply by adjusting the oil phase and 
surfactant used for miniemulsion. This work opens a new opportunity to 
synthesize functional water-dispersible fluorescent CP NPs. 
2.2 Experimental Section 
2.2.1 Materials 
Glycidol, potassium methylate solution in methanol (CH3OK, 25%), 
N,N’-dicyclohexylcarbodiimide (DCC), 5-hexynoic acid (HA), 4-
(dimethylamino) pyridine (DMAP), MTT, bovine serum albumin (BSA), γ-
globulins from bovine blood, sodium dodecyl sulfate (SDS), and sodium azide 
were purchased from Sigma-Aldrich. Glycidol (96%) was purified by vacuum 
distillation and stored in a refrigerator (-4 
o
C) before use. Dioxane and 
methanol was distilled before use. NMR solvents were purchased from 
Cambridge Isotope Laboratories, Inc. Poly[9,9’-bis(6’’-bromohexyl)fluorene-
co-4,7-(2,1,3-benzothiadiazole)] (PFBT-Br, Mn 15000, PDI 1.87) was 
synthesized according to our previous report.
[148] 
All other chemicals were 
analytical grade and used as received without further purification. Milli-Q 




Fourier transform infrared (FT-IR) spectra were recorded using a PE 
Paragon 1000 spectrometer (KBr disk). NMR spectra were collected on 
Bruker Avance 500 (DRX 500, 500 MHz). UV-vis spectra were recorded on a 
Shimadzu UV-1700 spectrometer. PL measurements were carried out on a 
Perkin-Elmer LS-55 equipped with a xenon lamp excitation source and a 
Hamamatsu (Japan) 928 PMT, using 90 degree angle detection for solution 
sample. PL QYs were measured using quinine sulphate as the standard, with a 
QY of 55% in H2SO4 (0.1 M). DLS measurements were performed using 
Brookhaven Instrument Corporation (BIC) 90 Plus with λ = 659 nm. FE-TEM 
studies were performed on a JEOL JEM-2010 electron microscopy with an 
accelerating voltage of 200 kV. Gel permeation chromatography (GPC) 
analysis was conducted with a Waters 2690 liquid chromatography system 
equipped with Waters 996 photodiode detector, using polystyrene as the 
standard and LiBr/DMF (0.01 mol/L) (for HPG and HPG-Alk) or THF (for 
PFBT-N3) as the eluent at a flow rate of 1 mL/min. Confocal laser-scanning 
microscopy (CLSM) images was recorded on a Zeiss LSM 410 (Jena, 
Germany) with imaging software (Fluoview FV500). 
2.2.3 Synthesis of PFBT-N3 
PFBT-Br (624 mg, 1 mmol of PFBT repeat unit) was dissolved in 100 
mL of THF. Sodium azide (NaN3, 260 mg, 4 mmol) was dissolved in DMF 
(50 mL). Then the PFBT-Br and NaN3 solutions were mixed in a 250 mL flask 
equipped with a magnetic stirring bar. The mixture was heated to reflux for 2 
days, filtrated, concentrated, and then precipitated in methanol. After removal 





H NMR (500 MHz, CDCl3, ppm) δ = 8.15-7.97 (m, 6H), 7.96-7.81 
(m, 2H), 3.26-3.06 (m, 6H), 2.26-2.04 (m, 4H), 178-1.42 (m, 4H), 1.39-1.04 
(m, 8H) 0.95-0.85 (m, 4H). FT-IR (KBr, cm
-1): ν = 2926 and 2862 (-CH2, -
CH3), 2098 (-N3). Element analysis calculated (%): C 67.88, H 5.48, N 20.43. 
Found: C 67.88, H 5.48, N 20.43. GPC (THF as eluent): number-average 
molecular weight (Mn) = 14200, polydispersity index (PDI) = 1.87. 
2.2.4 Synthesis of HPG  
HPGs with molecular weight 15.5 KDa was prepared according to the 
literature.
[149,150]
 Typically, in a three-neck flask, trimethylolpropane (TMP) 
(20.1 mg, 0.15 mmol) was added to the flask under argon atmosphere 
followed by 100 μL of potassium methylate solution in methanol (25 wt %) 
and 2 mL methanol. The mixture was stirred for 30 min at 45 
o
C, and then 
excess methanol was removed in a vacuum. Anhydrous dioxane (15 mL) was 
added. The flask was kept in an oil bath at 95 
o
C, and 20 mL of glycidol (0.3 
mol) was added dropwise over a period of 24 h. After completion of monomer 
addition the mixture was stirred for an additional 5 h. The product was 
dissolved in methanol then was precipitated in acetone, and this process was 
repeated at least three times. 
1H NMR (500 MHz, DMSO, ppm) δ = 4.83-4.39 
(-OH), 3.82-3.25 (-CH, -CH2).
 13C NMR (500 MHz, DMSO, ppm) δ: 80.5-
55.6.  FT-IR (KBr, cm
-1): ν = 3440 (-OH), 2926 and 2862 (-CH2, ν-CH3), 1120 
(C-O-C). GPC (DMF as eluent): Mn = 15500 (210 -OH groups per HPG 
macromolecule), PDI = 1.23.  
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2.2.5 Synthesis of HPG-Alk  
Typically, HPG (740 mg, 10.0 mmol -OH) was mixed with 25 mL of 
DMF solution containing the DCC (60 mg, 0.29 mmol) and DMAP (30 mg, 
0.25 mmol). Then 340 mg of 5-hexynoic acid (28 mg, 0.25 mmol) was added 
to the mixture at room temperature under magnetic stirring for 24 h. After 
removing the insoluble dicyclohexylurea (DCU) by filtration and 
centrifugation, the centrifugal liquid was precipitated in diethyl ether and then 
in acetone. The final obtained HPG-Alk straw yellow viscous liquid can be 
dissolved in organic solvents such as chloroform and dichloromethane but 
cannot be dissolved in water anymore. 
1H NMR (500 MHz, DMSO, ppm) δ = 
4.77-4.37 (-OH), 4.25-4.01 (HPG conjugated HA unit, -CH, -CH2), 3.85-3.14 




-1): ν = 3440 (-OH), 2926 and 
2862 (-CH2, -CH3), 2105 (-C≡CH), 1724 (-C=O) 1120 (C-O-C). GPC (DMF 
as eluent): Mn = 19200 (about 20% of –OH groups were transformed into -
C≡CH groups), PDI = 1.32.  
2.2.6 Preparation of CP-HPG NPs  
Typically, HPG-Alk (11.8 mg, 0.025 mmol of -C≡CH) and PFBT-N3 
(7.0 mg, 0.025 mmol of -N3) were dissolved in chloroform (1 mL) and stirred 
at room temperature for 0.5 h before pouring into the SDS (65 mg, 0.23 mmol) 
containing water (25 mL). Then the mixture was ultrasonicated for 10 min in a 
water-ice bath to obtain miniemulsion. After stir at room temperature for 1 h, 
the reaction temperature was rise to 85 
o
C and stirred for additional 24 h to 
ensure the complete of click reaction. After reaction, the formed CP-HPG NPs 
were freeze-dried and washed by hexane repeatedly. Subsequently, the CP-
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HPG NPs were dispersed in water again and dialysed against Milli-Q water for 
5 days using a cut off 3500 membrane. 
2.2.7 Cell Imaging  
MCF-7 breast cancer cells were cultured in folate-free RPMI 1640 
medium containing 10% fetal bovine serum and 1% penicillin-streptomycin at 
37 °C in a humidified environment containing 5% CO2. Before experiment, 
the cells were precultured until confluence was reached. MCF-7 breast cancer 
cells were cultured in the chambers at 37 
o
C. After 80% confluence, the 
medium was removed and the adherent cells were washed twice with 1 × PBS 
buffer. The CP-HPG NP suspension (1 µM of PFBT repeat unit, 0.4 mL) was 
then added to the chamber. After incubation for 2 h, cells were washed three 
times with 1 × PBS buffer and then fixed by 75% ethanol for 20 min, which 
was further washed twice with 1 × PBS buffer and imaged by CLSM (Zeiss 
LSM 410, Jena, Germany) with imaging software (Fluoview FV1000) . 
2.2.8 Cytotoxicity Evaluation 
The cytotoxicities of CP-HPG-1 NPs were examined using MTT assay. 
MCF-7 breast cancer cells were seeded in 96-well plates (Costar, IL, USA) at 




. After 24 h incubation, the medium was 
replaced by the CP-HPG NP suspension at PFBT repeat unit concentrations of 
10, 5, and 2 µM, and the cells were then incubated for 24, and 48 h, 
respectively. After the designated time intervals, the wells were washed twice 
with 1 × PBS buffer, and 100 µL of freshly prepared MTT (0.5 mg/mL) 
solution in culture medium was added to each well. The MTT medium 
solution was carefully removed after 3 h incubation. DMSO (100 µL) was 
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then added into each well, and the plate was gently shaken for 10 min at room 
temperature to dissolve all precipitates formed. The absorbance of MTT at 570 
nm was monitored by the microplate reader (Genios Tecan). Cell viability was 
expressed by the ratio of absorbance of the cells incubated with CP-HPG-1 to 
that of the cells incubated with culture medium only.  
2.3 Results and Discussion 
2.3.1 Synthesis and Characterization of PFBT-N3 and HPG-Alk 
 
Scheme 2.1 Schematic illustration of the preparation of CP-HPG NPs. 
The synthetic route to water-dispersible CP NPs is depicted in Scheme 
2.1. Poly[9,9′-bis(6″-bromohexyl)fluorene-co-4,7-(2,1,3-benzothiadiazole)] 
(PFBT-Br, Mn = 15000, polydispersity (PDI) = 1.75) was synthesized 
according to our previous report.
[148]
 The -Br groups were then transformed to 
-N3 groups by reaction between PFBT-Br and sodium azide to afford 
poly[9,9′-bis(6″-azidohexyl)fluorene-co-4,7-(2,1,3-benzothiadiazole)] (PFBT-
N3) in 95% yield. After the reaction, the resonance peaks at around 3.30 ppm 
for -CH2Br disappears and new peaks appear at 3.18 ppm for -CH2N3 in the 
1
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to -N3. This is further verified by the appearance of an obvious peak at 2104 
cm
-1
 corresponding to -N3 groups in the FT-IR spectrum of PFBT-N3 (Figure 
2.1).  
 
Figure 2.1 FT-IR spectra of HPG, HPG-Alk, PFBT-N3 and CP-HPG-1. 
HPG (Mn = 15500, PDI = 1.23) was synthesized by anionic ring-
opening polymerization according to the literature,
[149-151]
 which has excellent 
water solubility. The structure of HPG was characterized by FT-IR and NMR 
spectra (Figure 2.1 and experimental section). The degree of branching (DB) 
for the HPG calculated from the results of inverse-gated 
13
C NMR spectrum is 
about 0.53.
[149,152]
 The surface hydroxyl groups of HPG were subsequently 
esterified with 5-hexynoic acid (HA) in the presence of DCC to afford alkyne-
modified HPG (HPG-Alk). As compared to the FT-IR spectrum of HPG, two 
new peaks at 2105 and 1724 cm
-1
 corresponding to -C≡CH and -C=O groups 
appear on the FT-IR spectrum for HPG-Alk. In addition, the resonance peaks 
at 2.27 ppm (-CH2C≡CH), 2.0 ppm (-C≡CH), and 1.85 ppm (-CH2CH2C≡CH) 
in the 
1
H NMR spectrum of HPG-Alk also suggest its right structure. The 
conversion efficiency of the hydroxyl groups to alkyne groups calculated from 
























H NMR spectra of HPG and HPG-Alk is ∼20%, which is further 
confirmed by the GPC result of HPG-Alk (Mn = 19200, PDI = 1.32) relative 
to HPG. It should be noted that the HPG-Alk still possesses numerous 
hydroxyl groups (∼168 -OH groups per HPG-Alk macromolecule calculated 
from the GPC and NMR results). 
The HPG-Alk shows good solubility in organic solvents such as 
dichloromethane and chloroform but is not dispersible in water. The detailed 
synthesis and characterization are shown in the experimental section. Similar 
to HPG-Alk, HPG-Alk2 (Mn = 35600, PDI = 1.20) with over 80% surface 
alkyne groups was also synthesized simply by increasing the feed ratio of HA 
to HPG. 
2.3.2 Synthesis and Characterization of CP-HPG NPs 
















CP-HPG-1 1 9.5 83 0.046 0.24 
CP-HPG-2 2 9.5 114 0.053 0.23 
CP-HPG-3 3 9.5 152 0.048 0.21 
CP-HPG-4 1 12.5 44 0.042 0.25 
CP-HPG-5 1 8.0 210 0.068 0.21 
CP-HPG-6 1 0 135 0.724 0.17 
[a]
Volume of the water phase is 20 mL. The feed amounts of PFBT-N3 and 
HPG-Alk are 11.8 and 7 mg, respectively; [azide]/[alkyne] = 1:1. 
[b]




Figure 2.2 (A) Hydrodynamic radius distribution and (B) FE-TEM image of 
CP−HPG-1. UV−vis absorption (dashed line) and emission (solid line) spectra 
(C) of PFBT−N3 in dichloromethane and CP−HPG−1 in aqueous solution (λex 
= 450 nm). The inset shows the aqueous solution of CP−HPG-1 NPs under 
daylight (left) and 365 nm UV light illumination (right). 
 
Figure 2.3 Hydrodynamic radius distribution of (A) CP–HPG–2, (B) CP–
HPG–3, (C) CP–HPG–4 and (D) CP–HPG–5. 
As copper ions are toxic to biosubstrates, biocompatible copper-free 
click coupling was adopted to synthesize CP-HPG NPs using thermal 































































































































initiation in oil-in-water miniemulsion.
[153,154]
 PFBT-N3 and HPG-Alk with 1:1 
azide/alkyne ratio were first dissolved in chloroform (oil phase) and then the 
mixture was miniemulsified with water in the presences of SDS surfactant. As 
the temperature increased to 85 °C, click reaction between HPG-Alk and 
PFBT-N3 occurred. After reaction, transparent orange aqueous solution was 
obtained, indicating good water dispersibility of the CP-HPG NPs. The 
disappearance of the peak at about 2100 cm
-1
 corresponding to alkyne or azide 
groups in the FT-IR spectrum of CP-HPG confirms the nearly complete “click” 
cross-linking and efficient thermal initiation (Figure 2.1). Meanwhile, the peak 
at 3400 cm
-1
 remains strong, indicating that the CP-HPG NPs possess 
numerous hydroxyl groups. 
To probe the effect of miniemulsion conditions on the size of CP-HPG 
NPs, we conducted a series of experiments by changing the feed ratio of oil 
phase or surfactant to water (Table 2.1). The sizes of the obtained CP-HPG 
NPs were investigated by DLS and the respective results are shown in Figure 
2.2A and Figure 2.3. As the critical micelle concentration (CMC) for SDS in 
water is about 8.0 mM, we first fixed the concentration of SDS (CSDS) at 9.5 
mM. The size of CP-HPG NPs increased from 83 to 152 nm with increased oil 
phase from 1 to 3 mL. This is due to the fact that more oil phase could result 
in the formation of bigger micelles at the same CSDS in an oil-in-water 
system.
[155]
 On the other hand, it is found that at a constant oil-to-water ratio, 
the size of CP-HPG increased from 44 to 210 nm when the CSDS was varied 
from 12.5 to 8.0 mM (Table 2.1). This is consistent with previous reports on 
using miniemulsion to synthesize polystyrene and poly(N-isopropylacrylamide) 
NPs.
[156]
 These results indicate that the size of CP-HPG NPs could be fine-
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tuned simply by adjusting the oil phase and surfactant used in the 
miniemulsion. All the CP-HPG NPs synthesized with SDS as the surfactant 
showed narrow size distribution (PDI < 0.07) and good water dispersibility. 
FE-TEM further verified the well-defined nanostructure and uniform size. As 
shown in Figure 2.2B, the CP-HPG-1 NPs exhibit spherical shape with an 
average size of 78 nm, which is slightly smaller than that for DLS data (Table 
2.1). 
 
Figure 2.4 Photograph of HPG–Alk (left), PFBT–N3 (middle), and CP–HPG 
NPs (right) in the mixture of water and chloroform. 
It is worth noting that both the HPG-Alk and the PFBT-N3 have good 
solubility in chloroform. Interestingly, after click reaction, the products show 
good dispersibility in water phase as shown in Figure 2.4. The SDS surfactant 
should be removed by repeated washing with hexane, followed by dialysis 
against Milli-Q water for five days. We deduce that the good water 
dispersibility of the CP-HPG NPs is attributed to the presence of numerous 
hydrophilic hydroxyl groups on the surface of CP-HPG NPs while the 
hydrophobic domain is encapsulated as the core after the click reaction. To 
prove this conjecture, first, a control experiment for CP-HPG-6 in the absence 
of SDS was conducted (Table 2.1). The resulted CP-HPG-6 presents good 
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dispersibility in the upper aqueous layer of a water/chloroform mixture, which 
indicates that SDS is not directly related to water dispersibility of the CP-HPG 
NPs, although it significantly affects the nanoparticle size and morphology 
(Figure 2.5). In addition, HPG-Alk2 was also reacted with PFBT-N3 (1:1 
alkyne/azide) in miniemulsion and the product showed good dispersibility in 
water. However, when HPG-Alk2 with 4:1 alkyne/azide was used, the 
resulting CP-HPG NPs exhibited amphibious dispersibility that can be 
dispersed both in water and in chloroform phase as a result of the presence of 
hydroxyl groups and un-cross-linked HA chains on their surface. Based on 
these results, the good water dispersibility of the CP-HPG NPs is attributed to 
the presence of numerous hydrophilic neutral hydroxyl groups on the surface 
of CP-HPG NPs. These results also suggest that the surface functionality of 
CP-HPGs can be easily fine-tuned by choosing suitable cross-linkers. 
 
Figure 2.5 FE-TEM image of CP–HPG–6 NPs. 
The absorption and emission spectra of CP-HPG-1 NPs in aqueous 
solution are shown in Figure 2.2C. Compared with the PFBT-N3 in 




peaks of the CP-HPG-1. All the CP-HPG NPs prepared using SDS as 
surfactant exhibit strong fluorescence with QYs higher than 20% (Table 2.1), 
which compare favorably to other reported CP NPs based on PFBT with QYs 
less than 10%.
[101]
 Such a high fluorescence QY of CP-HPG NPs could be 
attributed to the minimized self-quenching of PFBT in the CP NPs format. As 
compared to the CP NPs prepared by the precipitation approach, the 
introduction of HPG as a spherical scaffold to the polymer side chain can 
effectively reduce the chain tangling and π-π stacking of CPs, leading to 
reduced polymer fluorescence self-quenching. Therefore, using HPG as cross-
linker can not only endow CPs with hydrophilic neutral hydroxyl groups 
associated with good water dispersibility but also can retain strong 
fluorescence of the CPs. 
2.3.3 Stability Characterization of CP-HPG1 
Considering the complex physiological environment for bioimaging 
applications, the physical stability of CP-HPG NPs in aqueous solution was 
examined under different conditions. Because all the CP-HPG NPs show 
similar optical properties, CP-HPG-1 was chosen as a representative for the 
following studies. The concentration of CP-HPG-1 solution was calculated 
based on the concentration of PFBT repeat unit (RU). The fluorescence 
change of CP-HPG-1 at [RU] = 20 μM and different pH is shown in Figure 
2.6A. Less than 5% variation in emission intensity is observed when the pH is 
changed from 3 to 11. In addition, there is very little fluorescence change 
when the solution ionic strength is increased from 0 to 1 M (Figure 2.6B). This 
compares favourably to CPEs and other CP NPs with a charged surface that 





In addition, the CP-HPG-1 possesses high colloidal stability in 
water and no obvious precipitate is observed even after being stored at room 
temperature for three months. 
 
Figure 2.6 pH (A), NaCl concentration (B), BSA and γ-globulin concentration 
(C) dependent fluorescence intensity ratio (I/I0), where I0 is the emission 
intensity of CP-HPG-1 in aqueous solution at pH 6.8 without addition of 
NaCl, BSA and γ-globulin, and I is the emission intensity of CP-HPG-1 in 
aqueous solution at different (A) pH or (B) different concentrations of NaCl, 
(C) BSA and γ-globulin. (D) Radiation time dependent fluorescence intensity 
ratio (I/I0) of CP-HPG, Alexafluo 488, and fluorescein, the radiation was 
provided by confocal laser, where I0 and I are the emission intensity of 
fluorescent probe without and with radiation for different time, respectively. 
As proteins largely exist in biological media, BSA and γ-globulin (a 
kind of immunoglobulin in blood) were chosen as the representative examples 
to study their interactions with CP-HPG-1. As shown in Figure 2.6C, the CP-
HPG-1 fluorescence remains unchanged when the protein concentrations are 
increased from 0 to 300 μg/mL. DLS measurements further confirm that there 
is no significant difference in size and size distribution of CP-HPG-1 in 
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aqueous solution before and after the addition of BSA and γ-globulin, 
suggesting good antiprotein adsorption property of CP-HPG-1. In addition, the 
photostability of CP-HPG-1 was studied by continuousimaging using CLSM 
for 10 min. For comparison, commercially available fluorescent dyes such as 
Alexafluo 488 and fluorescein were also investigated under the same condition. 
As shown in Figure 2.6D, the emission intensities decrease by 11%, 28%, and 
90% at 10 min for CP-HPG-1, Alexafluo 488, and fluorescein, respectively. 
These studies indicate that the CP-HPG-1 NPs possess good physical and 
photo stabilities, which make them good candidates for biological applications. 
2.3.4 Cellular Imaging of CP-HPG1 
The cytotoxicity of CP-HPG-1 was evaluated for MCF-7 breast cancer 
cells using MTT cell-viability assay. Figure 2.7A summarizes the in vitro 
MCF-7 cell viability after being cultured for 24 or 48 h. It is noteworthy that 
the concentrations of the CP-HPG-1 solution are much higher than that used 
for cell imaging ([RU] = 1 μM). The cell viabilities are close to 100% at [RU] 
= 2 and 5 μM and close to 90% at [RU] = 10 μM within the tested period, 
suggesting the low cytotoxicity of CP-HPG-1. This result is consistent with 
the previous studies of CP NPs prepared by precipitation technique.
[59]
 The 
good biocompatibility of CP-HPG-1 should also benefit from the highly 
biocompatible HPG. To demonstrate the CP-HPG NPs in cell imaging, MCF-




Figure 2.7 (A) Cell viability of MCF-7 cells after incubation with CP−HPG-1 
at different concentrations for 24 and 48 h, respectively. Confocal 
fluorescence image of MCF-7 cells upon incubation (B) with and (D) without 
CP−HPG-1 ([RU] = 1 μM) for 2 h. (C) 3-D confocal image of cell line MCF-7 
incubated with CP-HPG-1 for 2 h. 
μM. After 2 h incubation, the cells were fixed for fluorescence imaging by 
CLSM. The excitation wavelength was fixed at 488 nm, and the fluorescent 
signals were collected above 540 nm. The CLSM image of CP-HPG-1 stained 
MCF-7 cells is displayed in Figure 2.7B. Strong fluorescence from the cellular 
cytoplasm is observed for MCF-7 cells, implicating that CP-HPG-1 is 
efficiently internalized by MCF-7 cells and accumulated in the cytoplasm, 
which is further confirmed by the 3D CLSM image (Figure 2.7C). In contrast, 
no fluorescence can be observed for the cells without incubation of CP-HPG-1 
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(Figure 2.7D). These data suggest that CP-HPG-1 can be used as an effective 
fluorescent stain for cell imaging with good fluorescence contrast.  
2.4 Conclusion 
In this chapter, we have successfully demonstrated a simple and 
effective approach to fabricate robust CP-HPG NPs via copper-free click 
reaction in oil-in-water miniemulsion. The CP-HPG NPs with tunable size are 
born with multiple surface neutral hydroxyl groups, which have shown good 
water dispersibility, bright fluorescence, good optical stability, and low 
cytotoxicity. As the first example to combine dendritic polymer and CP by 
covalent cross-linking, this study not only exploits a new type of CP NP with 
desired properties, but also provides new opportunities and fundamental 












A GENERAL APPROACH TO PREPARE CONJUGATED 
POLYMER DOT EMBEDDED SILICA NANOPARTICLES 
WITH A SIO2@CP@SIO2 STRUCTURE FOR TARGETED 
HER2-POSITIVE CELLULAR IMAGING  
3.1 Introduction 
Fluorescence microscopy technique has attracted great interest in 
biological research and cancer diagnosis due to its noninvasive, real time and 
high resolution characteristics.
[159-163]
 It has been recognized that fluorescent 
probes with high brightness, good photostability, benign biocompatibility and 
easy surface functionalization capabilities are beneficial for achieving optimal 
physiological performance in biological studies. The traditional small 
fluorophores and fluorescent proteins show small Stokes shift and poor 
photostability,
[164,165]
 while semiconductor QDs have the notorious 
cytotoxicity,
[166-168]
 all hindering their practical biological applications. 
Recently, CPs have emerged as effective fluorescent materials due to their 
distinguished advantages.
[33,36,169]
 CP based materials show large absorption 
cross section, strong fluorescence, high photostability and favourable 
biocompatibility, which meet the requirements of fluorescent probes for 
biological applications.
[25,26,35,51,170,171]
 As the inherent hydrophobic backbones 
hinder CPs to soluble in aqueous environment, strategies to endow CPs with 
good water solubility or dispersibility are highly desirable.
[33,35,36]
 
So far, three main strategies have been developed to render CPs with 
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water solubility or dispersibility. One strategy is to graft ionic side chains to 
CP backbones to yield CPEs, which can further self-assemble in aqueous 
media.
[36,98]
 Unfortunately, the generated CPEs often create problems of 
nonspecific interaction with biosubstrates because of their charged side chains. 
Another strategy is to prepare cross-linked CP NPs with high stability by click 
chemistry,
[99,100,172]
 which involves multiple-step monomer modification. The 
third strategy is to prepare CP NPs through precipitation or emulsion 
method,
[59,65,68,69,101,138,173]
 which requires mixing of organic phase with 
aqueous phase under sonication or magnetic stirring. The CP NPs are formed 
based on the weak hydrophobic interaction between CPs and polymer matrix, 
which could result in low stability in aqueous media for long term studies. In 
addition, CP NPs prepared via nanoprecipitation or emulsion method could 
easily lose their physical stability and may not be redispersed in water after 
drying.
[99,172]
 As a result, development of a facile and effective approach for 
fabricating CP NPs that simultaneously possess good water dispersibility, 
excellent structural and optical stability and surface functional groups remains 
challenging. 
The pioneer work by Stöber has stimulated the development of silica 
NPs for a variety of applications in biomedicine and photonics.
[174-180]
 Organic 
dye doped silica NPs have shown great promise in various biological 
applications due to their good photostability, excellent brightness and benign 
biocompatibility.
[178,180]
 In view of the notable advantages of silica matrix, it 
holds great potential to improve CP NP performance in stability and 
biocompatibility through encapsulate CPs into silica matrix. As the highly 
hydrophobic CP chains are immiscible with the hydrophilic silica matrix, the 
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encapsulation of CPs in silica NPs generally requires the assistance of block 
copolymers
[181]
 or tedious modification of CP chain and silanes.
[178,180]
 
Although mesoporous silica matrices have also been used to directly 
encapsulate untreated CPs, the porous structure is unable to protect CPs from 
the invasion of solvents or oxygen molecules, leading to poor stability for long 
term biological applications.
[171,182-184]
 As a consequence, a more general and 
straightforward approach to prepare CP embedded silica NPs is still in 
demand.  
In this chapter, we report a general, simple and effective strategy to 
synthesize CP embedded silica NPs with a unique SiO2@CP@SiO2 structure 
(SiO2@CP@SiO2 NPs) by integrating a precipitation method and a modified 
Stöber approach. This approach allows the encapsulation of CPs inside the 
silica NPs without sophisticated CP modification or tedious silane monomer 
conjugation. The obtained SiO2@CP@SiO2 NPs not only show high stability 
but also have surface functionalized amine groups that enable bioconjugation 
for further biological applications. The formation mechanism of 
SiO2@CP@SiO2 NPs is investigated by FE-TEM and their detailed optical 
properties are also studied. The application of SiO2@CP@SiO2 NPs as an 
effective fluorescent probe is demonstrated by functionalization of NP 
surfaces with a HER2 specific peptide (GGHAHFG) for targeted cellular 
imaging using HER2-overexperssed SKBR-3 breast cancer cells as an 
example. In conjugation of its simple synthetic procedure, high fluorescence 
QY, excellent physical stability and good photostability, the developed 




3.2 Experimental Section 
3.2.1 Materials 
 Poly(9,9′-dihexylfluorene-alt-1,4-phenylene) (PFP), poly(9,9′-
didehexylfluorenyl divinylene-alt-1,4-phenylene) (PFVP), poly(9,9-
dihexylfluorene-alt-2,1,3-benzothiadiazole) (PFBT) and poly[(9,9-
dihexylfluorenyl-co-2,1,3,-benzothiadiazole)-co-4,7-di(thiophen-2-yl)-2,1,3-
benzothadiazole] (PFBTDBT) were synthesized according to the previous 
reports.
[185-188]
 Tetraethsilane (TEOS), 3-aminopropyl triethoxysilane 
(APTES), 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride 
(EDAC), N-hydroxysulfosuccinimide (Sulfo-NHS), trifluoroacetic acid (TFA), 
N,N-diisopropylethylamine (DIEA), acetic anhydride (Ac2O), 
triisopropylsilane (TIS), 4',6-diamidino-2-phenylindole (DAPI), quinine 
sulphate, fluorescein, 4-(dicyanomethylene)-2-methyl-6-(p-dimethylamino-
styryl)-4H-pyran, MTT, penicillin-streptomycin solution and DMSO were 
purchased from Sigma-Aldrich. DMEM, fetal bovine serum (FBS) and 
trypsin-EDTA solution were purchased from Gibco (Lige Technologies, Ag, 
Switzerland). Hexane, DCM, dimethylformamide (DMF), ethanol, methanol, 
THF, concentrated sulphuric acid and ammonia solution were obtained from 
Merck (Germany). Rink-amide resin, O-benzotriazole-N,N,N’,N’-tetramethyl-
uronium-hexafluoro-phosphate (HBTU), N-hydroxybenzotriazole (HOBt) and 
Fmoc-protective amino acids were purchased from GL Biochem Ltd. Milli-Q 
water was supplied by Milli-Q Plus System (Millipore Corporation, Breford, 
USA). SKBR-3 breast cancer cells and NIH/3T3 fibroblast cells were 




The UV-vis absorption spectra of CP solutions and their corresponding 
NPs were measured using a Shimadzu UV-1700 spectrophotometer. Their 
fluorescence spectra were measured using a fluorometer (LS-55, Perkin Elmer, 
USA). The average particle sizes and size distributions were determined by 
laser light scattering with a particle size analyzer (90 Plus, Brookhaven 
Instruments Co. USA) at a fixed angle of 90° at room temperature. The 
surface morphologies of SiO2@CP@SiO2-NPs were studied with FE-TEM 
(JEM-2010F, JEOL, Japan). Zeta potential was measured using a zeta potential 
analyzer (ZetaPlus, Brookhaven Instruments Co. USA) at room temperature.  
3.2.3 Preparation of SiO2@CP@SiO2 NPs 
The SiO2@CP@SiO2 NPs were prepared by the combination of a 
precipitation method and a modified Stöber approach. Typically, a THF 
solution (0.3 mL) containing CP (0.15 mg) was poured into a mixture of 
ethanol and water (v/v = 9:1, 10 mL) under sonication using a microtip probe 
sonicator (XL2000, Misonix Incorporated, NY) for 2 min. The solution was 
then stirred at room temperature for 2 h to evaporate THF. Subsequently, 100 
μL of TEOS was added into the mixture followed by 300 μL of ~30% 
ammonium solution. The solution was further stirred for 12 h at room 
temperature. To investigate the evolution mechanism of the formed NPs, 
aliquots were taken from the solution at different time points to conduct FE-
TEM measurements. Followed, 40 μL of APTES was added into the above 
reaction mixture and stirred for another 12 h. The formed SiO2@CP@SiO2-
NPs were then centrifuged for 10 min at 7500 rpm and washed with ethanol 
five times to remove ammonia and impurities. In between the washing steps, 
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SiO2@CP@SiO2 NPs were redispersed by sonication. 
3.2.4 Synthesis, Purification, and Characterization of Peptide  
GGHAHFG was synthesized using a standard Fmoc strategy with rink 
amide resin as the solid support.
[189]
 Standard HOBT/HBTU/DIEA coupling 
method was used throughout the whole process. The resin (100 mg, loading 
∼0.5 mmol·g-1) was swelled in HPLC-grade DMF for 1 h at room temperature. 
Subsequently, Fmoc group was deprotected in piperidine/DMF (v/v = 1:4) for 
2 h at room temperature. Following piperidine removal, the resin was washed 
extensively with DMF and DCM and dried thoroughly under high vacuum. 
Next, glycine was dissolved in dry DMF (1.5 mL) together with HBTU (4 
equiv), HOBt (4 equiv), and DIEA (8 equiv). The dry resin was then added 
and the resulting mixture was shaken at room temperature. After overnight 
reaction, the resin was filtered and washed thoroughly with DMF (3×), DCM 
(3×) and DMF (3×) until the filtrate became colorless. After drying thoroughly 
under high vacuum, the resin was deprotected again with 20% piperidine in 
DMF for the next coupling cycle. The above cycle was repeated until the last 
amino acid has been coupled. Finally, the resin was capped with a solution of 
Ac2O (10 eq) and DIEA (20 eq) in DCM (200 mL), and the mixture was 
allowed to react for 2 h at room temperature. After the whole coupling process, 
the resin was washed thoroughly with DMF and dried under high vacuum for 
2 h at room temperature. The peptide was then cleaved in a mixture of 95% 
TFA, 2.5% triisopropylsilane (TIS) and 2.5% H2O for 4 h at room temperature. 
Following prolonged concentration in vacuum until >80% of cleavage cocktail 
was removed. Cold ether (chilled to 20 °C) was added to the liquid residue to 
precipitate the peptide. The ether layer was then decanted and the precipitates 
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were dried thoroughly in vacuum. The resulting peptide was further purified 
by prep-HPLC and characterized by LC-MS. IT-TOF m/z calcd: 681.70, 
found 681.32. The HPLC condition is: 5-20% B for 10 min, then 20-40% B 
for 2 min, 5% B for 2 min (Solvent A: 100% H2O with 0.1% TFA; Solvent B: 
100% CH3CN with 0.1% TFA). 
3.2.5 Preparation of SiO2@PFBT@SiO2-Pep NPs  
The amine groups functionalized SiO2@PFBT@SiO2 NPs were firstly 
modified with maleic anhydride to render carboxyl acid groups functionalized 
SiO2 NPs. Typically, maleic anhydride (10 mg) in 10 mL of ethanol and 0.5 
mL of triethylamine were added into 10 mL of SiO2@PFBT@SiO2 NP 
suspensions and stirred overnight. Then 20 mL of H2O was added into the 
mixture, followed with washing with ethanol and H2O three times, 
respectively. Subsequently, 3.2 mg of EDAC and 3.6 Sulfo-NHS were added 
into NP suspension to activate carboxyl groups for 4 h at room temperature. 
The activated SiO2 NPs were centrifuged to remove excess ligands and 
redispersed into 5 mL H2O. 5 mL of 0.2 M borate buffer was then added to the 
suspension, which was followed with 0.1 mL of 0.1 M peptide (GGHAHFG). 
The mixture was stirred at room temperature overnight and then washed with 
water as well as DMSO to eliminate the excess peptide.  
3.2.6 Preparation of PFBT NPs 
PFBT NPs were prepared using a precipitation method.
[35]
 Briefly, a 
THF solution (1 mL) containing a mixture of PFBT (0. 5 mg) was poured into 
10 mL of MilliQ water under sonication. THF was then evaporated by 
magnetic stirring in fume hood. PFBT NPs were obtained by filtration through 
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a 0.2 μm filter. The QY of PFBT- NPs was estimated to be ~20% using 4-
(dicyanomethylene)-2-methyl-6-(p-dimethylamino-styryl)-4H-pyran in 
methanol as a standard. 
3.27 Cell Culture 
SKBR-3 breast cancer cells and NIH/3T3 fibroblast cells were cultured 
in folate-free DMEM medium containing 10% fetal bovine serum and 1% 
penicillin–streptomycin at 37 °C in a humidified environment containing 5% 
CO2. Before experiment, the cells were precultured until confluence was 
reached. 
3.2.8 Cellular Imaging 
SKBR-3 breast cancer cells were cultured in chamber (LAB-TEK, 
Chambered Coverglass System) at 37 °C. After 80% confluence, the medium 
was removed and the adherent cells were washed three times with 1× 
phosphate buffer saline (PBS) buffer. SiO2@PFBT@SiO2-pep NP and 
SiO2@PFBT@SiO2-COOH NP suspensions at 100 μg·mL
-1
 NPs in FBS free 
DMEM medium were then added to the chamber. After incubation for 2 h, 
cells were washed three times with 1× PBS buffer and then fixed by 75% 
ethanol for 10 min. Subsequently, the cells were incubated with DAPI for 15 
min to stain the cell nuclei. The cell monolayer was further washed three times 
with 1× PBS buffer and imaged by CLSM (Zeiss LSM 410, Jena, Germany) 
with imaging software (Fluoview FV1000). The confocal images of NIH/3T3 
cells treated with SiO2@PFBT@SiO2-pep SiO2@PFBT@SiO2-COOH NPs 
under the same condition were also studied. 
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3.2.9 Flow Cytometry Study 
Three groups of SKBR-3 breast cancer cells were cultured in a 6-well 
culture plate to achieve the desired confluence. One group was used as the 
control without treatment. The other two groups were treated with 
SiO2@PFBT@SiO2-pep NP and SiO2@PFBT@SiO2-COOH NP suspensions 
at 100 μg·mL-1 NPs in FBS free DMEM medium, respectively. After 
incubation for 2 h at 37 °C, the control and sample groups were washed with 
1× PBS buffer three times and then treated with 1× PBS trypsin, followed by 
washing with DMEM medium through centrifugation. MCF-7 breast cancer 




 were dispersed in FBS free 
DMEM medium (2 mL) for both control and sample groups. Flow cytometry 
measurements were conducted using Cyan-LX (DakoCytomation). The mean 
fluorescence was determined by counting 10,000 events (λex = 488 nm, 680/40 
nm bandpass filter). 
3.2.10 Cytotoxicity of SiO2@PFBT@SiO2-pep NPs 
MTT assays were performed to assess the metabolic activity of 
NIH/3T3 fibroblast cells. NIH/3T3 fibroblast cells were seeded in 96-well 




. After 24 h 
incubation, the medium was replaced by SiO2@PFBT@SiO2-pep NP 
suspensions with various NP concentrations (100, 500 and 1000 μg·mL-1), and 
the cells were further incubated for 24 and 48 h, respectively. After the 
designated time intervals, the wells were washed three times with 1× PBS 
buffer, and freshly prepared MTT (0.5 mg·mL
-1
) solution (100 µL) in culture 
medium was added to each well. The MTT medium solution was carefully 
removed after 3 h incubation in the incubator. DMSO (100 µL) was then 
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added into each well and the plate was gently shaken for 10 min at room 
temperature to dissolve all precipitates. The absorbance of MTT at 570 nm 
was monitored by the microplate reader (Genios Tecan) after subtracting the 
absorbance of the corresponding control cells incubated with 
SiO2@PFBT@SiO2-pep NPs at the same concentration but without the 
addition of MTT to eliminate the absorbance interference from PFBT. Cell 
viability was expressed by the ratio of absolute absorbance of the cells 
incubated with NP suspensions to that of the cells incubated with culture 
medium only. 
3.2.11 Photostability of SiO2@PFBT@SiO2-pep NPs 
To compare the photostability of SiO2@PFBT@SiO2 NPs with that of 
fluorescein and PFBT NPs, the photostablility of SiO2@PFBT@SiO2-pep, 
PFBT NPs and fluorescein was investigated. SKBR-3 breast cancer cells 
incubated with SiO2@PFBT@SiO2-pep NPs, PFBT NPs and fluorescein were 
prepared according to the procedures described above. The CLSM images of 
the sample were recorded at 1 min interval under continuous laser scanning at 
excitation wavelength of 488 nm with a laser power of 4.75 mW. The 
fluorescence intensity of each image was analyzed by Image Pro Plus 
software. Their photostability was expressed by the ratio of the fluorescence 
intensity after excitation for a designated time interval to its initial value as a 
function of the exposure time. 
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3.3 Results and Discussion 
3.3.1 Preparation and Characterization of SiO2@CP@SiO2 NPs 
 
Scheme 3.1 Chemical structures of four CPs used in this study. 
To synthesize SiO2@CP@SiO2 NPs, the THF solution of CP was first 
poured into an ethanol/water mixture (v/v = 9:1) under sonication. Upon 
magnetic stirring, THF gradually evaporated and CPs formed small CP dots. 
The resulting solution was subsequently added with silica precursor, TEOS, as 
well as ammonia catalyst. A sol-gel silica reaction took place in the presence 
of the CP dots. After 12h, APTES was then added to modify silica NPs with 
amine functional groups for further bioconjugation. To the best of our 
knowledge, this is the first report on the synthesis of SiO2@CP@SiO2 NPs at 
room temperature without specific CP or silane modification. 
To demonstrate the versatility of this method for preparing CP 
encapsulated silica NPs, four different polymers with various emission colours 
were chosen in this study. These CPs are PFP, PFVP, PFBT and PFBTDBT, 
respectively, which were synthesized according to our previous reports
[185-
187,190]
. The fluorescence emission wavelengths of the CPs are fine-tuned from 




Figure 3.1 (A) Normalized UV-vis absorption (dashed line) and PL spectra 
(solid line) of SiO2@CP@SiO2 NPs in water. (B) Photographs of 
SiO2@CP@SiO2 NP suspensioin in water under a hand held UV lamp (excited 
at 365 nm). 
Table 3.1 Characterization of SiO2@CP@SiO2 NPs. 
Loaded CP PFP PFVP PFBT PFBTDBT 
Particle size (nm) 65 62 68 72 
Zeta potential (mV) +26 +23 +25 +25 
Encapsulation efficiency (%) 100 100 100 100 
QY (%)
a)
 54 35 27 20 
[a]
The QYs of SiO2@PFP@SiO2, SiO2@PFVP@SiO2, 
SiO2@PFBT@SiO2 and SiO2@PFBTDBT@SiO2 NPs were measured with 
quinine sulfate (0.1 M H2SO4; QY = 0.54),  fluorescein (0.1 M NaOH; QY = 
0.95), 4-(dicyanomethylene)-2-methyl-6-(p-dimethylamino-styryl)-4H-pyran 
(methanol; QY = 0.43) as the standard, respectively. 
Figure 3.1A shows the UV-vis absorption and fluorescence spectra of 
the prepared SiO2@CP@SiO2 NP aqueous suspensions. The increased 
baselines of the absorption spectra at the short wavelength are due to the 
strong scattering of silica matrix.
[178]
 The emission maxima of PFP-, PFVP-, 
PFBT- and PFBTDBT encapsulated silica NP suspensions are 421 nm, 482 
nm, 554 nm and 699 nm, respectively. It is noted that the emission maxima of 
PFP-, PFVP-, PFBT- and PFBTDBT-SiO2 NP suspensions are red-shifted by 
8 nm, 12 nm, 11nm and 41 nm, respectively, as compared to those of pure CPs 
in THF. The red shifts of the emission maxima of these NPs are mainly 
































derived from the aggregation of CP chains in silica NP formulation, which is 
consistent with the previous reports of CP NPs prepared through 
nanoprecipitation and emulsion methods.
[59,68,181]
 In addition, the aqueous 
suspensions of SiO2@CP@SiO2 NPs show bright and vivid colours under the 
excitation of a hand held UV lamp as shown in Figure 1b. These results 
illustrate that the photophysical properties of SiO2@CP@SiO2 NPs are tunable 
by choosing different CPs. 
Table 3.1 shows that the SiO2@CP@SiO2 NPs have an average 
diameter from ~60 to ~70 nm determined by laser light scattering. It has been 
reported that NPs with a size from 50 nm to 200 nm show good cellular uptake 
efficiency.
[191,192]
 The zeta potential of SiO2@CP@SiO2 NPs was measured to 
be around +25 mV in neutral aqueous environment, which is mainly derived 
from the grafted amine groups at NP surfaces. The positively charged surfaces 
of SiO2@CP@SiO2 NPs guarantee the electrostatic repulsion among particles, 
leading to a relatively good colloidal stability in water. The encapsulation 
efficiencies of the four CPs in silica matrix are calculated from the absorption 
difference of the CP solution in ethanol/water mixture prior to encapsulation 
and that of the supernatant after NP centrifugation, which are almost 100% 
under our experimental conditions. The QY of each SiO2@CP@SiO2 NP was 
measured using commercial fluorophores as the standard. The relatively high 
QYs (> 20%) for these four SiO2@CP@SiO2 NPs are comparable with the 
previously reported water dispersible CP NPs.
[35,68,138,181]
 The fluorescence 
stability of the obtained SiO2@CP@SiO2 NPs was also investigated by 
monitoring the fluorescence intensity change of SiO2@PFBT@SiO2 NPs upon 
incubation in PBS at 37 °C as an example. The fluorescence intensity of 
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SiO2@PFBT@SiO2 NP suspension remains ~92% of its initial value after 5 
day incubation in 1 × PBS. The excellent physical stability of CP NPs is 
ascribed to the protection of PFBT from the silica matrix.
[178-180]
 Moreover, the 
dried SiO2@CP@SiO2 NPs can be redispersed easily in ethanol or water due 
to the robust silica matrix. The high fluorescence QY and outstanding stability 
of SiO2@CP@SiO2 NPs benefit their biological applications.  
 
Figure 3.2 FE-TEM images of SiO2@PFBT@SiO2 NPs taken at different 
reaction times after adding TEOS (A-E) as well as APTES (F). All images 
share the same scale bar as that in F. 
It is generally observed that silica condensation in the presence of seed 
particles leads to core/shell morphologies.
[193,194]
 In the case of CPs and silica 
hybrid system, it is of interest to investigate the evolution of their structures at 
various reaction times. Taking PFBT as an example, the morphology and 
structure changes of CP-silica hybrid composites were studied with FE-TEM. 
In these experiments, PFBT dots were firstly obtained by precipitation method 
combining ultrasonication and solvent evaporation. Upon addition of TEOS, a 
sol-gel silica reaction proceeded in the suspension of PFBT dots. During the 
process of silica NP formation, aliquots were taken from the reaction solution 
20 min 40 min 60 min






at the time interval of 20 min, 40 min, 60 min, 3 h and 12 h after TEOS 
addition. The FE-TEM samples were prepared by directly dropping the 
reaction solution onto copper grid with subsequent drying in vacuum oven to 
minimize further TEOS precursor cross-linking. As shown in Figure 3.2, at the 
initial 20 min, small black PFBT dots are adsorbed on the silica NP surfaces. 
The sizes of PFBT dots and silica NPs are estimated to be ~3 nm and ~27 nm, 
respectively, from Figure 3.2A. The 3 nm PFBT dot should only contain a 
single polymer chain according to the estimation method described in the SI. 
Each PFBT dot is adsorbed at silica NP surface to form a PFBT dots-
punctuated silica NP structure. This interesting pattern may result from the 
phase separation between the immiscible PFBT and silica matrix components. 
The sizes of silica NPs increase to ~32 nm at 40 min (Figure 3.2B) and further 
grow to be ~35 nm (Figure 3.2C) and ~42 nm (Figure 3.2D) at the time 
intervals of 1h and 3h, respectively. There is little difference in silica NP size 
between samples prepared at 3h and 12h. During the time interval from 20 min 
to 12 h, the small black PFBT dots with a size ~3 nm can be clearly observed, 
further illustrating that hydrophobic PFBT dots cannot be encapsulated into 
hydrophilic silica matrix.  
It is worth noting that PFBT dots are not stable in the absence of silica 
matrix. The FE-TEM image of PFBT dots in ethanol/water mixture without 
TEOS addition is shown in Figure 3.3. No regular PFBT aggregates are 
observed in Figure 3.3, indicating small PFBT dots are not stable and 
aggregate easily even during the sample preparation. However, the silica 
substrate provides a robust support for PFBT dots, leading to an observable 




Figure 3.3 FE-TEM images of PFBT dots in ethanol/water mixture (v/v = 9:1) 
upon sonication.  
 
Figure 3.4 FE-TEM images of the mixture of SiO2 NPs and CP dots before 
APTES addition (A) and further reaction for 12 h in the presence of APTES 
(B). 
Interestingly, if SiO2 NPs and CP dots were synthesized separately, 
mixed and followed by 12 h stirring, the PFBT dots-punctuated SiO2 NPs 
could also be observed (Fig 3.4), which further confirm that CP dots tend to be 
absorbed at the SiO2 NP surfaces rather than encapsulated inside of SiO2 cores. 
After reaction for 12 h, APTES was further added into the reaction mixture, 
which was followed by another 12 h magnetic stirring. The FE-TEM image of 
the PFBT-silica mixture after 12 h reaction with APTES is shown in Figure 
3.4B. An interesting surface morphology evolution from PFBT dots-
punctuated silica NP patterns (Figure 3.2A-3.2E) to smooth silica NP surfaces 
100 nm




(Figure 3.2F) is observed. The disappearance of small black PFBT dots after 
APTES addition illustrates that PFBT dots are more likely encapsulated into 
the silica matrix upon APTES hydrolysis. It is noted that the size of 
SiO2@PFBT@SiO2 NPs can be easily controlled by changing the amount of 
TEOS precursor in the reaction. Doubling the TEOS concentration at the feed 
will lead to the size of SiO2@PFBT@SiO2 NPs increase from ~40 to ~65 nm. 
 
Figure 3.5 FE-TEM images of SiO2@PFBT@SiO2 NPs with the addition of 
APTES (upper row; A, B) or TEOS (bottom row; C, D) for further 12 h 
reaction followed by centrifuging once (A, C) and five times (B, D). The 
insets show the respective photographs of SiO2@PFBT@SiO2 NPs after 
centrifugation. All images share the same scale bar as that in D. 
The successful embedment of PFBT dots into silica layers was further 
confirmed by checking the colours of the precipitations and supernatants after 
centrifugation. The yellow precipitation and a clear supernatant are obtained 
by centrifugation of the reaction solution upon addition of APTES after 12 h 







times, the yellow colour is still present in the precipitate (Figure 3.5B inset), 
indicating that PFBT is stably embedded in silica NPs upon APTES cross-
linking. However, addition of TEOS into the PFBT dots-punctuated silica NP 
suspension followed by 12 h reaction cannot encapsulate PFBT dots in silica 
matrix and the supernatant remains yellow (Figure 3.5C inset). In fact, black 
PFBT dots are separated from silica NPs upon sonication/centrifugation 
washing as shown in Figure 3c. Further washing will only lead to clean silica 
NPs as white precipitates (the inset of Figure 3.5D). These data not only 
illustrate that CP dots cannot be embedded by further addition of TEOS 
reagents, but also indicate that CP dots adsorbed at silica surfaces are not 
stable and can be easily removed by sonication/centrifugation treatment. The 
other three CPs including PFP, PFVP and PFBTDBT can also be embedded 
into silica NPs with the assistance of APTES reagents (data not shown). Based 
on FE-TEM images from Figure 3.2 and Figure 3.4, a possible mechanism of 
the formation of SiO2@CP@SiO2 NPs has been proposed. 
Scheme 3.2 illustrates our proposed mechanism for the formation of 
SiO2@CP@SiO2 NPs. CP dots are firstly obtained in ethanol/water mixture 
(v/v = 9:1) through unltrasonication and THF evaporation (Scheme 3.2A). 




Scheme 3.2 Schematic illustration of the synthesis of SiO2@PFBT@SiO2 NPs 
with surface functionalized targeting peptide. (A) Sonicatioin of a THF 
solution of CPs in ethanol/water mixture (v/v = 9:1) affords single CP chain 
dots. (B) Addition of TEOS and ammonia into the CP dots dispersed solution 
leads to the formation of CP dots-punctuated silica NP pattern after reaction. 
(C) Further addition of APTES into the mixture results in CP dots embedded 
silica NPs with surface functionalized amine groups. (D1) Surface 
carboxylation with maleic anhydride in the presence of Et3N. (D2) Peptide 
conjugation via EDC/NHS reaction. 
 mixture, CP dots are obtained upon THF evaporation. After adding TEOS, a 
sol-gel procedure is performed which may take the present CP dots as 
nucleation centers.
[194]
 However, the hydrophilic silica component cannot 
grow homogeneously around hydrophobic CP dots due to their different 
hydrophilicities. On the other hand, the hydrophobic CP dots are not stable in 
the polar ethanol/water mixtures. To minimize the surface energy, CP dots 
tend to be adsorbed at the surfaces of the formed silica NPs rather than being 
encapsulated inside SiO2 core (Scheme 3.2B). As the aminopropyl groups 
from APTES can entangle with the hydrophobic CP dots, a self-assembled 







outwards is obtained upon APTES addition. The silane groups can further 
react with other monomers to form a cross-linked network, leading to the 
encapsulation of CP dots in silica matrix (Scheme 3.2C). Moreover, APTES 
monomers can render the surface of SiO2@CP@SiO2 NPs with functional 
amine groups, which facilitate further conjugation with peptides for targeted 
cellular imaging (Scheme 3.2D).  
3.3.2 Surface Functionalization with HER2 Targeting Peptide 
 
Scheme 3.3 The chemical structure of peptide, GGHAHFG. 
To demonstrate the potential of SiO2@CP@SiO2 NPs in biological 
application, SiO2@PFBT@SiO2 NPs were chosen as an example for targeted 
cellular imaging. As the positively charged amine groups tend to stick to the 
negatively charged cell membranes,
[162,163,192]
 we first modified NP surfaces 
with carboxyl groups using maleic anhydride to minimize the non-specific 
interaction between NPs and cells. The successful grafting of carboxyl groups 
at silica NP surfaces was confirmed by the zeta potential measurement. The 
zeta potential changed from +25 mV for SiO2@PFBT@SiO2 NPs with surface 
functionalized amine groups to -34 mV for SiO2@PFBT@SiO2 NPs with 
surface functionalized carboxyl acid groups (SiO2@PFBT@SiO2-COOH NPs). 
The peptide, GGHAHFG, which can selectively bind to HER2 overexpressed 
SKBR-3 breast cancer cells was chosen to endow NPs with targeting 
ability.
[195]
 The amine-bearing GGHAHFG peptide was synthesized by 
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standard solid-phase fluorenylmethoxy carbonyl peptide chemistry.
[195]
 The 
detailed synthetic procedure is illustrated in the experiment section and its 
structure is show in Scheme 3.3. The peptide was further purified by HPLC 
and confirmed by LC-MS characterization. Subsequent coupling between 
SiO2@PFBT@SiO2-COOH NPs and the peptide via the carbodiimide 
chemistry yielded fluorescent NPs (SiO2@PFBT@SiO2-Pep NPs) with 
targeting ability to HER2 positive cancer cell lines. The zeta potential of 
SiO2@PFBT@SiO2-Pep NPs was further changed to -11 mV, demonstrating 
the successful coupling between carboxyl groups at NP surface and amine 
groups of the peptides. 
3.3.3 Targeted Cellular Imaging 
To examine targeting ability of SiO2@PFBT@SiO2-Pep NPs, 
SiO2@PFBT@SiO2-COOH NPs were used as a control in cellular imaging by 
CLSM. In these experiments, SKBR-3 breast cancer cells were incubated with 
both NP suspensions in culture medium for 2 h at 100 μg·mL-1 NPs. The 
CLSM images of SKBR-3 breast cancer cells after incubation with both NPs 
are shown in Figures 3.6A and 3.6B, respectively. The higher fluorescence 
intensity in Figure 3.6A as compared to that in 3.6B clearly indicates that the 
peptide promotes cellular uptake due to the over-expressed HER2 on SKBR-3 
breast cancer cell membranes. The low fluorescence intensity from Figure 
3.6B also illustrates that the carboxyl groups grafted at NP surfaces reduce 
non-specific interaction between NPs and breast cancer cells.
[196-198]
 It is noted 
that there is no autofluorescence from the control cells without incubation of 
NPs under the same experimental conditions as shown in Figure 3.7A. The 3D 
image of SKBR-3 cells incubated with SiO2@PFBT@SiO2-Pep indicates that 
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NPs are mainly located in cell cytoplasm as shown in Figure 3.7B. As a 
control, NIH/3T3 fibroblast cells with low HER2 receptors were also 
incubated with both NP suspensions. The fluorescence intensity from NIH/3T3 
cells upon treatment with SiO2@PFBT@SiO2-Pep NPs (Figure 3.6C) is 
similar to that from cells upon treatment with SiO2@PFBT@SiO2-COOH NPs 
(Figure 3.6D). In addition, the fluorescence intensities from Figures 3.6C and 
3.6D are lower than that from Figure 3.6A. These data indicate the receptor 




Figure 3.6 Confocal fluorescence images of SKBR-3 breast cancer cells after 
2 h incubation with (A) SiO2@PFBT@SiO2-pep and (B) SiO2@PFBT@SiO2-






images of NIH/3T3 fibroblast cells after 2 h incubation with (C) 
SiO2@PFBT@SiO2-pep and (D) SiO2@PFBT@SiO2-COOH NP suspensions 
at 100 μg mL-1 NPs at 37 °C. All images have the same scale bar as that in A. 
 
Figure 3.7 (A) CLSM fluorescence image of SKBR-3 breast cancer cells 
without incubation with SiO2@PFBT@SiO2 NPs. (B) 3D CLSM fluorescence 
image of SKBR-3 breast cancer cells incubated with SiO2@PFBT@SiO2-pep 
NPs. 
 
Figure 3.8 Flow cytometry histograms of pure SKBR-3 breast cancer cells 
without NP incubation (black) and SKBR-3 breast cancer cells after 2 h 
incubation with SiO2@PFBT@SiO2-Pep NP (red) and SiO2@PFBT@SiO2-
COOH NP (blue) suspensions at 100 μg·mL-1 NPs. 
To obtain quantitative analysis of the targeting effect of the peptides on 
NP surfaces, flow cytometry was used to evaluate the intracellular 
fluorescence for SKBR-3 breast cancer cells upon incubation with both NPs. 
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SiO2@PFBT@SiO2-Pep NPs is ~2-fold higher as compared to that upon 
incubation with SiO2@PFBT@SiO2-COOH NPs as shown in Figure 3.8. 
These data further prove that peptide functionalized NPs favour their cellular 
uptake by SKBR-3 breast cancer cells due to receptor mediated endocytosis. 
3.3.4 Cytotoxicity and Photostability 
 
Figure 3.9 (A) Metabolic viability of SKBR-3 breast cancer cells after 
incubation with SiO2@PFBT@SiO2-pep at various NP concentrations for 24 h 
(gray) and 48 h (shadow). (B) Photostability of SiO2@PFBT@SiO2-pep NPs, 
PFBT NPs and fluorescein in SKBR-3 breast cancer cells upon continuous 
laser excitation at 488 nm for 10 min. I0 is the initial fluorescence intensity 
and I is the fluorescence intensity of the sample at different time points after 
illumination. 
The cytotoxicity of the SiO2@PFBT@SiO2-Pep NPs was evaluated by 
metabolic viability of NIH/3T3 fibroblast cells after incubation with NP 
suspensions at 100, 500 and 1000 g·mL-1 NPs for 24 h and 48 h, respectively. 
As shown in Figure 3.9A, the cell viabilities remain ~90% upon incubation 
with SiO2@PFBT@SiO2-pep NP suspension for 48 h at 1000 µg·mL
-1
 NP, a 
concentration that is 10-fold higher than that used for imaging. These results 
indicate the low cytotoxicity of the probe, which is ideal for targeted cellular 
imaging. The photostability of SiO2@CP@SiO2-Pep NPs in cellular 
environment was also investigated using SiO2@PFBT@SiO2-Pep NPs as an 
example under continuous laser scanning upon excitation at 488 nm. And the 






















































results were compared with those of fluorescein and PFBT NPs prepared with 
a typical precipitation method. The photostability results for 
SiO2@PFBT@SiO2-pep NPs, PFBT NPs and fluorescein are shown in Figure 
3.9B. After 10 min continuous laser illumination, the fluorescence intensity 
from SKBR-3 breast cells incubated with SiO2@PFBT@SiO2-Pep NPs 
decreases ~9%, which is obviously better than that for PFBT NPs. Under the 
same condition, the fluorescence intensity of fluorescein is almost completely 
quenched by laser illumination. The improved photostability for PFBT-SiO2-
Pep NPs as compared to PFBT NPs is expected to result from the robust silica 
matrix protection, which is beneficial for long term bioimaging studies.  
3.4 Conclusion 
In this chapter, we developed a simple yet effective strategy to prepare 
CP embedded NPs with a unique SiO2@PFBT@SiO2 structure via an 
integration of the precipitation method and a modified Stöber approach. 
Through FE-TEM investigation of the sample aliquots at various reaction 
times, the morphology change from CP dots-punctuated silica NPs to CP 
embedded silica NPs with smooth surfaces was observed. The successful 
encapsulation of CPs into silica matrix is resulting from the entanglement 
between hydrophobic CP chains and APTES reagents. The as-prepared NPs 
exhibit high QY, excellent photostability, low cytotoxicity and surface 
available functional groups, benefiting their conjugation with targeting 
ligands. By conjugation with a specific targeting peptide, the obtained NPs 
also allow targeted imaging of SKBR-3 breast cancer cells in a high contrast 
manner. Based on the developed strategy for simple synthesis of 
SiO2@CP@SiO2 NPs, further encapsulation of metal NPs into silica core can 
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easily lead to nanocomposites with metal enhanced fluorescence.
[200,201]
 
Furthermore, the incorporation of magnetic NPs could afford multimodal 
nanocomposites with imaging and therapeutic functions,
[69,202]
 which may 


















MICELLE/SILICA CO-PROTECTED CONJUGATED 
POLYMER NANOPARTICLES FOR TWO-PHOTON 
EXCITED BRAIN VASCULAR IMAGING 
4.1 Introduction  
Two-photon fluorescence imaging (TPFI) has recently attracted great 
research interest as a non-invasive technique to investigate complex biological 
issues.
[203-206]
 As TPFI is usually excited by NIR lasers (700-1000), it shows 
obvious advantages in deeper penetration depth, lower autofluorescence, less 
scattering and minimal phototoxicity as compared with the conventional one-
photon excited technique.
[207-210]
 To design a two-photon absorption (TPA) 
material, the two-photon action cross section (defined as ηδ, where η is the 
fluorescence QY and δ is the TPA cross section) is a paramount parameter to 
be considered. Large ηδ could allow spatial resolution go down to nanometer 
level or require less excitation power to reach the same resolution, which 
would further minimize photodamage to fluorescent materials as well as 
biological targets.
[211-215]
 Although a number of organic TPA materials show 
high ηδ values in organic solvents, their ηδ values, especially QY, decrease 
significantly due to severe aggregation caused fluorescence quenching after 
being transferred to aqueous media upon either ionic side chain modification 
or NP formulation.
[216-226]
 As a result, development two-photon excited probes 




CPs are macromolecules consisting of a delocalized π-electron system 
along the polymer backbone.
[26-28,33]
 Due to their large absorption coefficient 
and high fluorescence efficiency, CPs have been widely applied in 
optoelectronic devices.
[25,28]
 Advances in the progress of material and 
chemistry science have facilitated fine-tuning of CP structures and their 
photophysical properties, which have further broadened their applications to 
biological fields.
[27,28,33,34,65,101,128,138,140]
 As hydrophobic CPs cannot be 
dispersed in aqueous media, approaches to render CPs with good water 
dispersibility have been developed. So far, CPs have been mainly endowed 








types of CP NPs are generally formed with the hydrophobic CP chains in the 
core and hydrophilic side chains or matrices in the shell, resulting in water 
dispersible CP NPs. The reported CP NPs have shown large absorption cross 
section, moderate to high fluorescence QY and low toxicity upon one-photon 
excitation.
[68,101,138,140,188,228]
 However, the conventional issue of aggregation 
caused polymer fluorescence self-quenching is disregarded in these reported 
CP NPs. When CPs are in the solid or aggregated states, excitons could 
migrate along both interchains and intrachains to find the low energy traps, 
leading to non-radiative decay to result in severe fluorescence quenching.
[25,26]
 
Although the previously reported CP NPs have shown reasonable brightness, 
little research has been conducted to optimize their QYs.
[183,229-234]
 Improving 
fluorescence QYs of CP NPs would not only improve their brightness under 
one-photon excitation, but also increase two-photon action cross sections (ηδ), 
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both facilitating their biological applications. These benefits inspire us to 
further explore strategies that could increase the fluorescence QY of CP NPs.  
Previous studies have shown that blending CPs with other inert 
polymers or surfactants could reduce CP self-aggregation, leading to improved 
fluorescence QYs in the film state.
[229,230,234]
 In addition, stretching CP chains 
in the solid film of polystyrene could also optimize their photophysical 
properties.
[233]
 On the other hand, encapsulation of CPs in mesoporous silica 
matrices could also enhance their fluorescence QYs by blocking oxygen 
attacking to CP backbones.
[183,231]
 These studies imply that controlling the 
morphology or formation of CP domains in NP formulations may help to 
optimize their QYs. Recently, Tian et. al. reported that the fluorescence QY of 
PFBT NPs could be enhanced to 75% by decreasing CP concentration in NPs 
via a nanoprecipitation method.
[91]
 However, these CP NPs are built on weak 
hydrophobic interactions between CP backbones and amphiphilic matrices, 
which are not redispersable in water after drying.
[68,80,99,172,235 ]
  
In this contribution, we report a simple and efficient approach to 
improve the QY as well as TPA cross section of CP NPs through the 
micelle/silica co-protection strategy. By isolating CP chains in NP formulation 
and blocking oxygen and water molecule attacking to CPs, the QYs of the 
obtained CP NPs have been significantly improved. Taking PFBT as an 
example, CP NPs were encapsulated into the micelles formed by a triblock 
polymer, poly(ethylene oxide)-block-poly(propylene oxide)-block-
poly(ethylene oxide) (F127), followed by silica cross-linking. The obtained 
CP NPs show a QY of 75%, among the highest for PFBT based NPs.
[34,101,236]
 
In addition, PFBT loaded 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-
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N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000) NPs with a QY of 
40% were prepared according to the conventional precipitation 
method.
[173,228,237] 
Both static and dynamic photoluminescence comparison 
between the two types of PFBT NPs were conducted to understand the QY 
enhancement of NPs prepared with the micelle/silica approach. Moreover, 
single NP imaging was also conducted to compare their brightness using a 
commercial QD as reference. In conjugation with their large TPA cross 
section, excellent stability and benign biocompatibility, the obtained PFBT 
NPs have been successfully utilized in real-time two-photon brain vascular 
imaging.  
4.2 Experimental Section 
4.2.1 Materials 
PFBT was synthesized according to the previous report.
[235]
 DSPE-
PEG2000 was purchased from Avanti Polar Lipids, Inc. QD655 was purchased 
from Invitrogen (Eugene, OR, USA). F127, TEOS, dimethyldimethoxysilane 
(DMDMS), 4-(dicyanomethylene)-2-methyl-6-(p-dimethylamino-styryl)-4H-
pyran, MTT, penicillin-streptomycin solution, FBS, trypsin-EDTA solution, 
Evans blue, methanol and THF were purchased from Sigma-Aldrich. Milli-Q 
water was supplied by Milli-Q Plus System (Millipore Corporation, Breford, 
USA). NIH/3T3 fibroblast cells were provided by American Type Culture 
Collection. 
4.2.2 Characterization 
The UV-vis absorption spectra of CP NPs were measured using a 
Shimadzu UV-1700 spectrophotometer. The fluorescence spectra were 
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measured using a fluorometer (LS-55, Perkin Elmer, USA). The surface 
morphologies of PFBT-F127-SiO2 NPs were studied with FE-TEM (JEM-
2010F, JEOL, Japan). Average particle size and size distribution of the NPs 
were determined by DLS with particle size analyzer (90 Plus, Brookhaven 
Instruments Co. USA) at a fixed angle of 90° at room temperature. 
Fluorescence lifetime measurements were performed on a FluoTime 200 
TCSPC fluorescence platform from Picoquant GmbH (Berlin, Germany). A 
Titanium-sapphire 100 fs laser (Chameleon, Coherent) with second- and third-
harmonic generation was used as the excitation source with an excitation 
wavelength of 460 nm. In time correlated single photon counting (TCSPC) 
apparatus, the detector is a microchannel plate (MCP) PMT system HAM-
R3809U-50 (Hamamatsu) and has a spectral sensitivity from 160 nm to 850 
nm and instrument response function of 30 ps. Fluorescence lifetimes were 
extracted from the decay curves using commercially available fluorescence 
lifetime analysis software (FluoFit Pro. PicoQuant GmbH). Fluorescence 
decay curves were fitted using a two or three exponential mode. 
4.2.3 TPA Measurements 
TPA spectra were measured using two-photon induced fluorescence 
spectroscopy. The samples were excited with laser pulses of 100 fs produced 
by the mode-locked Ti:Sapphire laser (Spectraphysics Tsunami) with a 
repetition rate of 82 MHz, and a femtosecond optical parametric amplifier 
(OPA) was used within the spectral range 800-920 nm. The emission from 
PFBT aqueous suspensions was collected at a 90
o
 angle by a high numerical 
aperture lens and directed to a spectrometer’s entrance slit. Rhodamine 6G in 
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Where δ1 and δ2 are the TPA cross sections, F1 and F2 are the TPIF intensities, 
η1 and η2 are the fluorescence QYs, c1 and c2 are the concentrations, n1 and n2 
are the refractive indexes of solvents (1 corresponds to Rhodamine 6G, 2 is 
PFBT-F127-SiO2 NPs or Evans blue). The concentration of PFBT-F127-SiO2 
NP suspensions is calculated based on PFBT chains. 
4.2.4 Wide-Field Microscopy Imaging  
Fluorescence imaging of individual PFBT-F127-SiO2 NP, PFBT-
DSPE NPs and QD655 was performed with a Wide-Field Microscope (WFM) 
based on a Nikon ECLIPSE Ti-U inverted microscope frame. Light from a 
CW multi-line Ar ion laser (Melles Griot, CA, USA) emitting at 488 nm (0.55 
mW, measured above the glass cover slide) was ﬁber-coupled to a Nikon 
TIRF attachment and focused on the back aperture of a high NA objective 
(Nikon TIRF Apo 100x, NA = 1.49, oil immersion) after passing through an 
excitation filter (z488/10x ). Immersion oil (nD = 1.4790, Cargille, USA) was 
added between the high NA objective and the cover slip for index matching. 
The luminescence was collected by the same objective and after passing 
through the dichroic mirror (Z514RDC) and the emission ﬁlter (HQ530 LP ) it 
was directed onto an iXonEM+897 EMCCD camera (512 x 512 pixels, 150 
nm per pixel resolution, Andor Technology, Northern Ireland) connected to 
the side port of the microscope. The camera was connected to a computer 
furbished with camera-dedicated software to control the imaging parameters, 
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and for data acquisition. The samples were prepared by depositing a droplet of 
nanoparticle solutions on a glass cover slide, waiting for 30s for particles 
adsorption to the substrate, removing excess of liquid and drying under N2. 
Fluorescence intensity time-traces were obtained by acquiring 1000 
consecutive frames at a rate of 10 frames per second (100 ms exposure time, 
100 s time-traces) and extracting the number of counts per particle at each 
frame. The images were analysed using Andor Solis (ver. 4.14.30001.0, Andor 
Technology, Northern Ireland) and NIS Elements Ar 4.10.00 (Nikon, Japan) 
software. Statistical analysis of the data was performed using a custom 
analysis software (based on LabView, National Instruments) and OriginPro8 
software (OriginLab Corporation, USA). 
4.2.5 Synthesis of PFBT-F127-SiO2 NPs 
Micelle/Silica co-protection NPs (PFBT-F127-SiO2 NPs) were 
synthesized by modifying a previously reported experiment.
[239]
 Firstly, F127 
(100 mg) and PFBT (0.5 mg) were dissolved in 1.5 mL THF in a 20 mL glass 
vial and stirred for 3 h at room temperature to obtain a homogeneous solution. 
The THF solvent was then evaporated with a gentle nitrogen flow to yield a 
solid residue. Subsequently, 1.6 mL of 0.85 M hydrochloride solution was 
added into the solid F127/PFBT mixture, which was followed by 10 min 
sonication to form a homogeneous suspension.   Then, 180 µL of TEOS were 
added into the mixture and the solution was further stirred for 2 h at room 
temperature. 30 µL of DMDMS were subsequently added to terminate the 
silica shell growth at NP surfaces. The mixture was kept stirring for another 24 
h at room temperature. Finally, the solution was dialyzed with a cut-off 
molecular weight of 14 000 membrane against Milli-Q water for three days to 
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remove hydrochloride as well as unreacted reagents. The suspension was then 
purified with a 0.2 µm syringe filter to attain PFBT-F127-SiO2 NPs. 
4.2.6 Synthesis of PFBT-DSPE NPs 
A THF solution (1 mL) containing DSPE-PEG2000 (20 mg) and PFBT 
(0.1 mg) was poured into water (10 mL) upon sonication. The sonication 
lasted for 60 seconds at 12 W output using a microtip probe sonicator 
(XL2000, Misonix Incorporated, NY). The mixture was then stirred at room 
temperature overnight to evaporate THF. The NP suspension was further 
purified with a 0.2 µm syringe filter to obtain PFBT-DSPE NPs.  
4.2.7 Synthesis of PFBT-F127 NPs 
A THF solution (1 mL) containing F127 (20 mg) and PFBT (0.1 mg) 
was poured into water (10 mL) upon sonication. The sonication lasted for 60 
seconds at 12 W output using a microtip probe sonicator (XL2000, Misonix 
Incorporated, NY). The mixture was then stirred at room temperature 
overnight to evaporate THF. The NP suspension was further purified with a 
0.2 µm syringe filter to obtain PFBT-F127 NPs.  
4.2.8 Fluorescence Stability of PFBT-F127-SiO2 NPs 
The fluorescence stability of PFBT-F127-SiO2 NPs in 1 × PBS at 
37 °C was monitored by a fluorometer. At designed time interval, the 
fluorescence intensity of the incubated NP suspension was measured with the 
fluorometer, which was further expressed by I/I0, where I0 is the fluorescence 
intensity at 545 nm of fresh prepared PFBT-F127-SiO2 NP suspension and I is 
that of NPs after incubation at designed time, respectively. 
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4.2.9 Photostability of PFBT-F127-SiO2 NPs 
To compare the photostability of PFBT loaded F127 NPs with and 
without protection silica layer, 20 µL of both NPs at same PFBT 
concentrations were put in 96 well and irradiated at excitation wavelength of 
both 405 nm and 488 nm with 100% confluence. The fluorescence intensity at 
the designed time interval was measured by the fluorometer. The 
photostability was expressed by the ratio of the fluorescence intensity after 
excitation for a designated time interval to its initial value as a function of the 
exposure time. 
4.2.10 Cytotoxicity of PFBT-F127-SiO2 NPs 
NIH/3T3 fibroblast cells were cultured in DMEM containing 10% fetal 
bovine serum and 1% penicillin streptomycin at 37 °C in a humidified 
environment containing 5% CO2. The metabolic activity of NIH/3T3 
fibroblast cells was evaluated using MTT assays. NIH/3T3 cells were seeded 





24 h incubation, the medium was replaced by PFBT-F127-SiO2 NP 
suspensions at different NP concentrations, and the cells were then incubated 
for 24 and 48 h, respectively. After the designated time intervals, the wells 
were washed twice with 1 × PBS and 100 µL of freshly prepared MTT (0.5 
mg·mL
-1
) solution in culture medium was added into each well. The MTT 
medium solution was carefully removed after 3 h incubation in an incubator. 
DMSO (100 µL) was then added into each well and the plate was gently 
shaken for 10 minutes at room temperature to dissolve all the precipitates 
formed. The absorbance of MTT at 570 nm was monitored by the microplate 
reader (Genios Tecan). Cell viability was expressed by the ratio of absorbance 
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of the cells incubated with NP suspensions to that of the cells incubated with 
culture medium only. 
4.2.11 Real-Time Two-Photon Intravital Blood Vascular Imaging 
The experimental setup for two-photon intravital blood vascular 
imaging is described elsewhere.
[240]
 First, a skin incision was made to expose 
the skull. The head was then immobilized on a custom-built intravital imaging 
stage.
[241]
 A a small 2 mm circular piece of parietal bone was excised using a 
dental drill, exposing the meninges and the brain of the immobilized mouse. 
For TPFI experiments, mice were anesthetized (150 mg/kg ketamine and 10 
mg/kg xylazine) and placed on a heating pad to maintain a core body 
temperature of 37 °C throughout each imaging procedure. 200 µL of PFBT-
F127-SiO2 NPs at the PFBT concentration of 2 µM were administered via 
retro-orbital injection prior to imaging. As a control, a group of mice without 
PFBT-F127-SiO2 were also imaged under the same experimental conditions. 
All procedures were performed under the guidelines of Institutional Animal 
Care and Use Committee. A TriM Scope II single-beam two-photon 
microscope (LaVision BioTec) with a tunable 680-1080 nm laser (Coherent) 
was used to acquire the images. PFBT-F127-SiO2 NPs and second harmonic 
generation were excited at 810 nm, and the emitted light was split by 560 nm 
and 495 nm long pass mirrors and detected through 542/27 nm and 390/40 nm 
filters, respectively.  
Chapter 4 
93 
4.3 Results and Discussion 
4.3.1 Synthesis and Characterization of PFBT-F127-SiO2 NPs 
 
Scheme 4.1 (A) Chemical structure of F127 and PFBT. (B) Schematic 
illustration of the fabrication of PFBT-F127-SiO2 NPs.  
The PFBT loaded fluorescent NPs were prepared via a one-pot reaction 
using the commercially available triblock polymer F127 as the template.
[239]
 
The chemical structures of PFBT and F127 are shown in Scheme 4.1A. PFBT 
was synthesized according to our previous report.
[235]
 F127 is a biocompatible 
triblock copolymer composed of a central hydrophobic chain of 
poly(propylene oxide) (PPO) connected with two hydrophilic chains of 
poly(ethylene oxide) (PEO). To prepare the NPs, the THF solution of F127 
and PFBT was dried with nitrogen blow. Upon sonication in hydrochloride 
solution, micelles were formed with the entangled hydrophobic PPO segments 
and PFBT chains in the core and the hydrophilic PEO segments extending into 
aqueous phase, which could help to prevent nonspecific interaction with 










of hydrophilic PEO shell through TEOS hydrolysis under acidic condition.
[239]
 
Adding DEDMS could terminate the silicate cross-linking and provide 
micelles with thin silica shells (Scheme 4.1B). The mixture was further 
dialyzed to remove excess hydrochloride and excess reactants. The silica cross 
linked PFBT doped F127 NPs (PFBT-F127-SiO2 NPs) were finally obtained 
through filtration with 0.2 µm membrane filter.  
 
Figure 4.1 (A) UV-vis (dash-dotted line) and PL (solid line) spectra of PFBT-
F127-SiO2 NPs (red) and PFBT-DSPE NPs (black) at 25 µg/mL of PFBT. (B) 
Fluorescence decay curves of PFBT-F127-SiO2 NPs (red) and PFBT-DSPE 
NPs (black). Instrument response (IRF) (blue) is also indicated. FE-TEM 
images of PFBT-F127-SiO2 NPs (C) and PFBT-DSPE NPs (D). 
FE-TEM shows that PFBT-F127-SiO2 NPs have a relative uniform 
size of 12 nm as shown in Figure 4.1C. No obvious size variation of PFBT-
F127-SiO2 NPs was observed in 10 days by laser light scattering measurement 
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(Figure 4.2), indicating their excellent colloidal stability. In addition, PFBT 
loaded DSPE-PEG2000 NPs (PFBT-DSPE NPs) were also synthesized through 
the conventional reported precipitation methods.
[173,228]
 The detailed 
preparation procedure is illustrated in the experimental section. The size of 
PFBT-DSPE NPs was estimated to be 30 ± 10 nm using FE-TEM as shown in 
Figure 4.1D.  
The UV-vis absorption and PL spectra of PFBT-F127-SiO2 NP and 
PFBT-DSPE NP suspensions are shown in Figure 4.1A. Both NP suspensions 
have similar absorption peaks around 320 nm and 460 nm, which are ascribed 
to the fluorene and benzothiadiazole units, respectively. Although both NPs 
exhibit similar absorbance, PFBT-F127-SiO2 NPs show much higher 
fluorescence intensity than that of PFBT-DSPE NPs. The QYs of PFBT-F127-
SiO2 NPs and PFBT-DSPE NPs were measured to be 75% and 40% using 4-
(dicyanomethylene)-2-methyl-6-(p-dimethylamino-styryl)-4H-pyran in 
methanol as the standard. To the best of knowledge, the 40% QY of PFBT-
DSPE NPs is higher than most reported PFBT NPs, while the 75% QY of 
PFBT-F127-SiO2 NP is the highest among PFBT NPs.
[34,80,101,232]
  
To understand the high QY of PFBT-F127-SiO2 NPs as compared to 
PFBT-DSPE NPs as well as other reported PFBT based NPs, the different 
condition of PFBT chains in their respective NP formulations should be 
clarified. One of the most important different environments between PFBT-
F127-SiO2 NPs and PFBT-DSPE NPs is that there is a protection silica shell at 
the surface of PFBT-F127-SiO2 NPs. As well known, the silica matrices or 
silica layers at NP surfaces could help to prevent the attack of organic 
fluorophores and CPs by water or oxygen molecules, which facilitate the 
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increase of NP QYs.
[175,180,230,231,242]
  To verify this hypothesis, PFBT-F127 
NPs without silica shell were also synthesized according to the procedure 
listed in the experimental section. However, PFBT encapsulated F127 NPs 
without silica protection layers (PFBT-F127 NPs) also shows a higher QY of 
70%, which is only a little lower that that with silica layer (PFBT-F127-SiO2 
NPs) as shown in Figure 4.3A. This comparison demonstrates that the F127 
matrices could already help prevent the attack of PFBT chains by water or 
oxygen molecules and the protection effect of the silica layer in avoiding 
quencher attack is not the dominant factor to greatly enhance the fluorescence 
QY. One noteworthy function of the silica layer is that it could help to 
improve the photostability of PFBT-F127-SiO2 NPs as compared to that 
without silica layers (PFBT-F127 NPs) upon laser irradiation (Figure 4.3B). 
Carefully comparing the F127 matrix with the DSPE-PEG2000
 
matrix, we find 
that F127 chain have a much longer hydrophobic PPO segments (201 
hydrophobic carbon atoms) than that of DSPE-PEG2000 matrix (34 
hydrophobic carbon atoms). The longer hydrophobic PPO segments in F127 
chains could entangle with PFBT backbones more efficiently than that in 
DSPE-PEG2000 matrices, leading to successful isolation of the CPs in the 
PFBT-F127 NPs. In theory, the isolation of CP chains could help to reduce CP 
interchain interaction, benefiting their fluorescence QY enhancement.
229,230,234
 
As a result, the high fluorescence QY of PFBT-F127-SiO2 NPs should be 
mainly ascribed to the sufficient isolation and protection of PFBT chains by 
the longer hydrophobic PPO segments from F127 matrices and less protection 




Table 4.1 Emission decay components of PFBT-F127-SiO2 NPs and PFBT-
DSPE NPs. 
sample 1 (ns) A1 (%) 2 (ns) A2 (%) 3 (ns) A3 (%) av 
2
 
F127 0.16 39.44 0.71 39.55 2.96 21.01 0.97 1.04 
DSPE 0.18 48.14 0.52 49.90 2.15 1.96 0.38 1.03 
     ∑      , where  is the decay time and A is the amplitude; 
2 
is the 
value of fit. 
 
Figure 4.2 The DLS size evolution of PFBT-F127-SiO2 NPs in 10 days. 
 
Figure 4.3 (A) UV-vis (dashed) and PL (solid) spectra of PFBT loaded F127 
NPs with (red) and without (black) silica layers, respectively. (B) 
Photostability of PFBT loaded F127 NPs with and without the protection silica 
layer upon continuous laser excitation at both 405 nm and 488 nm with 100% 
light confluence, where I0 is the initial fluorescence intensity and I is the 
fluorescence intensity of the sample at different time points after illumination. 















































































 To better understand the enhanced QY of PFBT-F127-SiO2 NPs as 
compared to that of PFBT-DSPE NPs, the fluorescence lifetimes for both NPs 
were investigated with the FluoTime 200-Fluorescence system. The QY () 
and fluorescence lifetime () of a fluorophore is given by  =  / ( + knr) and 




 where  is the radiative decay rate, and knr is the non-
radiative decay rate. In general, the radiative lifetime () of a fluorophore is its 
intrinsic property, which is considered to be a constant. As such, the changes 
in QY () and lifetime () are mainly due to the change in non-radiative decay 
rate (knr), and the values of QY () and lifetime () of a fluorophore should 
change in the same direction, either both increasing or both decreasing.
[243]
 As 
shown in Figure 4.2, the average fluorescence lifetime of PFBT-F127-SiO2 
NPs (0.97 ns) is much longer than that of PFBT-DSPE NPs (0.38 ns). The 
elongated lifetime of PFBT-F127-SiO2 NPs should result from the blocking of 
non-radiative decay pathways of PFBT chains through minimizing their self-
aggregation and environment attack, resulting in the observed higher QY of 
PFBT-F127-SiO2 NPs. In addition, the respective emission decay components 
of PFBT-F127-SiO2 NPs and PFBT-DSPE NPs are shown in Table 4.1. 
Generally, the longer lifetime component (2.96 ns for PFBT-F127-SiO2 NPs 
and 2.15 ns for PFBT-DSPE NPs) represents fluorescence decay from the 
isolated polymer chains.
[230,234]
 The other two short decay components are 
related to quenching process induced by self-aggregation or attacking from 
molecular quenchers (e.g. oxygen and water).
[234]
 Clearly, the data in Table 4.1 
validate that the micelle/silica approach is able to increase the percentage of 
the isolated single chain and decrease the environment quenching influence on 
CP fluorescence.  
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4.3.2 Single NP Imaging of PFBT-F127-SiO2 NPs 
To further investigate the behavior of individual PFBT-F127-SiO2 NP 
and PFBT-DSPE NP, single NP fluorescence imaging was conducted upon 
excitation at 488 nm, using a commercial QD655 as the benchmark. The 
intensity time-traces of PFBT-F127-SiO2 NPs, PFBT-DSPE NPs and QD655 
were collected by integrating the emission from individual NPs over 100 s  
 
Figure 4.4 Histograms of the total number of photons collected for (A) PFBT-
F127-SiO2 NPs, (B) PFBT-DSPE NPs and (C) QD655. Note the different 
binning and scales for A, B and C, λex = 488 nm for all samples. 
for 1000 consecutive frames. The histograms of the total number of photon 
emitted by each type of NPs in 100 s are shown in Figure 4.4A to 4.4C. The 
average number of the total photons emitted by single PFBT-F127-SiO2 NP 
(9.4105 counts) is similar with that of PFBT-DSPE NP (9.6105 counts), and 
much higher than that QD655 (2.8105 counts). Considering the smaller size 
of PFBT-F127-SiO2 NPs (~12 nm) than that of PFBT-DSPE NPs (~30 nm), 
on average, each PFBT-F127-SiO2 NPs should has less CP chains than PFBT-
DSPE NPs. The similar counts for both NPs further support the higher 








































































4.3.3 Fluorescence Stability and Cytotoxicity of PFBT-F127-SiO2 NPs 
 
Figure 4.5 (A) PL intensity evolution of PFBT-F127-SiO2 NPs upon 
incubation with 1 × PBS at 37 °C for different times, where I0 is the 
fluorescence intensity at 545 nm for the fresh NP suspension and I is that for 
NPs after incubation for different time, respectively. The inset shows the PL 
spectra of freshly prepared PFBT-F127-SiO2 NPs (black) and after 10 days 
incubation with 1 × PBS at 37 °C (red). (B) Metabolic viability of NIH/3T3 
fibroblast cells after incubation with PFBT-F127-SiO2 NP suspensions at 
various NP concentrations for 24 h and 48 h, respectively. 
Excellent fluorescence stability in aqueous media is essential for 
biological applications, especially in long-term studies. The fluorescence 
intensity evolution of PFBT-F127-SiO2 NPs was investigated by monitoring 
their fluorescence changes upon incubation with PBS at 37 °C for different 
time. As shown in Figure 4.5A and its inset, no obvious fluorescence decrease 
is observed after 10 days incubation of the PFBT-F127-SiO2 NPs with 1 × 
PBS at 37 °C, suggesting outstanding stability of the prepared NPs. To 
evaluate the cytotoxicity of the PFBT-F127-SiO2 NPs, the metabolic viability 
of NIH/3T3 fibroblast cells after incubation with NPs was investigated at 
different NP concentrations. Figure 4.5B shows the cytotoxicity results of the 
PFBT-F127-SiO2 NPs upon incubation with suspensions at 100 to 1000 
g/mL NPs for 24 h and 48 h, respectively. The cell viabilities remain ~90% 
upon incubation with PFBT-F127-SiO2 NPs for 48 h at 1000 µg/mL 
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concentration, indicating the low cytotoxicity of the probe, which is ideal for 
biological imaging. 
4.3.4 TPA Spectra of PFBT-F127-SiO2 NPs 
In vivo visualizing blood vessels is essential to investigate biological 
processes, such as angiogenesis, vascular leakage, and leukocyte 
extravasation.
[240,244,245]
 Materials with large TPA cross section is beneficial to 
achieve a good imaging resolution. The TPA spectra of PFBT-F127-SiO2 NP 
aqueous suspensions were measured with a TPIF microscope with a tunable 
Ti:Sapphire laser. As a comparison, the TPA property of Evans blue, a 
commonly used blood vascular imaging contrast,
[240]
 was also investigated. 
The relative TPFI intensities of PFBT-F127-SiO2 NPs and Evans blue were 
measured using Rhodamine 6G in methanol as the standard. The emission 
signals were collected from an excitation spectra ranging from 800 nm to 920 
nm at 10 nm intervals. Details of the measurement and calculation method are 
provided in the experimental section. The TPA cross section of PFBT-F127-
SiO2 NPs was calculated based on CP chain concentrations and the obtained 
TPA spectra of PFBT-F127-SiO2 NPs as well as Evans blue are shown in 
Figure 4.6 The maximum δ is ~1085 GM at 810 nm, which gives a ηδ value of 
814 GM, which is much larger than that of Evans blue. This larger TPA active 
cross-section of PFBT-F127-SiO2 NPs in aqueous media is highly desirable to 




Figure 4.6 TPA spectra of PFBT-F127-SiO2 NPs (based on CP chain 
concentration) and Evans blue in water. 
4.3.5 Intravital TPFI  of PFBT-F127-SiO2 NPs 
After investigate the TPA properties of PFBT-F127-SiO2 NPs, their biological 
application was demonstrated by labeling and visualizing the brain vasculature 
of an anaesthetized mouse using two-photon microscopy. The PFBT-F127-
SiO2 NPs were administered intravenously prior to imaging and the two-
photon excited fluorescence was collected at 542  27 nm upon excitation at 
800 nm.
[240]
 Figures 4.7A-4.7G show representative images of the blood 
vessels at various depth in the brain imaged through a cranial window over 20 
minutes. The major blood vessels as well as the smaller capillaries in the pia 
mater could be visualized with the help of PFBT-F127-SiO2 NPs. In addition, 
no large aggregates are observed in brain blood vessels, owing to the PEO 
segments on the surface of NPs blocking nonspecific binding. More 
importantly, microvasculature deep in the brain that lies beyond the pia matter 
(500 µm) could still be detected with high resolution (Figure 4.7G). As a 
control, no fluorescence was detected from the brain blood vessels before 
PFBT-F127-SiO2 NPs was administered (Figure 4.8). The 3D reconstruction 































(Figure 4.7H) and Z-projected (Figure 4.7I) images of the brain vasculature 
illustrate that our probe can efficiently label the blood vasculature in in vivo 
condition. 
 
Figure 4.7 Intravital TPFI of PFBT-F127-SiO2 NPs stained blood vessels of 
mice brain at depth of 0 µm (A), 50 µm (B), 100 µm (C), 200 µm (D), 300 µm 
(E), 400 µm (F) and 500 µm (G), and the respective Z-projected image (H) as 
well as 3D image (I). All the images share the same scale bar of 50 µm. 
50 µm0 µm 100 µm








Figure 4.8 Images of intravital TPFI of brain blood vessels in mouse without 
injection of PFBT-F127-SiO2 NPs. The scale bar is 50 µm.  
 
4.4 Conclusion 
In conclusion, we developed a simple and effective strategy to increase the 
QY as well as tow-photon action cross section of PFBT NPs using F127 as the 
matrices and silica shells as the protection layer. The obtained PFBT-F127-
SiO2 NPs show a high QY of 0.75 by reducing CP self-aggregation and 
environment quenching, which was evidenced by fluorescence lifetime 
measurements. In addition, single NP study illustrates that the bright PFBT-
F127-SiO2 NPs exhibit good photostability as compared to PFBT-DSPE NPs. 
Moreover, PFBT-F127-SiO2 NPs show a large two-photon action cross section 
and non-toxic biocompatibility, benefiting their biological applications as 
TPFI probes. Real-time in vivo TPFI reveals that PFBT-F127-SiO2 NPs could 
be utilized as an effective TPA probe for in vivo blood vascular imaging with a 
deep depth of 500 µm and high contrast. The strategy developed in this study 
should provide a new avenue for CP NPs in both one-photon and two-photon 




ORGANIC NANOPARTICLES WITH PROCESSABLE 
CONJUGATED POLYMER FOR PHOTOACOUSTIC 
VASCULAR IMAGING  
5.1 Introduction 
Photoacoustic (PA) imaging is an emerging technique in biological 
imaging due to its noninvasive, high resolution and deep penetration 
characteristics.
[13,246-248]
 Currently, PA imaging technique has three major 
implementations: dark-field photoacoustic microscopy (PAM), photoacoustic 
computed tomography (PAT) and photoacoustic endoscopy (PAE). Whereas 
PAM and PAE usually aim to image millimeter deep at micrometer-scale 
resolution, PAT can be implemented for deeper imaging ability with few 
hundred micrometer-scale resolution. PA imaging is based on the 
measurement of ultrasonic waves generated by the targets upon pulse laser 
absorption.
[12,249]
 Utilizing the intrinsic optical contrast molecules in biological 
systems, PA imaging has been successfully applied in imaging blood 
vessels,
[250]
 studying brain hemodynamic changes,
[14,251-253]
 and visualizing 
tumor angionenesis
[254]
. Unfortunately, most intrinsic optical contrast agents, 
such as hemoglobin and deoxy-hemoglobin, absorb light in the visible spectral 
region, where exists the overwhelming light scattering in biological tissues, 
resulting in limited sensitivity and resolution.
[246,247]
 In addition, many 
biological objects (e.g. disease signal molecules) do not absorb light in any 





 Exogenous contrast agents can not only enhance the 
sensitivity of PA imaging by enabling the absorption region in NIR region to 
reduce the scattering interference but also target the specific biological objects 
to generate sufficient PA signals for accurate analysis.
[250,255-258]
  
To increase the detection sensitivity and resolution, several optically 
absorptive contrast agents have been developed for biological applications.
[258-
261]
 So far, the most widely used PA contrast agents are gold nanomaterials 
including nanorods, nanocages and nanoshells.
[12,262-267]
 In addition, several 
reports have also utilized carbonous nanomaterials, such as carbon nanotubes 
and polyhydroxy fullerenes.
[268-271]
 The recent research interest in the 
development of PA probes has been extended to NIR dyes and organic NPs 
due to their benign biocompatibility.
[250,254,256,272,273]
 For example, Indocyanine 
green (ICG), a nontoxic and water soluble dye, can help to visualize more 
detailed vasculature structures in sentinel lymph nodes brain as compared to 
the intrinsic signals.
[250,256,273]
 In addition, organic dye loaded polymer NPs 
and porphysome organic NPs have also been utilized as PA contrast agents for 
targeted tumor imaging.
[256,274,275]
 These successful examples have motivated 
researchers to look for organic biocompatible materials with large absorption 
coefficients for further improvement of PA contrast. 
CPs are macromolecules characterized with π-conjugated backbone 
and readily modified electrical and optical properties, which have been widely 
applied in optoelectronic devices and biomedical field.
[25-28,51]
 The extensive 
bioimaging studies based on CPs have revealed that they exhibit good 
photostability and benign biocompatibility.
[33,35,36,98,128,188]
 In view of their 
conjugated backbones, CPs generally show much larger absorption coefficient 
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as compared to their small molecular counterparts, which provide the new 
opportunity for them to serve as organic exogenous contrast agents for PA 
imaging. Recently, polypyrrole-based NPs, prepared through oxidative 
polymerization of pyrrole monomer using PVA as stabilizing agent and FeCl3 
as catalyst, have been successfully applied as PA contrast agent in deep tissue 
imaging.
[12]
 The NPs show strong absorption in the NIR region with high PA 
signals. However, polypyrrole is not soluble in almost any organic solvent and 
the chemical processability of this polymer is poor. In addition, the NPs 
generated from in-suit polymerization can be hardly modified with functional 
groups for further modification. Nonetheless, the successful application of 
polypyrrole for PA imaging has opened new opportunities for the development 
of CP based PA reagents.  
The well-developed nanoparticle encapsulation strategy requires the 
encapsulated polymers to be soluble in organic solvents. An effective strategy 
to obtain CPs with NIR absorption is the combination of electron-rich and 
electron-deficient moieties in an alternating fashion to form alternating donor-
acceptor (D‒A) backbone structure. In this regard, thiadiazoloquinoxaline 
derivatives are good electron acceptors due to their high electron-deficiency, 
which are ideal for achieving small band gap CPs with long wavelength 
absorption. In this chapter, we synthesize poly[9,9-bis(4-(2-
ethylhexyl)phenyl)fluorene-alt-co-6,7-bis(4-(hexyloxy)phenyl)-4,9-
di(thiophen-2-yl)thiadiazolo-quinoxaline] (PFTTQ) and its NP formation to 
yield a potential PA probe. Using DSPE-PEG2000 as the encapsulation 
matrix,
[173,228]
 the obtained PFTTQ loaded DSPE-PEG2000 NPs (PFTTQ NPs) 
show strong absorbance in NIR range with high non-radiative QY. To evaluate 
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the PA signal from the PFTTQ NPs, Au NRs with a strong NIR extinction 
coefficient have also been synthesized. The PA intensities of both PFTTQ NPs 
and Au NRs with the same absorbance have been studied using a 50-MHz 
dark field confocal PAM system. In addition, the photostability and 
biocompatibility of the PFTTQ NPs have also been investigated. The potential 
of PFTTQ NPs as a PA probe was further demonstrated using brain vascular 
imaging as an example.  
5.2 Experimental Section 
5.2.1 Materials 
DSPE-PEG2000 was purchased from Avanti Polar Lipids, Inc. MTT, 
penicillin-streptomycin solution, FBS, trypsin-EDTA solution, methanol and 
THF, 4-iodophenol, 1-bromohexane, trimethylsilylaceylene, copper iodide, 2-
(tributylstannyl)thiophene, N-bromosuccinimide (NBS), palladium(II) acetate 
(Pd(AcO)2), tricyclohexylphosphine (Cy3P) and tetraethylammonium 
hydroxide (Et4NOH) solution (35 wt% in H2O) were purchased from Sigma-
Aldrich and used as received. Toluene used for Suzuki polycondensation was 
pretreated with sulfuric acid followed by distillation. All other chemical 









prepared according to previous reports. Milli-Q water was supplied by Milli-Q 
Plus System (Millipore Corporation, Breford, USA). NIH/3T3 fibroblast cells 
were provided by American Type Culture Collection. 
5.2.2 Characterization 
Nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 
Avance 500 NMR spectrometer (500 MHz for 1H, referenced to TMS at δ = 
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0.00 ppm and 125 MHz for 
13
C, referenced to CDCl3 at 77.0 ppm). Average 
particle size and size distribution of the NPs were determined by DLS with 
particle size analyzer (90 Plus, Brookhaven Instruments Co. USA) at a fixed 
angle of 90° at room temperature. FE-TEM studies were performed on a JEOL 
JEM-2010 electron microscope with an accelerating voltage of 200 kV. 
UV‒vis spectra were collected on a Shimadzu UV-1700 spectrometer. All 
UV-vis spectra were collected at 24 ± 1 
o
C. MilliQ water (18.2 MQ) was used 
for all the experiments.  
5.2.3 PA Measurement 
Polyethylene tubing (~20 cm) was filled with various designed 
samples. Afterwards, the tubing was positioned at a depth of the transducer’s 
focus, i.e., the depth of 9 mm with respect to the transducer in water tank. The 
system was maintained in a 25°C water bath throughout the experiment. The 
contrast changes of the developed probes were imaged using a 50-MHz dark 
field confocal PAM system with 32 × 61-m resolution (Scheme 5.3). An 
optical parametric oscillator pumped by a frequency-tripled Nd:YAG Q-
switched laser was employed to provide ~4-ns laser pulses at a pulse repetition 
rate of 10 Hz. Laser energy was delivered by a 1-mm multimode fiber. The 
fiber tip was coaxially aligned with a convex lens, an axicon, a plexiglass 
mirror, and an ultrasonic transducer on an optical bench, forming dark field 
illumination that is confocal with the focal point of the ultrasonic transducer. 
Laser pulses at two visible wavelengths, 800 (λ480) was used for PA wave 
excitation. A large numerical-aperture, wideband 50-MHz ultrasonic 
transducer was employed to allow for the efficient collection of PA signals. 
The scanning step size was 20 m for each B-scan.  
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The PA signals received by the ultrasonic transducer were pre-
amplified by a low-noise amplifier (noise figure 1.2 dB, gain 55 dB, AU-3A-
0110, Miteq, USA), cascaded to an ultrasonic receiver (5073 PR, Olympus, 
USA), then digitized and sampled by a computer-based 14-bit analog to digital 
(A/D) card (CompuScope 14200, GaGe, USA) at a 200-MHz sampling rate 
for data storage. Fluctuations in the laser energy were monitored by a 
photodiode (DET36A/M, Thorlabs, USA). Recorded photodiode signals were 
applied to compensate for PA signal variations caused by laser energy 
instability before any further signal processing. No signal averaging was 
performed in this study. Note that the amplitude of the envelope-detected PA 
signal was used in the imaging analysis. 
5.2.4 Synthesis of Monomers and PFTTQ  
1-Hexyloxy-4-iodobenzene (1). To a solution of tetrabutylammonium 
bromide (100 mg, 0.31 mmol) and 4-iodophenol (5 g, 22.7 mmol) in aqueous 
possium hydroxide (50 mL, 50wt%) at 100 
o
C was added 1-bromohexane 
(4.37 mL, 31.1 mmol) in one portion. The reaction was kept for 1 h at this 
temperature. After stopping the reaction, the mixture was extracted with 
dichloromethane, washed with water and dried over MgSO4. After solvent 
removal, the residue was purified by silica gel column chromatography using 
hexane as eluent to provide 1-hexyloxy-4-iodobenzene as colorless liquid (6.3 
g, yield: 91%). 
1
H NMR (500 MHz, CDCl3, ppm) δ: 7.53 (d, J = 8.5 Hz, 2 H), 
6.67 (d, J = 8.5 Hz, 2 H), 3.91 (t, J = 6.5 Hz, 2 H), 1.75 (m, 2 H), 1.45 (m, 2 
H), 1.33 (m, 4 H), 0.91 (t, J = 7 Hz, 3 H). 
13
C NMR (125 MHz, CDCl3, ppm) δ: 
159.06, 138.16, 116.97, 82.40, 68.16, 31.57, 29.14, 25.69, 22.60, 14.04. 
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((4-(Hexyloxy)phenyl)ethynyl)trimethylsilane (2). To a solution of 
1-hexyloxy-4-iodobenzene (3.25 g, 10.69 mmol), copper iodide (104 mg, 0.54 
mmol) and Pd(PPh3)2Cl2 (150 mg, 0.21 mmol) in 
diisopropylamine/tetrahydrofuran (30/10 mL) at room temperature under 
argon atmosphere was added trimethylsilylaceylene (2.45 g, 25 mmol) via 
syringe. The reaction was performed at room temperature overnight. The 
mixture was diluted with dichloromethane, filtered through a celite pad, 
concentrated under reduced pressure and purified by silica gel column 
chromatography using hexane as eluent to afford ((4-
(hexyloxy)phenyl)ethynyl)trimethylsilane as colorless liquid (2.8 g, yield: 
95%). 
1
H NMR (500 MHz, CDCl3, ppm) δ: 7.38 (d, J = 8.5 Hz, 2 H), 6.79 (d, 
J = 8.5 Hz, 2 H), 3.94 (t, J = 6.5 Hz, 2 H), 1.75 (m, 2 H), 1.45 (m, 2 H), 1.33 
(m, 4 H), 0.89 (t, J = 7 Hz, 3 H), 0.29 (s, 9 H). 
13
C NMR (125 MHz, CDCl3, 
ppm) δ: 159.37, 133.44, 115.02, 114.36, 105.34, 92.27, 68.07, 31.57, 29.15, 
25.68, 22.58, 14.00, 0.08.  
1-Ethynyl-4-(hexyloxy)benzene (3). A round bottle flask was charged 
with ((4-(hexyloxy)phenyl)ethynyl)trimethylsilane (2.74 g, 10 mmol), 
potassium hydroxide (5.6 g, 100 mmol), THF (50 mL), methanol (25 mL) and 
water (18 mL). The mixture was stirred at room temperature under argon 
atmosphere for 1 h. After solvent removal, the residue was subsequently 
redissolved in dichloromethane, washed with water and dried over MgSO4. 
The crude product was purified by silica gel column chromatography using 
hexane as eluent to yield 1-ethynyl-4-(hexyloxy)benzene as colorless liquid 
(1.9 g, yield: 94%). 
1
H NMR (500 MHz, CDCl3, ppm) δ: 7.42 (d, J = 8.5 Hz, 2 
H), 6.83 (d, J = 8.5 Hz, 2 H), 3.95 (t, J = 6.5 Hz, 2 H), 3.00 (s, 1 H), 1.77 (m, 2 
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H), 1.46 (m, 2 H), 1.35 (m, 4 H), 0.93 (t, J = 7 Hz, 3 H). 
13
C NMR (125 MHz, 
CDCl3, ppm) δ: 159.59, 133.57, 114.49, 113.95, 83.80, 75.67, 68.08, 31.59, 
29.17, 25.71, 22.61, 14.03. 
1,2-Bis(4-(hexyloxy)phenyl)ethyne (4). A solution of 1-ethynyl-4-
(hexyloxy)benzene (2.02 g, 10 mmol), 1-hexyloxy-4-iodobenzene (3.19 g, 
10.5 mmol), copper iodide (95 mg, 0.50 mmol) and Pd(PPh3)2Cl2 (140 mg, 
0.20 mmol) in diisopropylamine (30 mL) was stirred for 20 h at room 
temperature under argon atmosphere. After the removal of solvent, the residue 
was subsequently redissolved with dichloromethane, washed with water and 
dried over MgSO4. The crude product was purified by silica gel column 
chromatography (hexane/dichloromethane = 9/1) to afford compound 1,2-
bis(4-(hexyloxy)phenyl)ethyne as white solid (2.6 g, yield: 69%). 
1
H NMR 
(500 MHz, CDCl3, ppm) δ: 7.42 (d, J = 8.5 Hz, 4 H), 6.84 (d, J = 8.5 Hz, 4 H), 
3.97 (t, J = 6.5 Hz, 4 H), 1.78 (m, 4 H), 1.46 (m, 4 H), 1.35 (m, 4 H), 0.91 (t, J 
= 7 Hz, 6H). 
13
C NMR (125 MHz, CDCl3, ppm) δ: 158.99, 132.83, 115.54, 
114.52, 87.96, 68.09, 31.59, 29.19, 25.71, 22.59, 14.02. 
1,2-Bis(4-(hexyloxy)phenyl)ethane-1,2-dione (5). To a solution of 
1,2-bis(4-(hexyloxy)phenyl)ethyne (2.5 g, 6.6 mmol) in dichloromethane (20 
mL) was added tetrabutylammonium bromide (100 mg, 0.31 mmol), NaHCO3 
(1.2 g, 14.3 mmol), KMnO4 (3.3 g, 20.9 mmol) and water (40 mL). The 
mixture was vigorously stirred at room temperature for 2 days, then sodium 
bisulfite (8 g) and hydrochloric acid (10 mL) were subsequently added. The 
mixture was extracted with dichloromethane and washed with water, and the 
organic phase was dried over MgSO4. After solvent removal, the residue was 
purified by silica gel column chromatography (hexane/ethyl acetate = 19/1) to 
Chapter 5 
113 
afford white solid (2.5 g, yield: 92%). 
1
H NMR (500 MHz, CDCl3, ppm) δ: 
7.92 (d, J = 8.5 Hz, 4 H), 6.94 (d, J = 8.5 Hz, 4 H), 4.03 (t, J = 7 Hz, 4 H), 
1.80 (m, 4 H), 1.46 (m, 4 H), 1.34 (m, 4 H), 0.91 (t, J = 7 Hz, 6 H). 
13
C NMR 
(125 MHz, CDCl3, ppm) δ: 193.56, 164.50, 132.35, 126.13, 114.72, 68.48, 
31.50, 28.98, 25.60, 22.56, 13.99. 
4,7-Dibromo-5,6-dinitrobenzo[1,2,5]thiodiazole (6). To a mixture of 
sulphuric acid (10 mL) and nitric acid (70%, 10 mL) at 0 
o
C was added 4,7-
dibromo-2,1,3-benzothiodiazole (2 g, 6.8 mmol). After stirring at 100 
o
C 
overnight, the mixture was cooled down to room temperature and poured into 
ice-water (100 mL), followed by addition of sodium hydroxide solution to 
neutralize the excess acid. The precipitate was filtered and washed with water. 
The crude product was purified by silica gel column chromatography 
(hexane/dichloromethane = 8/2) to afford white solid (522 mg, yield: 20%). 
MS: m/z = 383.9. 
5,6-Dinitro-4,7-di(thiophen-2-yl)benzo[1,2,5]thiadiazole (7). This 
compound was prepared with modified procedures according to previous 
reports.
1
 In brief, a solution of 4,7-dibromo-5,6-dinitro-benzothiadiazole (250 
mg, 0.65 mmol), 2-(tributylstannyl)thiophene (971 mg, 2.6 mmol) and 
dichlorobis(triphenylphosphine)palladium (45 mg, 0.65 mmol) in anhydrous 
THF was heated to 80 
o
C under argon atmosphere. The mixture was allowed at 
80 
o
C overnight. After the solvent removal, the residue was purified by silica 
gel column chromatography (hexane followed by hexane/dichloromethane = 
7:3) to afford 5,6-dinitro-4,7-di(thiophen-2-yl)benzo[1,2,5]thiadiazole as 
orange solid (230 mg, yield : 90.7%). 
1
H NMR (500 MHz, CDCl3, ppm) δ: 




(8). This compound was prepared with modified procedures according to 
previous reports.
2
 In brief, a solution of 5,6-dinitro-4,7-di(thiophen-2-
yl)benzo[1,2,5]thiadiazole (230 mg, 0.59 mmol) in DMF (20 mL) was heated 
to 60 
o
C. The mixture was added N-bromosuccinimide (215 mg, 1.21 mmol) 
in one portion. Another portion of NBS (215 mg, 1.21 mmol) was added after 
1 h. 2 h later, TLC indicates all the starting material was completely consumed, 
and only one new spot appeared. The reaction mixture was cooled down to 
room temperature and poured into water. The collected precipitation was 
washed with methanol twice to afford 4,7-bis(5-bromothiophen-2-yl)-5,6-
dinitrobenzo[1,2,5]thiadiazole as orange solid (274 mg, yield: 85%). 
1
H NMR 
(500 MHz, CDCl3, ppm) δ: 7.29 (d, J = 4 Hz, 2 H), 7.22 (d, J = 4 Hz, 2 H). 
4,9-Bis(5-bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5] 
thiadiazolo[3,4-g]quinoxaline (9). A mixture of 4,7-bis(5-bromothiophen-2-
yl)-5,6-dinitrobenzo[1,2,5]thiadiazole (300 mg, 0.55 mmol) and fine iron 
powder (368 mg, 6.5 mmol) in acetic acid (20 mL) was heated to 80 
o
C. After 
6 h, the mixture was cooled down to room temperature and filtered off. The 
filtration was mixed with 1,2-bis(4-(hexyloxy)phenyl)ethane-1,2-dione (225 
mg, 0.55 mmol) and stirred at 135 
o
C under argon atmosphere for 24 h. After 
removing the solvent, the residue was washed with methanol. The 
precipitation was purified by silica gel column chromatography 
(hexane/dichloromethane = 7/3) to afford compound M3 as black-green solid 
(241 mg, yield: 51%). 
1
H NMR (500 MHz, CDCl3, ppm) δ: 8.83 (d, J = 4 Hz, 
2 H), 7.70 (d, J = 8.5 Hz, 4 H), 7.21 (d, J = 4 Hz, 2 H), 6.96 (d, J = 8.5 Hz, 4 
H), 4.05 (t, J = 6.5 Hz, 4 H), 1.85 (m, 4 H), 1.54 (m, 4 H), 1.38 (m, 8 H), 0.93 
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(t, J = 7 Hz, 6 H).
 13
C NMR (125 MHz, CDCl3, ppm) δ: 160.63, 153.01, 
150.67, 137.32, 133.79, 133.05, 132.50, 129.94, 129.40, 120.21, 119.46, 
114.11, 68.19, 31.68, 29.30, 25.81, 22.66, 14.09. 
Poly[9,9-bis(4-(2-ethylhexyl)phenyl)fluorene-alt-co-6,7-bis(4-
(hexyl-oxy)phenyl)-4,9-di(thiophen-2-yl)thiadiazoloquinoxaline] (PFTTQ). 
A Schlenk tube was charged with 4,9-bis(5-bromothiophen-2-yl)-6,7-bis(4-
(hexyloxy)phenyl)-[1,2,5]thiadiazolo[3,4-g]quinoxaline (100.0 mg, 0.116 
mmol), 2,7-bis(4,4,5,5-tetramethyl-1,3,3-dioxaboralan-2-yl)-9,9-bis(4-(2-
ethylhexyloxy)phenyl)fluorene (95.8 mg, 0.116 mmol), palladium acetate (3 
mg) and tricyclohexylphosphine (7 mg) in toluene (10 mL) before it was 
sealed with a rubber septum. The Schlenk tube was degassed with three 
freeze-pump-thaw cycles to remove air. After the mixture was heated to 80 
o
C, 
an aqueous Et4NOH solution (20 wt%, 1.5 mL) was added to initiate the 
reaction. After 18 h, the reaction was stopped and cooled down to room 
temperature. The mixture was dropped slowly into methanol (100 mL) to 
precipitate the crude polymer followed by centrifugation. The crude polymer 
was subsequently redissolved in chloroform (200 mL), washed with water 3 
times, and dried over MgSO4. After solvent removal, the polymer (45 mg, 
yield: 30%) was obtained as a black-green solid by precipitation in methanol. 
1
H NMR (500 MHz, CDCl3, ppm) δ: 9.00 (br, 4 H), 7.81‒7.14 (br, 14 H), 6.80 
(br, 8 H), 3.98 (br, 4 H), 3.78 (br, 4 H), 1.83 (br, 4 H), 1.67 (br, 2 H), 
1.50‒1.26 (br, 28 H), 0.93‒0.85 (br, 18 H). 
5.2.5 Synthesis of PFTTQ NPs  
A THF solution (1 mL) containing DSPE-PEG2000 (1.5 mg), and 
PFTTQ (1 mg) was poured into water (10 mL). This was followed by 
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sonicating the mixture for 2 minutes at 12 W output using a microtip probe 
sonicator (XL2000, Misonix Incorporated, NY). The mixture was then stirred 
at room temperature overnight to evaporate the organic solvent. The NP 
suspension was further purified with a 0.2 µm syringe filter to obtain PFTTQ 
NPs. 
5.2.6 Synthesis of Au NRs  
Au NRs was synthesized by a seed-mediated growth approach 
following the previous reports.
[280]
 Briefly, Au NP seed was prepared by 
rapidly injecting NaBH4 (0.01 M, 0.6 mL) in a mixture of HAuCl4 (0.01 M, 
0.25 mL) and cetyltrimethylammonium bromide (CTAB, 0.1 M, 9.75 mL). 
After stirring for 5 mins, the obtained brownish solution was kept for at least 2 
h at room temperature before being used as the seed. To grow Au NRs, 2 mL 
of HAuCl4 and 400 mL of AgNO3 were added into 40 mL of 0.1 M CTAB 
under gentle stirring. Subsequently, 0.8 mL of 1.0 mL HCL was added, 
following with 0.32 mL of 0.1 M ascorbic acid. Next, 8 μL of the seed 
solution were injected in the mixture and gentle stirred for another 5 mins. The 
reaction mixture was then left undisturbed overnight to get Au NRs. 
5.2.7 Cytotoxicity of PFTTQ NPs  
NIH/3T3 fibroblast cells were cultured in DMEM containing 10% fetal 
bovine serum and 1% penicillin streptomycin at 37 °C in a humidified 
environment containing 5% CO2. The metabolic activity of NIH/3T3 
fibroblast cells was evaluated using MTT assays. NIH/3T3 cells were seeded 





24 h incubation, the medium was replaced by PFTTQ NP suspensions at 
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different mass concentrations, and the cells were then incubated for another 24 
h. After the designated time interval, the wells were washed twice with 1 × 
PBS and 100 µL of freshly prepared MTT (0.5 mg·mL
-1
) solution in culture 
medium was added into each well. The MTT medium solution was carefully 
removed after 3 h incubation in an incubator. DMSO (100 µL) was then added 
into each well and the plate was gently shaken for 10 minutes at room 
temperature to dissolve all the precipitates formed. The absorbance of MTT at 
570 nm was monitored by the microplate reader (Genios Tecan) after 
subtracting the absorbance of the corresponding control cells incubated with 
PFTTQ NPs at the same concentration but without the addition of MTT to 
eliminate the absorbance interference from PFTTQ. Cell viability was 
expressed by the ratio of absolute absorbance of the cells incubated with NP 
suspensions to that of the cells incubated with culture medium only. 
5.2.8 Photostability of PFTTQ NPs and Au NRs 
The photostability of PFTTQ NPs as well as Au NRs was investigated 
by monitoring their respective UV-vis absorption intensity changes after pulse 
laser irradiation for different time intervals. At designed time interval, the UV-
vis absorption intensity of the NP suspension was measured with the 
spectrometer, which was further expressed by I/I0, where I0 is the absorption 
intensity at 800 nm of fresh NP suspension and I is that of NPs after 
irradiation, respectively. 
5.2.9 In Vivo PA Brain Vascular Imaging 
The experimental setup for brain vasculatur imaging using dark-field 
strong-focusing PAM is described elsewhere in detailed.
[251,281]
 Male Sprague 
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Dawley rats weighing 250 to 300 g each were used for PA imaging. The 
animals were housed at a constant temperature and humidity with free access 
to food and water. Before the imaging experiment, the rats were fasted for 24 
hours but given water ad libitum. All animal experiments were conducted in 
accordance with the guidelines of the Animal Research Committee of National 
University of Singapore. The animals were initially anesthetized with 3% 
isoflurane. Supplemental α-chloralose anesthesia (70 mg∕kg) was injected 
intraperitoneally as needed. The anesthetized rats were mounted on a custom 
built acrylic stereotaxic head holder, and the skin and muscle were cut off to 
expose the bregma landmark. The anteroposterior distance between the 
bregma and the interaural line was surveyed directly. Furthermore, the 
craniotomy was performed for each animal and the bilateral cranial window 
with approximately 6 (horizontal) × 3 (vertical) mm size was fashioned with a 
high-speed drill. The interaural and bregma references were then used to 
position the heads in the fPAM system without additional surgery in following 
experiments. Quantitative data were expressed as mean ± SD. Statistical 
comparisons were made by ANOVA analysis and Student’s t-test. P value < 
0.05 was considered statistically significant. 
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5.3 Results and Discussion 
5.3.1 Synthesis and Characterization of PFTTQ 
 
Scheme 5.1 Synthetic route and chemical structure of PFTTQ. Reagents and 
conditions: I) KOH, 1-bromohexane, H2O, 100 
o
C, 1 h; II) CuI, Pd(PPh3)2Cl2, 
trimethylsilylaceylene, i-Pr2NH/THF, room temperature, overnight; III) KOH, 
THF/MeOH/H2O, room temperature, 1 h; IV) CuI, Pd(PPh3)2Cl2, 1, i-
Pr2NH/THF, room temperature, overnight; V) KMnO4, NaHCO3, TBAB, 
CH2Cl2, room temperature, 2 days; VI) H2SO4, HNO3, 100 
o
C, overnight; VII) 
Pd(PPh3)2Cl2, 2-(tributylstannyl)thiophene, THF, 80 
o
C, overnight; VIII) NBS, 
DMF, 60 
o
C, 3 h; IX) i) Iron, acetic acid; ii) acetic acid, 135 
o
C, 24 h; X) 
Pd(OAc)2, Cy3P, Et4NOH, toluene, 18 h. 
PFTTQ was synthesized by Suzuki polymerization between 4,9-bis(5-
bromothiophen-2-yl)-6,7-bis(4-(hexyloxy)phenyl)-[1,2,5]thiadiazolo [3,4-




bis(4-(2-ethylhexyloxy)-phenyl)fluorene 10 in 57% yield. The synthetic route 
toward the monomer 9 is illustrated in Scheme 5.1. 1-Hexyloxy-4-
iodobenzene 1 was synthesized in 91% yield through alkylation of 4-
iodophenol in 50% KOH aqueous solution. Sonogashira reaction between 1 
and trimethylsilylaceylene was performed in the presence of CuI/Pd(PPh3)2Cl2 
to yield ((4-(hexyloxy)phenyl)-ethynyl)trimethylsilane 2 in 95% yield, which 
was followed by hydrolysis under alkaline conditions to afford 1-ethynyl-4-
(hexyloxy)benzene 3 in 95% yield. The Sonogashira reaction between 1 and 3 
yielded 1,2-bis(4-(hexyloxy)phenyl)ethyne 4 as a white solid in 69% yield, 
which was oxidized in the presence of KMnO4 to afford 1,2-bis(4-
(hexyloxy)phenyl)ethane-1,2-dione 5 in 92% yield. 4,7-Dibromo-5,6-
dinitrobenzo[1,2,5]thiodiazole 6, 5,6-dinitro-4,7-di(thiophen-2-
yl)benzo[1,2,5]thiadiazole 7, and 4,7-bis(5-bromothiophen-2-yl)-5,6-
dinitrobenzo[1,2,5]thiadiazole 8 were prepared according to previous 
reports.
[282]
 5 and 8 were treated in reflux acetic acid to afford 9 in 51% yield. 
The chemical structures of the intermediates and PFTTQ were verified 
by 
1
H NMR. The correct structure of 1 was confirmed by the appearance of a 
triplet at 3.91 ppm for ‒OCH2(CH2)4CH3. The strong singlet at 0.29 ppm for 2 
is attributed to ‒CCSi(CH3)3, and the integrated area ratio between peaks at 
0.29 ppm and 3.94 ppm (‒OCH2(CH2)4CH3) is calculated to be 4.5, which 
suggests the correct structure of 2. After hydrolysis, the ethynyl proton of 3 is 
observed at 3.00 ppm, which disappears in the 
1
H NMR spectrum of 4 due to 
the successful coupling reaction between 3 and 1. Compared to 4, the aryl 
protons of 5 are shifted toward downfield due to the presence of dione, which 
reduces electron density. As compared to the 
1
H NMR spectra of 9 and 10, the 
Chapter 5 
121 
broaden signals for PFTTQ are another evidence of successful polymerization. 
GPC results reveal that PFTTQ has a number-average molecular weight (Mn) 
of 12900. It is found that PFTTQ can be easily soluble in nonpolar organic 
solvent, such as toluene, tetrahydrofuran, dichloromehtane, etc. 
5.3.2 Preparation of PFTTQ NPs 
 
Scheme 5.2 Schematic illustration of the fabrication of PFTTQ NPs using 
DSPE-PEG2000 as the matrix through a precipitation method.  
PFTTQ NPs were synthesized through a modified precipitation method 
using DSPE-PEG2000 as the matrix (Scheme 5.2).
[173,228]
 A THF solution 
containing PFTTQ as well as the matrix of DSPE-PEG2000 was poured into 
water under sonication. The hydrophobic DSPE segments tend to entangle 
with PFTTQ chains and the hydrophilic PEG chains extend into aqueous 
phase under sonication. The NP suspension was obtained after THF 
evaporation under stirring overnight. The NP suspension was further purified 




Scheme 5.3 Experimental setup of the PAM system. The pulled tubing was 
filling with the venous samples in the focusing depth. The laser was pulsed 
with a pulse repetition rate of 10 Hz and coupled by a lens to an optical fiber 
to illuminate samples. PA waves were detected with a 50-MHz transducer and 
then through the A/D card to the PC for further data analysis. 
 
Figure 5.1 (A) UV-vis absorption spectra and (B) PA imaging as well as the 
PA intensity of PFTTQ NPs and Au NRs with same mass, the scale bar is 100 
µm. (C) The PA intensity of PFTTQ NPs at concentrations from 0.05 mg/mL 










































Figure 5.1 shows the UV-vis absorption spectrum of PFTTQ NP 
suspensions in water. The absorption band at 425 nm should result from π‒π* 
transition of the conjugated backbone, while the broad absorption spectrum 
from 700 to 850 nm arises from charge transfer between the fluorene (donor) 
units and the thiadiazolo-quinoxaline (acceptor) units. As we know, Au 
nanorods (NRs) show high extinction coefficient in NIR range, which have 
been widely applied to PA imaging with relatively high PA intensities.
[266]
 To 
evaluate the photophysical and PA signals of PFTTQ NPs, Au NRs with an 
extinction maximum at ~805 nm have been synthesized according to the seed-
mediated approach.
[280]
 The absorption coefficient of PFTTQ NPs is calculated 
to be 3.6 L/g·cm based on mass concentration, which is around 26% of that of 
Au NRs (13.9 L/g·cm).
[283]
  
The PA intensities of PFTTQ NPs and Au NRs under the same mass 
are evaluated using a non-absorbing polyethylene tube and a 50-MHz dark 
field confocal PAM system to collect the images (Scheme 5.3). To eliminate 
the absorbance influence of PFTTQ NPs and Au NRs on their PA generation 
capacity, their concentrations were adjusted so that they have the same 
absorbance at 800 nm (Figure 5.1A). Under this condition, PFTTQ NPs show 
a higher PA intensity as compare to that of Au NRs as shown in Figure 1b. 
Although the absorption intensity of PFTTQ NPs is only one quarter of the 
same mass amount of Au NRs, PFTTQ NPs still shows higher PA intensity in 




Figure 5.2 (A) UV-vis absorption spectra and (B) PA imaging as well as the 
PA intensity of PFTTQ NPs and Au NRs, the scale bar is 100 µm. 
To eliminate the absorbance influence of PFTTQ NPs and Au NRs on 
their PA generation capacity, their concentrations are adjusted so that they 
have the same absorbance at 800 nm (Figure 5.2A). Under this condition, 
PFTTQ NPs show a higher PA intensity as compare to that of Au NRs as 
shown in Figure 5.2B. This result further demonstrates that the PFTTQ NPs 
have stronger capacity to generate PA signal as compare to Au NRs.  It is 
worth noting that almost no NIR fluorescence from PFTTQ NPs are detected 
upon excitation at 800 nm, illustrating that most of the excited excitons return 
to the ground state via the non-radiative decay pathway. It is generally 
believed that large intrinsic extinction coefficient and high non-radiative QY 
(which is obtained by 1 – QY) are the two determining factors for organic 
materials to facilitate their PA signal generation.
[246,261]
 The strong PA signals 
from PFTTQ NPs should result from their large absorption coefficient and 
high non-radiative QY.
[246]
 Moreover, the PA intensities of PFTTQ NPs 
increase linearly with NP concentrations in aqueous medium as shown in 
Figure 5.1C. PFTTQ NPs show an average size of 50 ± 10 nm observed from 
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FE-TEM. The dark contrast of NPs results from the high electron density of 
PFTTQ chains (Figure 5.3C1). On the other hand, they show a hydrodynamic 
average effective diameter of 80 ± 20 nm, which should result from the 
extension of hydrophilic PEG chains at NP surfaces. 
5.3.3 Photostability Investigation of PFTTQ NPs 
Excellent NP stability in aqueous media is essentially important for biological 
applications, particularly in long-term studies. As such, the photostability of 
PFTTQ NPs as well as the conventional PA contrast, Au NRs, were 
investigated by monitoring their absorbance changes upon continuous laser 
irradiation at a power density of 15 mJ/cm
2
 for different time. As shown in 
Figure 5.3A, the absorbance intensity of PFTTQ NPs decrease around 17% 
after 10 mins pulse laser irradiation. On the contrary, Au NRs decrease more 
than 80% of their NIR absorption intensity at the same condition. Figure 5.3B 
shows that no obvious damage for the absorption spectrum of PFTTQ NPs; 
whereas the NIR absorption profile of Au NPs greatly decrease and the 
absorption intensity at ~520 nm increase upon laser irradiation for only 6 mins. 
Their respective morphology changes before and after laser irradiation were 
also studied by FE-TEM. As shown in Figure 5.3C, the PFTTQ NPs are kept 
well in sphere morphologies after laser irradiation. However, Au NRs are 
degraded and most of Au NRs are melted into Au NPs by pulse laser (Figure 
5.3D2). This result illustrates the excellent photostability of PFTTQ NPs as 
compared to Au NRs, benefiting long-term tracing of the obtained organic 
contrasts in biomedical studies. In addition, no obvious precipitation from the 
prepared PFTTQ NP suspensions was observed after being stored at 4 °C for 3 




Figure 5.3 (A) Absorbance intensity evolution of PFTTQ NPs and Au NRs 
upon continuous pulse laser irradiation with a power of 15 mJ/cm
2
 for 
different times, where I0 is the absorbance intensity at 800 nm for the fresh NP 
suspensions and I is that for NPs after irradiation for different time, 
respectively. (B) UV-vis absorption spectra of PFTTQ NPs and Au NRs 
before and after laser irradiation with a power density of 15 mJ/cm
2
 for 6 
mins. FE-TEM images of PFTTQ NPs (C) and Au NRs (D) before (1) and 




Figure 5.4 Metabolic viability of NIH/3T3 fibroblast cells after incubation 
with PFTTQ NP suspensions at various NP concentrations for 24 h. 
In addition to good photostability and physical stability, benign 
biocompatibility is also an important virtue to be considered for materials in 
biological applications. To evaluate the cytotoxicity of the PFTTQ NPs, the 
metabolic viability of NIH/3T3 fibroblast cells after incubation with NPs was 
investigated at different NP concentrations. Figure 5.4 shows the cytotoxicity 
results of the PFTTQ NPs upon incubation with NP suspensions at 50 to 500 
g/mL concentrations for 24 h. The cell viabilities remain ~90% upon 
incubation with the NP suspension at 500 µg/mL for 24 h, indicating their low 
cytotoxicity, which is ideal for biological studies. 
5.3.4 In Vivo Vasculature Imaging 
The application of PFTTQ NPs as PA contrast reagents in biological 
applications was demonstrated in conrtical vasculature imaging in living rat 
using PA microscopy at a 31 × 62 µm spatial resolution. As shown in Figure 


























Figure 5.5 (A) Schematic illustration of PA imaging for rat brain vasculature. 
(B) PA rat cortical vasculature C-scan images before and after 10 mins 
injection of PFTTQ NPs. (C) The evolution of the integrated PA intensity at 
the red line spot as a function of time.  
muscle were cut off from the skull to expose the bregma. The region of 
interest (indicated by the red line in Figure 5.5B), the superior sinus, was 
imaged at 800 nm before and after PFTTQ NP injection through retro-orbital. 
The images before PFTTQ NP injection as well as that after 10 mins 
administration of NPs are shown in Figure 5.5B. Only weak PA signals are 
collected from pure brain vessels, which may due to low absorption coefficient 
from hemoglobin at 800 nm. In contrary, the PA signal of blood vessels is 
greatly enhanced from circulating PFTTQ NPs upon NPs administration. The 
PA intensity is improved by ~3-fold after NP injection as compared to that 
before NP injection. The obvious differentiation of blood vessels and the brain 
parenchyma demonstrates the strong PA generation capacity of PFTTQ NPs, 
which should result from the large absorption coefficient and high non-
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radiative decay rate of PFTTQ NPs. Moreover, PA imaging of blood vessels 
remain similar resolution after 30 mins NP injection (Figure 5.5C), which may 
resulting from the suitable size as well as the PEG surface of the circulating 
PFTTQ NPs. 
5.4 Conclusion 
In this chapter, we have synthesized a CP as well as CP loaded NPs, 
PFTTQ NPs, and demonstrated their feasibility as an effective PA imaging 
probe in brain vasculature imaging. Due to the large conjugation system of 
PFTTQ chain, the obtained CP NPs show a large absorption coefficient in NIR 
range (700-850 nm). In addition, PFTTQ NPs shows weak fluorescence, in 
other word, high non-radiative QY, as a result of their charge transfer 
characteristic in their backbones. Both the large absorption coefficient and 
high non-radiative QY benefit the strong PA generation of PFTTQ in NP 
formulation. As a result, PFTTQ NPs even show higher PA intensity as 
compared to Au NR under the same absorbance condition. More importantly, 
PFTTQ NPs exhibit good photostability upon continuously pulse laser 
irradiation. In addition to their benign biocompatibility, PFTTQ NPs have 
been successfully applied in brain vasculature imaging with high PA contrast. 
Further conjugation PFTTQ NPs with specific targeting ligands could further 
broaden our probes in targeted biological imaging.
[267,284,285]
 Moreover, in 
view of their strong absorption coefficient and high non-radiative QY, PFTTQ 
NPs could also be applied in photothermal therapy,
[119,125,286,287]
 which may 





CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions 
CP NPs are emerging as attractive fluorescent probes in bioimaging 
due to the large extinction coefficient, strong luminescence signal, excellent 
photostability and benign biocompatibility. In these respects, CP NPs shows 
better performance as compared with the conventional organic dyes and QDs. 
Currently, CP NPs have been mainly fabricated through the emulsion method 
and the precipitation strategy. Unfortunately, CP NPs prepared by these 
approaches are mainly built up through weak hydrophobic interaction, 
resulting in their low structural stability in aqueous. In this thesis, we aimed to 
improve the performance of CP NPs in stability and fluorescent property as 
well as explore their bioimaging applications. 
Firstly, a new strategy has been developed to synthesize CP NPs with 
numerous surface hydroxyl groups via click chemistry between a CP (PFBT) 
and hyperbranched polyglycerol (HPG) in miniemulsion. DLS and FE-TEM 
characterizations indicate that the synthesized CP NPs have spherical shapes 
with uniform sizes tunable in the range of 40-210 nm simply by adjusting the 
feed amount of the oil phase or surfactant in the miniemulsion. The obtained 
CP NPs have good water dispersibility and orange emission with high 
fluorescence QYs of 23 %. Detailed spectroscopy studies reveal that the CP 
NPs have shown stable fluorescence against pH change, ionic strength 
variation, or protein disturbance. In addition, they have good photostability 
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and low cytotoxicity, which make them an ideal fluorescent moiety for cellular 
imaging. This study provides important fundamental understanding of cross-
linking modification on CP to form CP NPs. 
Secondly, we developed a one-step synthesis of CP embedded silica 
NPs with a SiO2@CP@SiO2 structure by combination of a precipitation 
approach and a modified Stöber method. Four types of CPs have been 
employed to demonstrate the versatility of the developed strategy, yielding 
fluorescent silica NPs with emission across the visible spectrum. The FE-TEM 
investigation reveal that the entanglement between hydrophobic CPs and the 
aminopropyl groups of 3-aminopropyl triethoxysilane contributes to the 
successful encapsulation of CPs into silica matrix. The synthesized NPs 
exhibit excellent physical stability and good photostability. In addition, they 
have amine groups on surfaces, which benefit further conjugation for 
biological applications. Through reaction with a peptide (GGHAHFG) that is 
specific to HER2 receptor, the synthesized NPs have been successfully applied 
for targeted cellular imaging of HER2-overexpressed SKBR-3 breast cancer 
cells. Along with its high QY and benign biocompatibility, the developed CP 
embedded silica NPs have a great potential for applications in biological 
imaging. 
Thirdly, taking PFBT as an example, we developed a one-step 
approach to synthesize PFBT loaded NPs with high fluorescence QY and large 
two-photon action cross section in aqueous medium through both micelle and 
silica co-protection strategy. PFBT NPs show a two photon absorption 
maximum of 814 GM at 810 nm and an emission maximum at 545 nm with a 
high fluorescence QY of 75%. The fluorescence lifetime investigation reveals 
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that the high fluorescence QY is mainly due to reduced polymer aggregation 
and minimized environment effect on CP fluorescence quenching. The 
synthesized PFBT NPs have shown good colloid stability and photostability as 
well as benign biocompatibility, which have been further applied to visualize 
the mouse brain vasculature through intravital two-photon excited brain 
vascular imaging with high contrast. The developed micelle/silica co-
protection strategy should be generally applicable to other CP NPs with 
improved brightness and stability for various biological applications.  
In addition to improve the performance of CP NPs in fluorescent 
imaging, we also explored their application in PA imaging. PA imaging is an 
emerging technique in biological imaging, which is able to provide high 
resolution and deep penetration depth. Exogenous contrast agents with strong 
NIR absorbance are highly desirable for PA imaging. In the fourth project, we 
synthesized PFTTQ by Suzuki polymerization, which shows strong absorption 
in the NIR range. Thanks to the processability of PFTTQ, it was further 
encapsulated into DSPE-PEG2000 matrix to yield PFTTQ loaded DSPE-
PEG2000 NPs (PFTTQ NPs). At the same mass or with the same absorbance at 
800 nm, PFTTQ NPs show stronger PA signal as compared to gold nanorods 
(Au NRs), one of the most widely used PA agent. In addition, PFTTQ NPs 
show much higher photostability in comparison with Au NRs upon laser 
irradiation. The obtained PFTTQ NPs has been successfully applied in rat 
brain vascular PA imaging. 
The developed strategies in this thesis efficiently improve the 
structural and mechanical stability of CP NPs. The detailed strategies are 
defined as HPG cross-linking, silica coating, silica and micelle co-protection. 
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In addition, they have been successfully applied in fluorescent biological 
imaging (e.g. cellular imaging, targeted cellular imaging and vascular 
imaging) with good performance. Moreover, these strategies could be 
generally explored to other CPs to improve their fluorescent performance and 
optimize their biological applications. Furthermore, to broaden the imaging 
modality of CP NPs, CP with strong NIR absorption and low fluorescence QY 
has also been synthesized followed by NP formulation. Thanks to the high 
non-radiative QY, the obtained CP NPs have shown strong PA signal in rat 
vasculature imaging. From the customized viewpoint, the CP NPs with desired 
optical properties and specific imaging modalities could be fine-tuned by 
choosing the suitable CPs. This project thus provides a new avenue to 
synthesize CP NPs for biological applications. 
6.2 Recommendations 
Based on the obtained results in this thesis, some future investigations 
are recommended to further optimize and broaden the application of CP NPs.  
Stable CP NPs have been successfully fabricated and applied in 
biological imaging in this thesis. However, the current application of CP NPs 
is limited in in vitro or in vivo subcutaneous model (tumour, blood vessel). 
This is due to the intrinsic drawback of fluorescence imaging, in which both 
absorption and emission lights could be largely absorbed and scattered by 
biological tissues. One approach to overcome this limitation is to fabricate 
multifunctional nanocomposites, which could integrate fluorescence imaging 
with other modalities to provide multiple signals. As well known, magnetic 
NP or gadolinium (Gd) based magnetic resonance imaging (MRI) can provide 





 On the other hand, as mentioned above, CP NP based fluorescence 
imaging could offer good resolution in in vitro subjects but poor penetration 
depth. Integration CP NPs with magnetic NPs or Gd based agents can 
simultaneously combine the advantages of both fluorescence imaging and 
MRI. For example, the cross-linked CP NPs (Chapter 2) have many free 
hydroxyl groups at surface, which could further react with 
diethylenetriaminepentaacetic acid for chelating with Gd to afford CP-Gd 
nanocomposites. In addition, magnetic NPs could be firstly covered with silica 
shell and further encapsulated CP dots at silica surface utilizing SiO2-CP-SiO2 
formulation (Chapter 3) to build Magnetic NP-SiO2-CP-SiO2 nanocomposites 
for multifunctional imaging. These multifunctional probes should facilitate 
both in vitro detection and deep in vivo cancer diagnosis. 
Another approach to conquer the restriction of low penetration depth of 
CP NP based optical imaging is to explore new imaging modalities by 
synthesizing CPs with unique properties. As an emerging non-invasive 
imaging modality, PA imaging has attracted great research interest in view of 
the deeper penetration depth in in vivo condition. As low absorption 
coefficient of most biological targets in the NIR range, only weak PA signal 
could be detected.
[253,265]
 As such, exogenous contrast agents with high PA 
generation capacity and good selectivity to targets are highly desirable. In 
view of large absorption coefficient and excellent stability, CP NPs have great 
potential to be applied as PA contrast agents. Our preliminary result (Chapter 
5) shows that CP NP based exogenous contrasts could provide high PA signal 
in in vivo condition. However, the relationship between CP structure and PA 
signal generation needs to be further investigated. In addition to the 
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development of CP based PA contrast agents, designing CP NPs with both 
fluorescence and PA signals may provide an advantageous nanoplatform for 
dual-modality imaging. Since fluorescence signal could provide high 
resolution and PA signal could endow deep penetration depth, complementary 
information from biological system could be obtained utilizing the designed 
multifunctional nanoplatform.  
The third important aspect deserved to be investigated is the toxicity 
and clearance of CP NPs in in vivo condition. So far, CP NPs have shown 
good biocompatibility in both in vitro and in vivo conditions based the 
fluorescence imaging modality. Although no obvious toxicity for CP NPs has 
been observed on H&E staining in many reports, their long term toxicities in 
in vivo condition have been less studied.
[288]
 In addition, the clearance time of 
CP NPs is hard to obtained only based on the fluorescence imaging. The PA 
signal from CP or integration CP NPs with other functional materials may 
provide new opportunities to study the clearance of CP NPs. For example, 
integration CP NPs with Gd could help to determine the residue amount of Gd 
in organs based on the ICP technique. This will no doubt help to determine the 
fate of CP based materials in in vivo condition.  
Finally, synthesizing CP based theranostic NPs is also an interesting 
topic.
[123,258,263]
 The materials with high extinction coefficient and low 
fluorescence QY could produce heat upon laser irradiation since most excited 
electrons return to ground state through non-radiative decay pathway. Several 
reports have shown that CP NPs could be utilized in PTT.
[121,124]
 On the other 
hand, the similar materials with large absorbance and low QY have been 
utilized in PA imaging.
[12]
 As such, there is a great potential to achieve both 
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imaging and therapeutic function with the same CP NPs. For example, PFTTQ 
NPs have shown high PA intensities in in vivo condition. In addition, they 
could also produce heat upon NIR laser irradiation. Conjugation of CP NPs 
with specific targeting ligands could endow PFTTQ NPs with good targeted 
capacity to specific cancer cell or tumor. The PA signal may help to track the 
location of PFTTQ NPs. When NPs arrived at tumor, therapy treatment would 
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